–{•¶‚ÖƒXƒLƒbƒv

ŽRŒ`Œ§‰q¶Œ€‹†Š‚ÍŒ§–¯‚ÌŠF—l‚ÌŒ’N‚ƈÀ‘S‚Ì‚œ‚߂Ɋˆ“®‚µ‚Ä‚¢‚Ü‚·B

TEL. 023-627-1358

§990-0031 ŽRŒ`Œ§ŽRŒ`Žs\“ú’¬1-6-6

”÷¶•š•”Dept. of Microbiology

Žå‚È”­•\ŽÀÑˆê——


”÷¶•š•”‚Å‚ÍAŠŽõÇ–@‚Ȃǂ̖@—¥‚ÉŠî‚­•aŒŽ‘̂̌ŸžE‰ðÍi’nˆæ‚ÌŒöO‰q¶‚ðŽç‚éŽæ‚è‘g‚݁jˆÈŠO‚ɁA‚»‚ê‚猟žE‰ðÍ‚ð’Ê‚¶‚Ä“Ÿ‚ç‚ꂜV‚œ‚È’mŒ©‚ðAŠw‰ï”­•\A˜_•¶•ñ‚Ȃǂ̂©‚œ‚¿‚ÅŠO•”‚ÉŒö•\‚µ‚Ä‚¢‚Ü‚·i’nˆæ‚ɂƂç‚í‚ê‚È‚¢ŒöO‰q¶Œüã‚Ì‚œ‚߂̎æ‚è‘g‚݁jBê–å“I‚ɂ͂Ȃè‚Ü‚·‚ªAˆÈ‰º‚É‚±‚ê‚܂ł̎å‚È”­•\‹ÆÑ‚ðŽŠ‚µ‚Ü‚·B
R8”N“x R7”N“x R6”N“x R5”N“x R4”N“x R3”N“x R2”N“x R1”N“x H30”N“x H29”N“x H28”N“x H27”N“x H26”N“x H25”N“x H24”N“x H23”N“x H22”N“x H21”N“x H20”N“x H19”N“x H18”N“x H17”N“x H16”N“x H15”N“x H14”N“x H13”N“x H12”N“x H11”N“x
ƒtƒŠ[ƒAƒNƒZƒX‚ÌŽGŽ‚ɂ͂ð•t‚¯‚Ä‚¢‚Ü‚·B
ƒgƒbƒvƒy[ƒWw‰qŒ€‚©‚ç‚Ì‚š’m‚点x‚©‚ç–K–â‚¢‚œ‚Ÿ‚¢‚œ•û‚́A‚Ì’†‚©‚ç–Ú“I‚̘_•¶‚ð‚š’T‚µ‚­‚Ÿ‚³‚¢B

—ߘa8”N“xi2026”N4ŒŽ-2027”N3ŒŽj

\R8˜_•¶”­•\“™\

  1. Matoba Y, Ogawa N, Takahashi T, Komabayashi K, Ikeda T, Matsuzaki Y, Mizuta K. Seroprevalence of coronavirus NL63 in Yamagata, Japan between 1976 and 2022. Can J Infect Dis Med Microbiol. 2026;7854122.

  2. Seto J, Lee K, Matoba Y, Izumiya H, Suzuki M, Ikeda T, Mizuta K, Sugawara Y, Sugai M, Akeda Y, Iyoda S. Food poisoning from raw horse meat contaminated with Shiga toxin-producing Escherichia coli O157 linked to nationwide spread of closely related strains, Japan, 2023. Microbiol Spectr. 2026;14:e04115-25.

  3. –ì’† ŠîO, ‰““¡ ‹M”V, ›ˆä “§, £ŒË ‡ŽŸ, ‘åŠÑ “TŽq. ‚Æ’{ê”À“ü”n‹y‚Ñ‹‚É‚š‚¯‚éŽu‰ê“Å‘fŽY¶«‘å’°‹Û•ۋۏ󋵒²ž. “ú–{bˆãŽt‰ïŽGŽ. 2026;79:158-161.

  4. £ŒË‡ŽŸC˜a“c’”VC–ì–{—³•œCˆÀˆä‘PGCì£…C—„’J—Y—ºCâãˆŸŠóŒbC…“cŽ–€C‹g‘º˜a‹vC’叡Œ’Žu. ’n•û‰q¶Œ€‹†Š‚É‚š‚¯‚é•aŒŽ‘̃Qƒmƒ€ƒf[ƒ^‰ðÍ‘S‘Œ€C‰ï‚̐¬‰Ê‚Æ“W–]. “ú–{ŒöO‰q¶ŽGŽ. 2026i‘ŠúŒöŠJ’†j.

  5. Seto J, Wada T, Murase Y, Mitarai S, Ikeda T, Mizuta K, Ahiko T. A hypothesis-generating study of collateral reactivation: a reanalysis of Mycobacterium tuberculosis genomes from 119 recurrent tuberculosis cases.J Infect Chemother. 2026;32:103109.

  6. Takumi-Tanimukai Y, Yamamoto S, Yoshida Y, Takahashi T, Takasawa A,Katsuyama A, Nishimaki T, Maeda H, Mizuta K, Idogawa M, MitsuhashiY, Takayanagi Y, Lokupathirage SMW, Yoshida K, Yamamoto K, Kakuki T, Jitsukawa S, Sato T, Sawa H, Orba Y, Sato A, Kojima T, Kamitani W, Ichikawa S, Nosaka T, Takano K, Yokota S, Ogasawara N. Sparfloxacin reveals a host-virus dual target antiviral scaffold against respiratory syncytial virus. Communications Biology. 2026;9:1434.

\R8Šw‰ï”­•\\

  1. …“cŽ–€A“Iê—m•œA¬ì’Œ”üAûü‹Ž’qŽqA‹î—ÑŒ«ˆêA’r“c’C–çAŒ›œ—tŽqF1976`2022”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒRƒƒiƒEƒCƒ‹ƒXNL63‚ÌŒŒŽ‰uŠwA‘æ78‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïEŠwpW‰ïA2026”N8ŒŽ20|21“úi‰—å‘äj

  2. …“cŽ–€A“Iê—m•œA¬ì’Œ”üAûü‹Ž’qŽqA‹î—ÑŒ«ˆêA’r“c’C–çAŒ›œ—tŽqF1976`2022”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒRƒƒiƒEƒCƒ‹ƒXNL63‚ÌŒŒŽ‰uŠwA‘æ30‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ïA‘æ67‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2026”N9ŒŽ26-27“úi‰—VŠƒj

  3. £ŒË‡ŽŸA˜a“c’”VA–ì–{—³•œAˆÀˆä‘PGAì£…A—„’J—Y—ºAâãˆŸŠóŒbA…“cŽ–€A‹g‘º˜a‹vA’叡Œ’ŽuF’n•û‰q¶Œ€‹†Š‚É‚š‚¯‚é•aŒŽ‘̃Qƒmƒ€ƒf[ƒ^‰ðÍ‘S‘Œ€C‰ï‚̐¬‰Ê‚Æ“W–]A‘æ85‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïA2026”N10ŒŽ29|31“úi‰—“Œ‹žj

    —ߘa7”N“xi2025”N4ŒŽ-2026”N3ŒŽj

    \R7˜_•¶”­•\“™\

    1. Matsuu A, Tatemoto K, Ishijima K, Nishino A, Inoue Y, Park E, Tamatani H, Seto J, Higashi H, Fukui Y, Noma T, Doi K, Nakashita R, Isawa H, Kasai S, Maeda K. Oz virus infection in 6 animal species, including macaques, bears, and companion animals, Japan. Emerg Infect Dis. 2025;31:720-727.

    2. Takashita E, Morita H, Nagata S, Fujisaki S, Miura H, Ikeda T, Komabayashi K, Sasaki M, Matoba Y, Takahashi T, Ogawa N, Mizuta K, Ito S, Kishida N, Nakamura K, Shirakura M, Watanabe S, Hasegawa H. Influenza A(H1N1)pdm09 virus with reduced susceptibility to baloxavir, Japan, 2024. Emerg Infect Dis. 2025;31:1019-23.

    3. Virhuez-Mendoza M, Ishijima K, Tatemoto K, Kuroda Y, Inoue Y, Nishino A, Yamamoto T, Uda A, Hotta A, Kabeya H, Shimoda H, Suzuki K, Komiya T, Seto J, Iwashina Y, Hirano D, Sawada M, Yamaguchi S, Hosaka F, Maeda K. Recent hepatitis E virus infection in wild boars and other ungulates in Japan. Viruses. 2025;17:524.

    4. Yamamoto K, Takeuchi S, Nakaya N, Fujiwara N, Seto J, Komukai J, Tsuda Y, Yoshida H, Wada T. Geodemographic analysis of socioeconomic area disparities in tuberculosis incidence in Osaka City, Japan. Sci Rep. 2025;15:15968.

    5. Matsuzaki Y, Sugawara K, Kadowaki Y, Kidoguchi Y, Shimotai Y, Mizuta K. Characterization of antigenically dominant regions in the hemagglutinin protein of B/Victoria-lineage influenza B virus using monoclonal antibody escape mutants. Virus Res. 2025;358:199598.

    6. Komabayashi K, Chikaoka S, Awano H, Abe A, Sendo D, Furuyama M, Kitamura M, Tanabe S, Wada M, Ogawa N, Sasaki M, Aoki Y, Matoba Y, Seto J, Ikeda T, Mizuta K. Parechovirus A3 infections, including myalgia, in Yamagata, Japan between 2022 and 2023 and their next-generation sequencing analyses. Jpn J Infect Dis. 2026:79:76-90.

    7. Tsukagoshi H, Nagashima M, Takahashi K, Mizuta K, Ikeda T, Shimada R, Kawase A, Shinomiya H,Okamoto-Nakagawa R, Shirabe K, Kaburagi Y, Ichikawa H, Taguchi M, Abe S, Saruki N. Phylogenetic analysis of the VP1 coding region of CA6 detected in hand-foot-and-mouth disease during surveillance from 2019 to 2024 in Japan. Jpn J Infect Dis. 2026;79:72-75.

    8. Seto J, Inoue S, Abe S, Terashita K, Endo Y, Fujii S, Sasaki Y, Kato Y, Yamashita H, Murase Y, Mitarai S, Ikeda T, Mizuta K, Ahiko T, Wada T. A case of endogenous and collateral reactivation caused by two Mycobacterium tuberculosis subclones. J Infect Chemother. 2025;31:102795.

    9. Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Kishida N, Nakamura K, Shirakura M, Sato A, Akimoto M, Sugawara H, Mitamura K, Abe T, Ichikawa M, Yamazaki M, Watanabe S, Odagiri T, Hasegawa H, the Influenza Virus Surveillance Group of Japan. Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24. Eurosurveillance 31; Issue 1, 08/Jan/2026 Article.

    10. Taniguchi I, Morimoto Y, Kimura Y, Seto J, Kawai Y, Kitahashi T, Aoki J, Terai K, Furuta T, Wakabayashi Y, Tanabe S, Hamasaki M, Abe Y, Sasaki M, Narimatsu H, Yokoyama E, Iyoda S, Hayashi T, Nakamura K. Global population structure of Shiga toxin-producing Escherichia coli O103:H2 and the variation in their major virulence factor-encoding genetic elements. Microb Genom. 2026;12:001625.

    11. Otomaru H, Kawazoe Y, Nguyen HAT, Vo HM, Le HH, Toizumi M, Mizuta K, Dang DA, Moriuchi H, Yoshida L. Clinical insights and severity of enterovirus D68 respiratory infections in Vietnamese children. Open Forum Infect Dis. 2026;13:ofag102.

    \R7Šw‰ï”­•\\

    1. £ŒË‡ŽŸFƒ[ƒNƒVƒ‡ƒbƒv4u2023”N‚Ì”nŽh‚µ‚É‚æ‚é’°ŠÇoŒŒ«‘å’°‹ÛH’†“ł̌ã•ûŽ‹“I’Ç‹†vA‘æ98‰ñ“ú–{×‹ÛŠw‰ï‘‰ïA2025”N5ŒŽ29-30“úi‰—ÎìŒ§j

    2. —é–Ø–ƒ—FA£ŒË‡ŽŸAŽR“cŒhŽqAˆ¢•F’‰”VFƒTƒuƒNƒ[ƒ“‚ð‰Á–¡‚µ‚œŒ‹Šj—FlŠÔŠŽõŽ–—á‚Ì’Ç‹†A‘æ100‰ñ“ú–{Œ‹ŠjE”ñŒ‹Šj«RŽ_‹ÛÇŠw‰ïŠwpu‰‰‰ïA2025”N6ŒŽ6|7“úi‰—‰¡•lŽsj

    3. …“cŽ–€A‹ß‰ªG“ñAˆŸ–ì—T‹MA˜a“cŠwAˆ¢•”‹ÅŽqAå“¹‘åAŒÃŽR­KA–k‘º³•qA“c•Ó‚³‚š‚èA‹î—ÑŒ«ˆêA¬ì’Œ”üA²X–Ø”üAÂ–Ø—mŽqA“Iê—m•œA£ŒË‡ŽŸA’r“c’C–çF2022`2023”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚é‹Ø’ɏǂðŠÜ‚ÞƒpƒŒƒRƒEƒCƒ‹ƒXA‚RŒ^‚Ì—¬só‹µA‘æ77‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïEŠwpW‰ïA2025”N8ŒŽ21|22“úi‰—O‘OŽsj

    4. …“cŽ–€A‹ß‰ªG“ñAˆŸ–ì—T‹MA˜a“cŠwAˆ¢•”‹ÅŽqAå“¹‘åAŒÃŽR­KA–k‘º³•qA“c•Ó‚³‚š‚èA‹î—ÑŒ«ˆêA¬ì’Œ”üA²X–Ø”üAÂ–Ø—mŽqA“Iê—m•œA£ŒË‡ŽŸA’r“c’C–çF2022`2023”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚é‹Ø’ɏǂðŠÜ‚ÞƒpƒŒƒRƒEƒCƒ‹ƒXA‚RŒ^‚Ì—¬só‹µA‘æ29‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ïE‘æ66‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2025”N9ŒŽ27|28“úi‰—ŽD–yŽsj

    5. …“cŽ–€F“Á•ʍu‰‰‚PuŽRŒ`‚É‚š‚¯‚éŒÄ‹zŠíŒŸ‘Ì‚©‚ç‚̃EƒCƒ‹ƒX•ª—£•šŒêvA‘æ29‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ïE‘æ66‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2025”N9ŒŽ27|28“úi‰—ŽD–yŽsj

    6. £ŒË ‡ŽŸA˜a“c ’”VA‘º£ —ǘNAŒäŽèô ‘A’r“c ’C–çA…“c Ž–€Aˆ¢•F ’‰”VFгŽÒ‘Ì“à‚ł̌‹Šj‹ÛƒTƒuƒNƒ[ƒ“‚̍¬ÝA‘æ9‰ñRŽ_‹ÛŒ€‹†‰ïA2025”N10ŒŽ18-19“úi‰—‘åãj

    7. Imamura T, Mori Y, Fujii S, Suzuki E, Yamada K, Ashino Y, Kato Y, Yamashita H, Seto J, Saito M, Kamigaki T, Shimada T, Suzuki M, Mizuta K, Ahiko T, Oshitani H. The effectiveness of forward contact tracing and backward source investigation in controlling COVID-19 transmission in Yamagata, Japan, between 2020-2022. IDWeek 2025. 19-22 October 2025. Atlanta, USA.

    8. Seto J, Wada T, Murase Y, Ikeda T, Mizuta K, Ahiko T. Collateral reactivation of tuberculosis -Proposal of a novel phenomenon-. Tuberculosis Molecular Research Meeting 2025. 21 January 2026 (Online)

    —ߘa6”N“xi2024”N4ŒŽ-2025”N3ŒŽj

    \R6˜_•¶”­•\“™\

    1. Matsuzaki Y, Sugawara K, Kidoguchi Y, Kadowaki Y, Shimotai Y, Katsushima Y, Katsushima F, Tanaka S, Matoba Y, Komabayashi K, Aoki Y, Mizuta K. Genetic reassortment in a child coinfected with two influenza B viruses, B/Yamagata lineage and B/Victoria-lineage strains. Viruses. 2024;16:983.

    2. Itagaki T, Komabayashi K, Sasaki M, Ogawa N, Seto J, Aoki Y, Ikeda T, Matsuzaki Y, and Mizuta K. Seroprevalence of enterovirus D68 in Yamagata, Japan between 1976 and 2019. J Med Virol. 2024;96:e29947.i‰{——‚̂݃tƒŠ[j

    3. Kishimoto M, Itakura Y, Tabata K, Komagome R, Yamaguchi H, Ogasawara K, Nakao R, Qiu Y, Sato K, Kawabata H, Kajihara M, Monma N, Seto J, Shigeno A, Horie M, Sasaki M, Hall WW, Sawa H, Orba Y, Matsuno K. A wide distribution of Beiji nairoviruses and related viruses in Ixodes ticks in Japan. Ticks Tick Borne Dis. 2024;15:102380.

    \R6Šw‰ï”­•\\

    1. £ŒË‡ŽŸA˜a“c’”VAˆ¢•F’‰”VF”­’[гŽÒ‚É”­Œ©‚Ì’x‚ꂪ‚ ‚Á‚œW’cŠŽõŽ–—á‚ÌŒ‹Šj‹ÛƒQƒmƒ€‰ðÍ‚©‚猩‚ЂĂ«‚œƒTƒuƒNƒ[ƒ“‚ð‰Á–¡‚µ‚œŒ‹‰Ê‰ðŽß‚̏d—v«A‘æ99‰ñ“ú–{Œ‹ŠjE”ñŒ‹Šj«RŽ_‹ÛÇŠw‰ïŠwpu‰‰‰ïA2024”N5ŒŽ31“úi‰—’·èŽsj

    2. …“cŽ–€A‹î—ÑŒ«ˆêA²X–Ø”üA¬ì’Œ”üAÂ–Ø—mŽqA’r“c’C–çA”Š_•ׁAŒ›œ—tŽqF2019`2022”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒXD68Œ^‚ÌŒŒŽ‰uŠwA‘æ76‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïEŠwpW‰ïA2024”N8ŒŽ19|20“úi‰—H“cŽsj

    3. —é–Ø–ƒ—FA£ŒË‡ŽŸA“Iê—m•œA’r“c’C–çA…“cŽ–€A‘åŠÑ“TŽqA—›ŒªˆêAò’JG¹:2023”N‚Ì”nŽh‚µ‚É‚æ‚é’°ŠÇoŒŒ«‘å’°‹ÛH’†“Å‚ÌŒŽˆö’Ç‹†A—ߘa6”N“xbˆãŠwp“Œ–k’n‹æŠw‰ïA2024”N9ŒŽ24-25“úi‰—ÂXŽsjbˆãŠwp“Œ–k’n‹æŠw‰ïŠw‰ï’·ÜŽóÜ

    4. …“cŽ–€A‹î—ÑŒ«ˆêA²X–Ø”üA¬ì’Œ”üAÂ–Ø—mŽqA’r“c’C–çA”Š_•ׁAŒ›œ—tŽqF2019`2022”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒXD68Œ^‚ÌŒŒŽ‰uŠwA‘æ‚Q‚W‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ïE‘æ‚U‚T‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2024”N10ŒŽ26|27“úi‰—–ŒŒÃ‰®Žsj

    5. ‹v•Û“c仍؁A’²P–ŸAŽl‹{”ސlA…“cŽ–€A’叡Œ’ŽuA•“–؍N˜YA‰Ž–ؐM—TF•aŒŽ‘ÌŒŸoƒ}ƒjƒ…ƒAƒ‹‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg‚©‚猩‚Š‚œ’n•û‰q¶Œ€‹†Š‚É‚š‚¯‚é‰Û‘èA2024”N10ŒŽ29“ú|31“úA‘æ83‰ñ“ú–{ŒöO‰q¶Šw‰ïi‰—ŽD–yŽsj

    6. £ŒË‡ŽŸF’n•û‰q¶Œ€‹†Š‚ƕی’Š‚̘AŒg‚É‚æ‚銎õÇ‰uŠwŒ€‹†‚ÌŽÀ‘HA‘æ83‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïA2024”N10ŒŽ29“ú|31“úi‰—ŽD–yŽsj“ú–{ŒöO‰q¶Šw‰ï§—ãÜŽóÜ

      š ŽóÜ‚ÉŠÖ‚·‚é‹LŽ–‚́A‰qŒ€ƒjƒ…[ƒX‘æ214†‚ð‚²——‚­‚Ÿ‚³‚¢

    7. Œ›œ—tŽqA›ŒŽŠš‰xAéŒËŒû—TŽqA–å˜e—tŽqA‰º•œ‹`—²AŸ“‡—R—˜ŽqAŸ“‡Žj•vA“c’†Ã‰ÀA“Iê—m•œA‹î—ÑŒ«ˆêAÂ–Ø—mŽqA¬ì’Œ”üA²X–Ø”üA’r“c’C–çA…“cŽ–€FŽRŒ`Œn“‚ƃrƒNƒgƒŠƒAŒn“‚Ì2Ží—Þ‚ÌBŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚ɏd•¡ŠŽõ‚µ‚œ¬Ž™‚ɐ¶‚¶‚œˆâ“`ŽqÄW‡‘̂̉ðÍA‘æ71‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2024”N11ŒŽ4“ú|6“úi‰—–ŒŒÃ‰®Žsj

    8. ŒàV •ü—tAÎ“c ‚݂̂èAŒ‘º GˆêA…“c Ž–€AŽs‘º GA¬—Ñ ‹œ‰îA¬’r ’qFƒGƒ“ƒeƒƒEƒCƒ‹ƒXA71‚̐_Œo•aŒŽ«‚ɉe‹¿‚·‚éƒQƒmƒ€—̈æ‚̉ðÍA‘æ71‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2024”N11ŒŽ4“ú|6“úi‰—–ŒŒÃ‰®Žsj

    9. —é–Ø–ƒ—FA£ŒË‡ŽŸA“Iê—m•œA’r“c’C–çA…“cŽ–€AŒÜ\—’_KA‘åŠÑ“TŽqAŒ“ƒW“ށA—›ŒªˆêAò’JG¹F2023”N‚Ì”nŽh‚µ‚É‚æ‚é’°ŠÇoŒŒ«‘å’°‹ÛH’†“Å‚ÌŒŽˆö’Ç‹†A‘æ42‰ñ“ú–{bˆãŽt‰ïbˆãŠwpŠw‰ï”NŽŸ‘å‰ïA2025”N1ŒŽ24|26“úi‰—å‘äŽsj

    10. —é–Ø–ƒ—FA£ŒË‡ŽŸA’r“c’C–çA…“cŽ–€Aûü‹ŽŒjŽqAŽá’ÎŒ’‘ŸAåb–ì‹g˜aA‘å’ˍ؏F2024”N‚̏¯“à’nˆæ‚É‚š‚¯‚é•S“úŠP—¬só‹µA‘æ51‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2025”N3ŒŽ10“úi‰—ŽRŒ`Žsj

    —ߘa5”N“xi2023”N4ŒŽ-2024”N3ŒŽj

    \R5˜_•¶”­•\“™\

    1. Ko Y, Furuse Y, Otani K, Yamauchi M, Ninomiya K, Saito M, Imamura T, Cook AR, Ahiko T, Fujii S, Mori Y, Suzuki E, Yamada K, Ashino Y, Yamashita H, Kato Y, Mizuta K, Suzuki M, Oshitani H.: Time-varying overdispersion of SARS-CoV-2 transmission during the periods when different variants of concern were circulating in Japan. Sci Rep. 2023;13:13230.

    2. Otomaru H, Nguyen HAT, Vo HM, Toizumi M, Le MN, Mizuta K, Moriuchi H, Bui MX, Dang DA, Yoshida LM. A decade of human metapneumovirus in hospitalized children with acute respiratory infection: molecular epidemiology in central Vietnam, 2007-2017. Sci Rep. 2023;13:15757.

    3. …“cŽ–€A¬ì’Œ”üA‹î—ÑŒ«ˆêA²X–Ø”üA“Iê—m•œA£ŒË‡ŽŸA”Š_•ׁA’r“c’C–ç. COVID-19‚̌ċzŠíƒEƒCƒ‹ƒXŠŽõÇ‚ւ̉e‹¿\“Á‚ÉRSEƒCƒ“ƒtƒ‹ƒGƒ“ƒUAŒ^E‹Gß«ƒRƒƒiƒEƒCƒ‹ƒXEƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXEƒpƒ‰ƒCƒ“ƒtƒ‹ƒGƒ“ƒU3Œ^—¬s‚Ì‹Gß«‚É’…–Ú‚µ‚ā[. —Տ°‚ƃEƒCƒ‹ƒX. 2023;51:270-274.

    4. Seto J, Takahashi J, Sampei M, Ikeda T, Mizuta K. A case of Legionella pneumophila serogroup 13 pneumonia based on the detection of serogroup-specific genes in culture-negative sputum. Jpn J Infect Dis. 2024;77:118-120.

    5. £ŒË‡ŽŸAˆ¢•F’‰”V. VNTR•ªÍ‚âƒQƒmƒ€‰ðÍ‚ð—p‚¢‚œŒ‹Šj•ªŽq‰uŠw’²ž. —Տ°‚Æ”÷¶•š. 2024;51:156-162.

    \R5Šw‰ï”­•\\

    1. £ŒË‡ŽŸF•ªŽq‰uŠw’²ž‚ÌŠˆ—pi“Á‚ɃQƒmƒ€‰ðÍjA‘æ98‰ñ“ú–{Œ‹ŠjE”ñŒ‹Šj«RŽ_‹ÛÇŠw‰ïŠwpu‰‰‰ïiŠw‰ï‘n—§100Žü”N‹L”O‘å‰ïjƒGƒLƒXƒp[ƒgƒZƒ~ƒi[A2023”N6ŒŽ10“úi‰—“Œ‹žj

    2. ‹î—ÑŒ«ˆêA£ŒË‡ŽŸA’r“c’C–çA…“cŽ–€Fƒƒ^ƒQƒmƒ€‰ðÍ‚ÌŽè–@‚É‚æ‚éƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA6•ª—£Š”‚̃Qƒmƒ€”z—ñŽæ“Ÿ‚Æ‚»‚Ì•]‰¿A‘æ75‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2023”N8ŒŽ21“úi‰—ŽRŒ`Žsj

    3. …“cŽ–€A²X–Ø”üA‹î—ÑŒ«ˆêA’r“c—zŽqAÂ–Ø—mŽqA”Š_•ׁAŸ“‡—R—˜ŽqAŸ“‡Žj•vAŒ›œ—tŽqF’·Šú‚ɂ킜‚éƒpƒŒƒRƒEƒCƒ‹ƒX‚`‚PŒ^‚̍RŒŽ‰ðÍ‚ÆŒŒŽ‰uŠwA‘æ75‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2023”N8ŒŽ21“úi‰—ŽRŒ`Žsj

    4. £ŒË‡ŽŸFVŒ^ƒRƒƒiƒEƒCƒ‹ƒXŠŽõÇ‚ɑ΂·‚é’n•ûީޡ‘̂̉q¶Œ€‹†Š‚ÉŠ‘®‚·‚éŒöO‰q¶bˆãŽt‚̑ΉžA‘æ166‰ñ“ú–{bˆãŠw‰ïŠwpW‰ïA2023”N9ŒŽ6“úiƒIƒ“ƒ‰ƒCƒ“j

    5. …“cŽ–€A£ŒË‡ŽŸAÂ–Ø—mŽqA²X–Ø”üA‹î—ÑŒ«ˆêA“¡ŒŽ’ŒÆA©”ü–çŽqA—é–Ø—DŽqA‘å’΂è‚ÂŽqF‹@ŠBŠwK‚É‚æ‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX×–E•ϐ«Œø‰ÊŽ©“®”»’è‹Zp‚̍\’zA‘æ70‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2023”N9ŒŽ26-28“úi‰—å‘äŽsj

    6. £ŒË‡ŽŸFŽRŒ`Œ§‚É‚š‚¯‚é‹ÛƒQƒmƒ€‰ðÍ‚ð—p‚¢‚œŒ‹ŠjгŽÒŠŽõŒo˜H„’èA‘æ70‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïICDuK‰ïA2023”N9ŒŽ28“úi‰—å‘äŽsj

    7. …“cŽ–€FŽRŒ`Œ§‰q¶Œ€‹†Š‚ÍPublic Health Laboratory‚Æ‚µ‚Ä‹@”\‚µ‚Ä‚¢‚é‚Ì‚©H‘æ27‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ï‘æ64‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2023”N10ŒŽ21-22“úi‰—Ã‰ªŽsj

    8. …“cŽ–€A²X–Ø”üA‹î—ÑŒ«ˆêA’r“c—zŽqAÂ–Ø—mŽqA”Š_•ׁAŸ“‡—R—˜ŽqAŸ“‡Žj•vAŒ›œ—tŽqF’·Šú‚ɂ킜‚éƒpƒŒƒRƒEƒCƒ‹ƒX‚`‚PŒ^‚̍RŒŽ‰ðÍ‚ÆŒŒŽ‰uŠwA‘æ27‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ï‘æ64‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ï‡“¯ŠwpW‰ïA2023”N10ŒŽ21|22“úi‰—Ã‰ªŽsj

    9. “Iê—m•œA£ŒË‡ŽŸA’r“c’C–çA…“cŽ–€A‰““¡—DŽqA‘å“à—æ“ށAŽO‰Y˜NŽqAˆÉ“¡‹žŽqAÂ–Ø•q–çA“¡ˆärŽiFŽ©‘‘……‚Ì•sŠ®‘S“ü‚ê‘Ö‚Š‚ðŒŽˆö‚Æ‚·‚郌ƒWƒIƒlƒ‰Ç‚̈ê—á|•ªŽq‰uŠw‚Ì—§ê‚©‚ç|A‘æ50‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2024”N3ŒŽ12“úi‰—ŽRŒ`Žsj

    10. £ŒË‡ŽŸA“Iê—m•œA’r“c’C–çAŽO‰Y˜NŽqA“¡ˆärŽiA…“cŽ–€AŽR“cŒhŽqAˆ¢•F’‰”VFŒ‹Šj‹ÛƒQƒmƒ€‰ðÍ‚ð—p‚¢‚œ2007”N‚É’T’m‚³‚ꂜŒ‹ŠjW’cŠŽõŽ–—á‚Ì’Ç‹†A‘æ50‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2024”N3ŒŽ12“úi‰—ŽRŒ`Žsj


    —ߘa4”N“xi2022”N4ŒŽ-2023”N3ŒŽj

    \R4˜_•¶”­•\“™\

    1. Tanaka W, Komabayashi K, Ikeda Y, Aoki Y, Itagaki T, Mizuta K. Seroprevalence of coxsackievirus A21 neutralizing antibodies in Yamagata, Japan between 1976 and 2019; coxsackievirus A21 has rarely affected young children. J Med Virol. 2022;94:2877-2881.i‰{——‚̂݃tƒŠ[j

    2. Takumi-Tanimukaia Y, Yamamoto S, Ogasawara N, Nakabayashi S, Mizuta K, Yamamoto K, Miyata R, Kakuki T, Jitsukawa S, Sato T, Tsutsumi H, Kojima T, Takano K, Yokota S. A hydroxypropyl methylcellulose plaque assay for human respiratory syncytial virus. J Virol Methods. 2022;304:114528.

    3. Seto J, Aoki Y, Tanaka S, Komabayashi K, Ikeda T, Mizuta K. A seroepidemiologic study of a measles outbreak, Yamagata Prefecture, Japan, 2017: the estimation of spreaders using serological assays in a measles elimination setting. J Infect Chemother. 2022;28:1018-1022.

    4. Mizuta K, Itagaki I, Chikaoka S, Wada M, Ikegami T, Sendo D, Iseki C, Shimizu Y, Abe S, Komabayashi K, Aoki Y, Ikeda T. Recombinant parechovirus A3 possibly causes various clinical manifestations, including myalgia; findings in Yamagata, Japan in 2019. Infect Dis. 2022;1-19.

    5. Fujiwara N, Onaga T, Wada T, Takeuchi S, Seto J, Nakaya T, Aihara K. Analytical estimation of maximum fraction of infected individuals with one-shot non-pharmaceutical intervention in a hybrid epidemic model. BMC Infect Dis. 2022;22:512.

    6. Hamamoto I, Takahashi H, Shimasaki N, Nakamura K, Mizuta K, Sato K, Nishimura H, Yamamoto N, Hasegawa H, Odagiri T, Tashiro M, Nobusawa E. Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility. Microbiol Immunol. 2022;66:361-370.

    7. £ŒË ‡ŽŸ, —é–Ø Œb”üŽq, ŽR“c ŒhŽq, Îì m, ‰Á“¡ —Tˆê, ‰Á“¡ ä•v, ŽR‰º ‰pr, ˆ¢•F ’‰”V, …“c Ž–€, ’†’J —FŽ÷. ŽRŒ`Œ§‚É‚š‚¯‚éŽž‹óŠÔŽOŽŸŒ³’n}‚ð—p‚¢‚œVŒ^ƒRƒƒiƒEƒCƒ‹ƒXŠŽõÇ—¬s‰ÂŽ‹‰»‚ÌŽæ‚è‘g‚Ý. “ú–{ŒöO‰q¶ŽGŽ. 2023;70:185-196.

    8. £ŒË ‡ŽŸ, ˜a“c ’”V, ‘º£ —ǘN, ŽO•r ”ü, ‰º‘º ‰ÀŽq, ×’J ^‹IŽq, …“c Ž–€, ŒäŽèô ‘, ˆ¢•F ’‰”V. ŽRŒ`Œ§‚É‚š‚¯‚éŒ‹Šj‹ÛƒQƒmƒ€‰ðÍ‚ð—p‚¢‚œŒ‹Šj•ªŽq‰uŠw’²ž. ŠŽõÇŠwŽGŽ. 2023;97:6-17.

    9. Seto J, Aoki Y, Komabayashi K, Yamada K, Ishikawa H, Ichikawa T, Ahiko T, Mizuta K. Measles Outbreak Response Activity in Japan, and a Discussion for a Possible Strategy of Outbreak Response Using Cycle Threshold Values of Real-Time Reverse Transcription PCR for Measles Virus in Measles Elimination Settings.Viruses. 2023;15:171.

    10. Takashita E, Murakami S, Matsuzaki Y, Fujisaki S, Morita H, Nagata S, Katayama M, Mizuta K, Nishimura H, Watanabe S, Horimoto T, Hasegawa H. Antiviral susceptibilities of distinct lineages of influenza C and D viruses. Viruses. 2023;15:244.

    11. Hirai S, Yokoyama E, Ando N, Seto J, Hazama K, Enomoto K, Izumiya H, Akeda Y, Ohnishi M. Another advantage of multi-locus variable-number tandem repeat analysis that can putatively subdivide enterohemorrhagic Escherichia coli O157 strains into clades by maximum a posteriori estimation. PLoS One. 2023;18:e0283684.

    12. Mizuta K, Itagaki T, Katsushima F, Katsushima Y, Sasaki M, Komabayashi K, Ikeda Y, Aoki Y, Matsuzaki Y. Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan. J Med Virol. 2023;95:e28696.i‰{——‚̂݃tƒŠ[j

    \R4Šw‰ï”­•\\

    1. …“cŽ–€A1976”N‚©‚ç2019”N‚ÌŽRŒ`‚É‚š‚¯‚éƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA21Œ^‚ÌŒŒŽ‰uŠwA‘æ63‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2022”N6ŒŽ18-19“úi‰—“Œ‹žj

    2. Žl‹{”ސlAŽR‰ºˆçFA…“cŽ–€A‚è’q•FA’叡Œ’ŽuAŠFì—mŽqA“c’†‹`lA‘œ‰®Š]ŽqAÂ–Ø‹IŽqA’n•û‰q¶Œ€‹†Š‚É‚š‚¯‚é‹}«”]‰ŠE”]Ç‹y‚Ñ‹}«’oŠÉ«–ƒáƒ‚Ì•aŒŽ‘ÌŒŸž‚̏󋵂ɂ‚¢‚āA‘æ63‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2022”N6ŒŽ18-19“úi‰—“Œ‹žj

    3. …“cŽ–€A“c’†˜a‰ÀA‹î—ÑŒ«ˆêA’r“c—zŽqAÂ–Ø—mŽqA”Š_•ׁA1976”N‚©‚ç2019”N‚ÌŽRŒ`‚É‚š‚¯‚éƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA21Œ^‚ÌŒŒŽ‰uŠwA‘æ74‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2022”N8ŒŽ22“ú-23“úi‰—•Ÿ“‡j

    4. £ŒË‡ŽŸA˜a“c’”VA‘º£—ǘNA‰º‘º‰ÀŽqA×’J^‹IŽqAŒäŽèô‘Aˆ¢•F’‰”VAŽRŒ`Œ§‚É‚š‚¯‚éƒQƒmƒ€‰ðÍ‚ðŽæ‚è“ü‚ꂜŒ‹Šj•ªŽq‰uŠw’²žA‘æ97‰ñ“ú–{Œ‹ŠjE”ñŒ‹Šj«RŽ_‹ÛÇŠw‰ï‘‰ïA2022”N7ŒŽ1-2“úi‰—ˆ®ìŽsj

    5. £ŒË‡ŽŸA…“cŽ–€AƒGƒNƒZƒ‹VBA‚ð—p‚¢‚œVŒ^ƒRƒƒiƒEƒCƒ‹ƒXŒŸž‘ä’ ƒVƒXƒeƒ€‚̍\’zA‘æ81‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïA2022”N10ŒŽ7-9“úi‰—ŽR—œŽsj

    6. ‹î—ÑŒ«ˆêA²X–Ø”üA’r“c—zŽqA£ŒË‡ŽŸAÂ–Ø—mŽqA”Š_•ׁA…“cŽ–€AŽRŒ`Œ§‰q¶Œ€‹†Š‚É‚š‚¯‚é2019-2022”N‚̌ċzŠíƒEƒCƒ‹ƒX‚ÌŒŸoó‹µA‘æ49‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2023”N3ŒŽ1“úi‰—ŽRŒ`Žsj

    7. £ŒË‡ŽŸAÂ–Ø—mŽqA²X–Ø”üA‹î—ÑŒ«ˆêA…“cŽ–€A“¡ŒŽ’ŒÆA©”ü–çŽqA—é–Ø—DŽqA‘å’΂è‚ÂŽqA‹@ŠBŠwK‚ð—p‚¢‚œƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚Ì”|—{×–E‚ɑ΂·‚é×–E•ϐ«Œø‰Ê‚Ì—L–³‚Ì”»’èA‘æ49‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2023”N3ŒŽ1“úi‰—ŽRŒ`Žsj


    —ߘa3”N“xi2021”N4ŒŽ-2022”N3ŒŽj

    \R3˜_•¶”­•\“™\

    1. Mizuta K, Aoki Y, Komabayashi K, Ikeda T. Proposal for the recognition of a new disease concept from Japan; Parechovirus A3-associated myalgia. Jpn J Infect Dis. 2021;74:259-272.

    2. Komabayashi K, Matoba Y, Seto J, Ikeda Y, Tanaka W, Aoki Y, Ikeda T, Matsuzaki Y, Itagaki T, Shirato K, Mizuta K. Isolation of human coronaviruses OC43, HKU1, NL63, and 229E in Yamagata, Japan, using primary human airway epithelium cells cultured by employing an air-liquid interface culture. Jpn J Infect Dis. 2021;74:285-292.

    3. Seto J, Amemura-Maekawa J, Sampei M, Araki K, Endo M, Kura F, Ikeda T, Kato K, Ohnishi M, Mizuta K. Investigation of a Legionnairesf disease outbreak using direct sequence-based typing in Yamagata City, Japan, 2019. Jpn J Infect Dis. 2021;74:491-494.

    4. Seto J, Aoki Y, Komabayashi K, Ikeda Y, Sampei M, Ogawa N, Uchiumi Y, Fujii S, Chiba M, Suzuki E, Takahashi T, Yamada K, Otani Y, Ashino Y, Araki K, Kato T, Ishikawa H, Ikeda T, Abe H, Ahiko T, Mizuta K. Epidemiology of coronavirus disease 2019 in Yamagata Prefecture, Japan, January-May 2020: The importance of retrospective contact tracing. Jpn J Infect Dis. 2021;74:522-529.

      š ã‹L˜_•¶‚Ì“ú–{ŒêŠT—v‚́A“–Šƒz[ƒ€ƒy[ƒWy˜_•¶ŠT—vzŽRŒ`Œ§‚ÌCOVID-19‘æˆê”g @`ŽRŒ`‚̐VŒ^ƒRƒƒi‚͂ǂ̂悀‚ɍL‚ª‚Á‚Ä‚¢‚œ‚ñ‚Ÿ‚ë‚€H`‚ðŽQÆ‚­‚Ÿ‚³‚¢B

    5. Kobayashi K, Nishimura H, Mizuta K, Nishizawa T, Chu ST, Ichimura H, Koike S. Virulence of enterovirus-A71 fluctuates depending on the phylogenetic clade formed in the epidemic year and epidemic region. J Virol. 2021;95:e01515-21.

    \R3Šw‰ï”­•\\

    1. …“cŽ–€AŒ›œ—tŽqAŽRŒ`Œ§‚É‚š‚¯‚é2010`2019”N‚Ì‹Gß«ƒRƒƒiƒEƒCƒ‹ƒX‚̉uŠwŒ€‹†A‘æ62‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2021”N6ŒŽ12-13“úiWebinarj

    2. …“cŽ–€A1976”N‚©‚ç2017”N‚ÌŽRŒ`‚É‚š‚¯‚éƒpƒŒƒRƒEƒCƒ‹ƒXA1/3/4Œ^‚ÌŒŒŽ‰uŠwA‘æ62‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2021”N6ŒŽ12-13“úiWebinarj

    3. £ŒË‡ŽŸA‹î—ÑŒ«ˆêA’r“c—zŽqAVŒ^ƒRƒƒiƒEƒCƒ‹ƒXƒQƒmƒ€‰ðÍ‚ÌŒ»ó‚ƉۑèA—ߘa3”N“xbˆãŠwp“Œ–k’n‹æŠw‰ï “ú–{bˆãŒöO‰q¶Šw‰ï“Œ–k’n‹æA2021”N10ŒŽ11“ú-31“úiƒIƒ“ƒfƒ}ƒ“ƒhj

    4. £ŒË‡ŽŸA’†’J—FŽ÷A—é–ØŒb”üŽqAŽR“cŒhŽqAÎìmA‰Á“¡ä•vA‰Á“¡—TˆêA ˆ¢•F’‰”VA…“cŽ–€AŽž‹óŠÔŽOŽŸŒ³’n}‚ð—p‚¢‚œCOVID-19—¬s‚̉Ž‹‰»A‘æ80‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïA2021”N12ŒŽ21-23“úAiƒIƒ“ƒfƒ}ƒ“ƒhj

    5. £ŒË ‡ŽŸA‹î—ÑŒ«ˆêA’r“c—zŽqAVŒ^ƒRƒƒiƒEƒCƒ‹ƒXƒQƒmƒ€‰ðÍ‚ÌŒ»ó‚ƉۑèA—ߘa3”N“x“ú–{bˆãŽt‰ïbˆãŠwpŠw‰ï”NŽŸ‘å‰ïA2022”N1ŒŽ21“ú-2ŒŽ6“úiƒIƒ“ƒfƒ}ƒ“ƒhj

    6. £ŒË‡ŽŸA“Œ‰p¶A“c’†Ã‰ÀA¬éLWA’†‘º–²“ށA’r“c’C–çA…“cŽ–€AŽRŒ`Œ§“àƒ}ƒ_ƒj‚Ì ƒ}ƒ_ƒj”}‰îŠŽõÇ•aŒŽ‘Ì’²žA—ߘa3”N“x“ú–{bˆãŽt‰ïbˆãŠwpŠw‰ï”NŽŸ‘å‰ïibˆãŠwp§—ãÜ‹L”Ou‰‰jA2022”N1ŒŽ21“ú-2ŒŽ6“úiƒIƒ“ƒfƒ}ƒ“ƒhj

    —ߘa2”N“xi2020”N4ŒŽ-2021”N3ŒŽj

    \R2˜_•¶”­•\“™\

    1. Matsuzaki Y, Shimotai Y, Kadowaki Y, Sugawara K, Seiji Hongo S, Mizuta K, Nishimura H. Antigenic changes among the predominantly circulating C/Sao Paulo lineage strains of influenza C virus in Yamagata, Japan, between 2015 and 2018. Infect Genet Evol. 2020;81:104269.

    2. Kobayashi K, Mizuta K, Koike S. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 2020:16;e1008428

    3. Takashita E, Yasui Y, Nagata S, Morita H, Fujisaki S, Miura H, Shirakura M, Kishida N, Nakamura K, Kuwahara T, Sugawara H, Sato A, Akimoto M, Kaido T, Watanabe S, Hasegawa H, and the influenza virus surveillance group of Japan. Detection of a peramivir-resistant influenza B/Yamagata-lineage virus imported from Indonesia in Aichi, Japan, March 2019. Jpn J Infect Dis. 2020;73:386-390.

    4. ²“¡‹óŒ©Žq, ‰iˆäÍŽq, ¬ŒŽ€, ‰““¡çt, —Ñ“N–ç, ‘剪—B—S, £ŒË‡ŽŸ, ‘ºãŒõˆê. ŽRŒ`Œ§“à‚Æ’{ê”À“ü“Ø‚ÌEscherichia albertii•ۋۏ󋵋y‚Ñ‚»‚̉uŠw“I“Á’¥. “ú–{bˆãŽt‰ïŽGŽ. 2020;73:265-273.

    5. £ŒË‡ŽŸ, “Œ‰p¶, “c’†Ã‰À, ¬éLW, ’†‘º–²“Þ, ’r“c’C–ç, …“cŽ–€. ŽRŒ`Œ§“àƒ}ƒ_ƒj‚̃}ƒ_ƒj”}‰îŠŽõÇ•aŒŽ‘Ì’²ž. “ú–{bˆãŽt‰ïŽGŽ. 2020;73:517-524.

    6. Komabayashi K, Seto J, Matoba Y, Aoki Y, Tanaka S, Ikeda T, Matsuzaki Y, Itagaki T, Mizuta K. Seasonality of human coronavirus OC43, NL63, HKU1, and 229E infection in Yamagata, Japan, 2010-2019. Jpn J Infect Dis. 2020;73:394-397.

      š ã‹L˜_•¶‚Ì“ú–{ŒêŠT—v‚́A“–Šƒz[ƒ€ƒy[ƒWu‹Gß«ƒRƒƒiƒEƒCƒ‹ƒXŠŽõÇ‚Í“~‚É—¬s‚·‚év‚ðŽQÆ‚­‚Ÿ‚³‚¢B

    7. Komabayashi K, Matoba Y, Tanaka S, Seto J, Aoki Y, Ikeda T, Shimotai Y, Matsuzaki Y, Itagaki T, Mizuta K. Longitudinal epidemiology of human coronavirus OC43 in Yamagata, Japan, 2010-2017: Two groups based on spike gene appear one after another. J Med Virol. 2021;93:945-951.i‰{——‚̂݃tƒŠ[j

    8. Seto J, Tanaka S, Kawabata H, Ito Y, Ikeda T, Mizuta K. Detection of tick-borne pathogens in ticks from dogs and cats in the Yamagata Prefecture, Japan, 2018. Jpn J Infect Dis. 2021;74:122-128.

      š ã‹L˜_•¶‚Ì“ú–{ŒêŠT—v‚́Au‰qŒ€ƒjƒ…[ƒX R3.3ŒŽ†iNo. 199jv‚ðŽQÆ‚­‚Ÿ‚³‚¢B

    9. Ikeda T, Aoki Y, Komabayashi K, Itagaki T, Mizuta K. Isolation of coxsackievirus A21 from patients with acute respiratory infection in Yamagata, Japan in 2019. Jpn J Infect Dis. 2021;74:172-174.

    10. Mizuta K, Komabayashi K, Aoki Y, Itagaki T, Ikeda T. Seroprevalence of parechovirus A1, A3, and A4 antibodies in Yamagata, Japan, between 1976 and 2017. J Med Microbiol. 2020;69:1381-1387.

      š ƒpƒŒƒRƒEƒCƒ‹ƒX‚ÉŠÖ‚·‚éî•ñ‚́A“–Šƒz[ƒ€ƒy[ƒWuƒpƒŒƒRƒEƒCƒ‹ƒX‚Æ—¬s«‹Ø’ɏǁv‚à‚²ŽQÆ‚­‚Ÿ‚³‚¢B

    11. Matsuzaki Y, Sugawara K, Shimotai Y, Kadowaki Y, Hongo S, Mizuta K, Nishimura H. Growth kinetics of influenza C virus antigenic mutants that escaped from anti-hemagglutinin esterase monoclonal antibodies and viral antigenic changes found in field isolates. Viruses. 2021;13:401.


    \R2Šw‰ï”­•\\

    1. …“cŽ–€AƒpƒŒƒRƒEƒCƒ‹ƒXA‚SŒ^‚ÌŒŒŽ‰uŠwA‘æ61‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2020”N10ŒŽ2“ú\31“ú(Webinar)

    2. …“cŽ–€Au“Á•ÊŠé‰æCOVID-19\19l‚̐ê–副‚©‚ç‚̃Aƒbƒvƒf[ƒgv@ŽRŒ`‰qŒ€‚É‚š‚¯‚éŒŸž‚ւ̑Ήž@`‚¢‚©‚É‚³‚΂­‚©`@‘æ61‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2020”N10ŒŽ2“ú\31“ú(Webinar)

    3. •Ћ˗SŽiA—é–Ø”Ž‹MAˆ¢•”CˆêA£ŒË‡ŽŸA˜a“c’”VAMycobacterium seoulense”xŠŽõÇ‚Ì1—áA‘æ95‰ñ“ú–{Œ‹ŠjE”ñŒ‹Šj«RŽ_‹ÛÇŠw‰ï‘‰ïEŠwpu‰‰‰ïA2020”N10ŒŽ11“ú\12“ú(ƒIƒ“ƒ‰ƒCƒ“)

    4. £ŒË‡ŽŸA Œ‹ŠjƒQƒmƒ€‰uŠw`ŠŽõŒo˜H’Ç‹†E–òÜŠŽŽó«„’è`@‘æ69‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•û‰ïŠwpW‰ï‹³ˆçƒZƒ~ƒi[A 2020”N10ŒŽ22“úiƒIƒ“ƒ‰ƒCƒ“j

    —ߘaŒ³”N“xi2019”N4ŒŽ-2020”N3ŒŽj

    \R1˜_•¶”­•\“™\

    1. Seto J, Otani Y, Wada T, Suzuki Y, Ikeda T. Araki K, Mizuta K, Ahiko T. Nosocomial Mycobacterium tuberculosis transmission by brief casual contact identified using comparative genomics. J Hosp Infect. 2019;102:116-119.

    2. Mizuta K, Tanaka W, Koimabayashi K, Tanaka S, Seto J, Aoki Y, Ikeda T. Longitudinal epidemiology of viral infectious diseases combining virus isolation, antigenic analysis and phylogenetic analysis as well as seroepidemiology in Yamagata, Japan between 1999 and 2018. Jpn J Infect Dis. 2019;72:211-223.

    3. Suzuki Y, Seto J, Shimotai Y, Itagaki T, Katsushima Y, Katsushima F, Ikeda T, Mizuta K, Hongo S, Matsuzaki Y. Polyclonal spread of multiple genotypes of Mycoplasma pneumoniae in semi-closed settings in Yamagata, Japan. J Med Microbiol. 2019;68:785-790.

    4. Yamamoto K, Takeuchi S, Seto J, Shimouchie A, Komukai J, Hase A, Nakamura H, Umeda K, Hirai Y, Matsumoto K, Ogasawara J, Wada T, Yamamoto T. Longitudinal genotyping surveillance of Mycobacterium tuberculosis in an area with high tuberculosis incidence shows high transmission rate of the modern Beijing subfamily in Japan. Infect Genet Evol. 2019;72:25-30.

    5. Seto J, Tanaka S, Murakata T, Sato H, Monma N, Arai R, Ikeda T, Mizuta K. Scrub typhus caused by Shimokoshi type Orientia tsutsugamushi showing variant 56-kDa type-specific antigen gene sequence in Tohoku region, Japan. Microbiol Immunol. 2019;63:280-284.

    6. Seki F, Miyoshi M, Ikeda T, Nishijima H, Saikusa M, Itamochi M, Minagawa H, Kurata T, Ootomo R, Kajiwara J, Kato T, Komase K, Tanaka-Taya K, Sunagawa T, Oishi K, Okabe N, Kimura H, Suga S, Kozawa K, Otsuki N, Mori Y, Shirabe K, Takeda M, the measles virus surveillance group of Japan and the technical support team for measles control in Japan. Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017. Front Microbiol.2019;10:1470.

    7. Harada Y, Takahashi H, Trusheim H, Roth B, Mizuta K, Hirata-Saito A, Ogane T, Odagiri T, Tashiro M, Yamamoto N. Comparison of MDCK suspension cells, MDCK adherent cells, and LLC-MK2 cells for selective isolation of influenza virus to use as vaccine seed. Vaccine 2019:37:6526-6534.

    8. Harada Y, Takahashia H, Trusheim H, Rothb B, Mizuta K, Hirata-Saito A, Ogane T, Odagiri T, Tashiro M, Yamamoto N. Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds. Influenza Other Respir Viruses.2020:14:204-209.

    9. Imura A, Sudaka Y, Takashino A, Tamura K, Kobayashi K, Nagata N, Nishimura H, Mizuta K, Koike S. Development of an enterovirus 71 vaccine efficacy test using human scavenger receptor B2 transgenic mice. J Virol. 2020;94:e01921-19.

    10. Onodera H, Uekita H, Watanabe T, Taira K, Watanabe C, Saito H, Seto J, Suzuki Y, Imaoka K. Rat-bite fever due to Streptobacillus moniliformis without bite history: An unexpected cause of consciousness disturbance. Jpn J Infect Dis. 2020;73:85-87.

    11. Suzuki Y, Seto J, Shimotai Y, Itagaki T, Katsushima Y, Katsushima F, Ikeda T, Mizuta K, Hongo S, Matsuzaki Y. Regional spread of three distinct genotypes of Mycoplasma pneumoniae and different timing of macrolide-resistant strain appearance among genotypes between 2011 and 2013 in Yamagata, Japan. Yamagata Med J. 2020;38:19-24.

    \R1Šw‰ï”­•\\

    1. £ŒË‡ŽŸAˆ¢•F’‰”VFŒöO‰q¶‚Ì‚œ‚߂̌‹Šj‹ÛƒQƒmƒ€‰ðÍA‘æ94‰ñ“ú–{Œ‹Šj•aŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒEƒ€uŒ‹Šj‹ÛƒQƒmƒ€Œ€‹†‚̐i•à@-Šî‘b‚Ɖž—pvA2019”N6ŒŽ7`8“úA‰—‘啪

    2. …“cŽ–€FƒEƒCƒ‹ƒXŠŽõÇA•Ï‚í‚Á‚œ‚±‚ƁA•Ï‚í‚ç‚È‚¢‚±‚ƁA‘æ60‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€‚QA2019”N5ŒŽ26“úA‰—–ŒŒÃ‰®

    3. …“cŽ–€A“c’†Ã‰ÀA‹î—ÑŒ«ˆêA’r“c’C–çAÂ–Ø—mŽqA“c’†˜a‰ÀAå“¹‘åAŽsì^—R”üA–L“cŒ’‘Ÿ˜YAŒÃŽR­KAŽRŒû‰À„A‰i‘òŒõA˜a“cŠwFƒpƒŒƒRƒEƒCƒ‹ƒXA3Œ^‚É‚æ‚é—¬s«‹Ø’ɏǂ̒T’m‚ɂ͏njóŒQƒT[ƒxƒCƒ‰ƒ“ƒX‚ª—LŒø‚Å‚ ‚éA‘æ73‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2019”N8ŒŽ23“úA‰—·‰ªŽs

    4. Ÿ“‡—R—˜ŽqAŸ“‡Žj•vA—é–Ø—TA£ŒË‡ŽŸA“c’†Ã‰ÀA…“cŽ–€AŒ›œ—tŽqF2012”N`2013”NƒV[ƒYƒ“ˆÈ~‚̃}ƒNƒƒ‰ƒCƒh‘ϐ«”x‰Šƒ}ƒCƒRƒvƒ‰ƒYƒ}‚̐„ˆÚA‘æ71‰ñ–k“ú–{¬Ž™‰ÈŠw‰ïA2019”N9ŒŽ15“úA‰—ŽRŒ`Žs

    5. …“cŽ–€F2017”NŽRŒ`‚É‚š‚¯‚éA”rœŒãÅ‘å‚́A38—á‚̏Cü–ƒ‚µ‚ñ‚Æ22—á‚Ì“TŒ^–ƒ‚µ‚ñ‚É‚æ‚é–ƒ‚µ‚ñ—¬sA‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïA2019”N10ŒŽ29`31“úA‰—“Œ‹ž

    6. ¬—Ñ ‹œ‰îAChu SonThanhA…“c Ž–€AŒ‘º GˆêAŽs‘º GA¬’r ’qF“ú–{‚ƃxƒgƒiƒ€‚ÌŽè‘«Œû•aгŽÒ‚©‚番—£‚³‚ꂜƒGƒ“ƒeƒƒEƒCƒ‹ƒX71‚Ì•aŒŽ«‰ðÍ‚Æ•aŒŽ«Œˆ’èˆöŽq‚Ì’TõA‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïA2019”N10ŒŽ29`31“úA‰—“Œ‹ž

    7. ‹g“c ˜a‰›A‘ºŒ ³“¹A…“c Ž–€AŽ… ”Ž”VF“ú–{‚Å•ª—£‚³‚ꂜƒGƒ“ƒeƒƒEƒCƒ‹ƒX D68Š”‚ɑ΂·‚é IVIG»Ü‚Ì’†˜aŠˆ«‚Ì‘ª’èA‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïA2019”N10ŒŽ29`31“úA‰—“Œ‹ž

    8. ‘ŠàV‹MŽjA —é–Ø”Ž‹MA ‘Ÿ“c—²mA •Ћ˗SŽiA ˆ¢•”CˆêA —é–Ø—TAˆ©’J‘å•ãA£ŒË‡ŽŸF”xMycobacterium paraenseÇ‚Ì1—áA‘æ68‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•û‰ïŠwpW‰ïA2019”N10ŒŽ16`18“úA‰—å‘ä

    9. Œ›œ—tŽqA”Š_•ׁA’r“c’C–çA…“cŽ–€F2019”N‚ÌBŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚ɑ΂·‚éƒoƒƒLƒTƒrƒ‹‚ÌŒø‰Ê‚ÆŽ¡—ÑOŒã‚̑ϐ«•ψقðŠÜ‚ÞƒEƒCƒ‹ƒXŒŸo‚̏󋵁A‘æ112‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2019”N12ŒŽ8“úA‰—ŽRŒ`Žs

    10. ’†’J—FŽ÷AŽR–{DA’|“à¹•œA£ŒË‡ŽŸA‰¥’·’©Œ÷A“¡ŒŽ’ŒÆA˜a“cF”VAŒ‹ŠjгŽÒ‚̃Qƒmƒ€•ψُã‚̋߂³‚Æ’n—“I‹ßÚ«‚ÌŠÖ˜A\‘åãŽs•aŒŽ‘̏î•ñ‚ð—p‚¢‚œ‰ðÍ\A‘æ30‰ñ“ú–{‰uŠw‰ï‘‰ïA2020”N2ŒŽ21“úA‹ž“sŽs

    11. ‹î—ÑŒ«ˆêA“Iê—m•œAÂ–Ø—mŽqA£ŒË‡ŽŸA’r“c’C–çA…“cŽ–€AŒ›œ—tŽqA”Š_•ׁFŽRŒ`Œ§‚É‚š‚¯‚éƒqƒgƒRƒƒiƒEƒCƒ‹ƒX‚Ì—¬só‹µA‘æ46‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2020”N3ŒŽ5“úA‰—•Ä‘òAiŽã”­•\j

    12. ŽO•r”üA¬ì’Œ”üA£ŒË‡ŽŸA’r“c’C–çA…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚éƒJƒ‹ƒoƒyƒlƒ€‘ϐ«’°“à×‹Û‰È×‹ÛiCREj‚ÌŒŸoó‹µA‘æ46‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2020”N3ŒŽ5“úA‰—•Ä‘òAiŽã”­•\j

    •œ¬30”N“xi2018”N4ŒŽ-2019”N3ŒŽj

    \H30˜_•¶”­•\“™\

    1. Seto J, Wada T, Suzuki Y, Ikeda T, Araki K, Umetsu Y, Ishikawa H, Mizuta K, Ahiko T. A case of laboratory cross-contamination of Mycobacterium tuberculosis identified by comparative genomics. Int J Tuberc Lung Dis. 2018;22:1239-1242.

    2. Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, Iwata-Yoshikawa N, Kotani O, Ami Y, Shimizu H, Nagata N, Mizuta K, Matsuzaki Y, Koike S. VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J Virol. 2018;92:e00682-18.

    3. Komabayashi K, Seto J, Tanaka S, Suzuki Y, Ikeda T, Onuki N, Yamada K, Ahiko T, Ishikawa H, Mizuta K. The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017. Jpn J Infect Dis. 2018;71:413-418.

    4. Seto J, Ikeda T, Tanaka S, Komabayashi K, Matoba Y, Suzuki Y, Takeuchi S, Yamauchi T, Mizuta K. Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era. Epidemiol Infect. 2018;146:1707-1713.

    5. Matsuzaki Y, Sugawara K, Furuse Y, Shimotai Y, Hongo S, Mizuta K, Nishimura H. Neutralizing epitopes and residues carrying potential antigenic drift of the hemagglutinin-esterase protein of influenza C virus. Viruses. 2018;10:417.

    6. Tanaka S, Sendo D, Ichikawa M, Toyota K, Furuyama M, Komabayashi K, Ikeda T, Mizuta K. Careful clinical surveillance is important for the identification of parechovirus type A3-associated myalgia/myositis: a sporadic case found in a season with a low level of its activity in Yamagata, Japan in 2017. Jpn J Infect Dis. 2019;72:71-72.

    7. Mizuta K, Aoki Y, Komabayashi K, Tanaka S, Yamakawa T, Shimizu Y, Itagaki T, Katsushima F, Katsushima Y, Ikeda T. Parechovirus A3 (PeVA-3)-associated myalgia/myositis occurs irrespective of its genetic cluster; a longitudinal molecular epidemiology of PeV-A3 in Yamagata, Japan between 2003 and 2016. J Med Microbiol. 2019;68:424-428.

    8. Mizuta K, Tanaka S, Komabayashi K,Aoki Y, Itagaki T, Katsushima F, Katsushima Y, Yoshida H, Ito S, Matsuzaki Y, Ikeda T. Phylogenetic and antigenic analyses of coxsackievirus A6 isolates in Yamagata, Japan between 2001 and 2017. Vaccine. 2019;37:1109-1117.

    9. Thu MJ, Qiu Y, Matsuno K, Kajihara M, Mori-Kajihara A, Omori R, Monma N, Chiba K, Seto J, Gokuden M, Andoh M, Oosako H, Katakura K, Takada A, Sugimoto C, Isoda N, Nakao R. Diversity of spotted fever group rickettsiae and their association with host ticks in Japan. 9:1500, 2019. https://doi.org/10.1038/s41598-018-37836-5

    10. Satoh H, Taya K, Shimizu H, Goto A, Tanaka S, Nakano T, Hotta C, Okazaki T, Itamochi M, Ito M, Nakagawa R, Yamashita Y, Arai S, Okuno H, Morino S, Oishi K. Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan. Vaccine. 2019;37:1964-1971.

    \H30Šw‰ï”­•\\

    1. Ooka T, Rakibul IMd, Ochiai S, Ogura Y, Seto K, Isobe J, Ikeda T, Seto J, Gotoh Y, Nishi J, Hayashi T: Genomic comparison of Stx2f phages from Escherichia coli and Escherichia albertii. 2018.5.6-9,VTEC2018, Florence, Italy.

    2. KOIKE S, IMURA A, SUDAKA Y, TAKASHINO A, KOBAYASHI K, FUJII K, NISHIMURA H, MIZUTA K. Establishment of EV71 vaccine efficacy test using human scavenger receptor B2 transgenic mice. Europic 2018, 3th to 7th June 2018. Egmond aan Zee, The Netherlands.

    3. …“cŽ–€FƒpƒŒƒRƒEƒCƒ‹ƒX3Œ^‚É‚æ‚é—¬s«‹Ø’ɏǁE‹Ø‰ŠA‘æ59‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€‚PA2018”N6ŒŽ9“úA‰—‘å‹{

    4. …“cŽ–€FŽRŒ`Œ§‰q¶Œ€‹†Š‚ÌŠˆ“®‚ð’Ê‚¶‚Ä’n•û‰q¶Œ€‹†Š‚Ì–ðŠ„‚ðl‚Š‚éA‘æ59‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[‚PA2018”N6ŒŽ9“úA‰—‘å‹{

    5. …“cŽ–€A“c’†Ã‰ÀA‹î—ÑŒ«ˆêAÂ–Ø—mŽqA’r“c’C–çA”Š_•ׁAŸ“‡Žj•vAŸ“‡—R—˜ŽqA‹g“cGAˆÉ“¡––ŽuAŒ›œ—tŽqF2001~2017”N‚ÉŽRŒ`‚Å•ª—£‚³‚ꂜƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA6Œ^‚Ì•ªŽq‰uŠwA‘æ72‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2018”N8ŒŽ18“úA‰—å‘ä

    6. Kyousuke Kobayashi, Chu Thanh Son, Ayako Takashino, Katsumi Mizuta, Hidekazu Nishimura, Hiroshi Ichimura, Satoshi Koike: Tissue culture adaptation of enterovirus 71 selects mutant viruses that bind to HS and are attenuated in vivo. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïA2018”N10ŒŽ28“ú-30“úA‰—‹ž“s

    7. Itsuki Hamamoto, Hitoshi Takahashi, Katsumi Mizuta, Takato Odagiri, Eri Nobusawa. Susceptibility of NIID-MDCK cells to human parainfluenza virus type 3 (HPIV3) in the presence of influenza virus. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ïA2018”N10ŒŽ28“ú-30“úA‰—‹ž“s

    8. ²“¡ OA‘œ‰®Š]ŽqAŽ…”Ž”VA‘åÎ˜a“¿AŒã“¡–ŸŽqAÂ–Ø—mŽqA’†–썄ŽuA–x“cçŒb”üA’·’Jì“¹–íA”ÂŽ‰ëŒbAˆÉ“¡ ‰ëA‰ª–{—æŽqA–L“ˆçrF•sŠˆ‰»ƒƒNƒ`ƒ““±“ü‚©‚猻Ý‚܂ł̃|ƒŠƒI‚Ì—\–hÚŽíó‹µER‘ۗ̕Ló‹µ‚̐„ˆÚ‚ɂ‚¢‚āiŠŽõÇ—¬s—\‘ª’²ž‚æ‚èjA‘æ22‰ñ“ú–{ƒƒNƒ`ƒ“Šw‰ïŠwpW‰ïA2018”N12ŒŽ8`9“úA‰—_ŒË

    9. ŽR“cŒhŽqAˆ¢•F’‰”VAÎìmA…“cŽ–€A£ŒË‡ŽŸF‚P“s‚SŒ§‚ÉŠg‘債‚œ–ƒ‚µ‚ñ‚̏W’cŠŽõ‚ðŒoŒ±‚µ‚āA‘æ77‰ñ“ú–{ŒöO‰q¶Šw‰ïA2018”N10ŒŽ24-26“úA‰—ŒSŽR

    10. Seto J, Mizuta K, Yamada K, Ishikawa H, and Ahiko T. Detection of modified and primary measles cases using a real-time RT-PCR. ‘æ77‰ñ“ú–{ŒöO‰q¶Šw‰ïA2018”N10ŒŽ24-26“úA‰—ŒSŽR

    •œ¬29”N“xi2017”N4ŒŽ-2018”N3ŒŽj

    \H29˜_•¶”­•\“™\

    1. Seto J, Wada T, Suzuki Y, Ikeda T, Mizuta K, Mitarai S, Ahiko T. Convenient PCR method for variable-number tandem-repeat typing of Mycobacterium tuberculosis clinical isolates. J Microbiol Methods. 2017;139:12-14.

    2. Tanaka S, Matoba Y, Unno M, Ikeda T, Itagaki T, Mizuta K. First isolation of human parechovirus type 4 in Yamagata, Japan. Jpn J Infect Dis. 2017;70:689-690.

    3. Itagaki T, Aoki Y, Matoba Y, Tanaka S, Ikeda T, Matsuzaki Y, Mizuta K. Detection of Saffold viruses from children with acute respiratory infections in Yamagata, Japan, between 2008 and 2015. J Med Virol. 2018;90:34-40.

    4. Matoba Y, Aoki Y, Tanaka S, Unno M, Komabayashi K, Ikeda T, Shimotai Y, Matsuzaki Y, Itagaki T, Mizuta K. The trends of human coronaviruses in Yamagata, Japan, in 2015 to 2016: Occurence of OC43 outbreak in June 2016. Jpn J Infect Dis. 2018;71:167-169.

    5. Suzuki Y, Shimotai Y, Itagaki T, Seto J, Ikeda T, Yahagi K, Mizuta K, Hongo S, Matsuzaki Y. Development of macrolide resistance-associated mutations after macrolide treatment in children infected with Mycoplasma pneumoniae. J Med Microbiol. 2017;66:1531-1538.

    6. Suzuki Y, Seto J, Shimotai Y, Itagaki T, Katsushima Y, Katsushima F, Ikeda T, Mizuta K, Hongo S, Matsuzaki Y. Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period. Jpn J Infect Dis. 2017;70:642-646.

    7. Itagaki T, Aoki Y, Matoba Y, Tanaka S, Ikeda T, Mizuta K, and Matsuaki Y. Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma. Infect Dis (Lond). 2018;50:303-312.

    8. ”Š_•ׁA“Iê—m•œA…“cŽ–€AŒ›œ—tŽqF‚Q‚O‚P‚T”NŽRŒ`Žs‹ßx‚Å—¬s‚µ‚œƒRƒƒiƒEƒCƒ‹ƒXOC43ŠŽõÇA“ú–{¬Ž™‰Èˆã‰ï‰ï•ñA2017;53:131-134.

    9. Yamakawa T, Mizuta K, Kurokawa K, Nagasawa H, Yamada T, Suzuki E, Wada M. Clinical characteristics of 17 adult patients with epidemic myalgia associated with human parechovirus type 3 infection.Rinsho Shinkeigaku. 2017;57:485-491.

    10. Ÿ“‡—R—˜ŽqAŸ“‡Žj•vA…“cŽ–€AŒ›œ—tŽqFƒpƒ‰ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚ª•ª—£‚³‚ꂜ”­]Ç‚Ì‚S—áA¬Ž™‰Èf—ÁA2018;81:125-128.

    11. £ŒË‡ŽŸAˆ¢•F’‰”VFŽRŒ`Œ§‚É‚š‚¯‚é‚—îŽÒ‚Ì“àˆö«Ä”RŒ‹ŠjÇ—á‚Ì‹Gß«AŒ‹ŠjA2018;93:93-100.

    \H29Šw‰ï”­•\\

    1. “Iê—m•œA…“cŽ–€AŒ›œ—tŽqF2014-2015”N‚É‚š‚¯‚éŽRŒ`Œ§‚̃qƒgƒRƒƒiƒEƒCƒ‹ƒX‚Ì—¬sA•œ¬29”N5ŒŽ27“úA‘æ58‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA‰—’·èŽs

    2. ¬–쎛Œ[Aã–k—m“¿A“n糒B–çA•œƒJƒ„ƒmA“n•”ç¹AÖ“¡”ŽŽqA£ŒË‡ŽŸA—é–Ø—TA¡‰ª_ˆêF™ù—ð‚̂Ȃ¢‘l™ùÇ‚Ì1—áA•œ¬29”N6ŒŽ17“úA‘æ211‰ñ“ú–{“à‰ÈŠw‰ï“Œ–k’n•û‰ïA‰—å‘äŽs
      Ë—DG‰‰‘èÜ‚É‘I‚΂ê‚Ü‚µ‚œI

    3. ‹î—ÑŒ«ˆêA’r“c’C–çA£ŒË‡ŽŸA“c’†Ã‰ÀA—é–Ø—TA“Iê—m•œAŠC–ì^‹IA…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚é–ƒ‚µ‚ñW’c”­¶A‘æ71‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2017”N8ŒŽ3-4“úA‰—å‘ä

    4. £ŒË‡ŽŸA—é–Ø—TA’r“c’C–çA…“cŽ–€F‚‚‚ª’Ž•a‚Ì“ä‚É”—‚éAŠÂ‹«”÷¶•šŒnŠw‰ï‡“¯‘å‰ï2017ƒVƒ“ƒ|ƒWƒEƒ€uŽ©‘RŠÂ‹«‰º‚ɐ¶‘§‚·‚é•aŒŽ‘Ì‚ð’T‚évA 2017”N8ŒŽ29“úA‰—å‘ä

    5. Hamamoto I, Takahashi H, Mizuta K, Sato K, Nishimura H, Odagiri T, and Nobusawa E. Evaluation of the virus clearance capacity of NIID-MDCK cells. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA•œ¬29”N10ŒŽ24-26“úA‰—‘åã

    6. Kobayashi K, Sudaka Y, Takashino A, Mizuta K, and Koike S. Attachment receptors negatively affect neurovirulence and positively affect in vitro replication of Enterovirus 71. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA•œ¬29”N10ŒŽ24-26“úA‰—‘åã

    7. Koike S, Imura A, Sudaka Y, Takashino A, Kobayashi K, Fujii K, Nishimura H, and Mizuta K. Establishment of EV71 vaccine efficacy test using human SCARB2 transgenic mice. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA•œ¬29”N10ŒŽ24-26“úA‰—‘åã

    8. £ŒË‡ŽŸAˆ¢•F’‰”VFŽRŒ`Œ§‚É‚š‚¯‚é‚—îŽÒ‚Ì“àˆö«Ä”RŒ‹ŠjгŽÒ‚Ì‹Gß«A‘æ76‰ñ“ú–{ŒöO‰q¶Šw‰ïA•œ¬29”N10ŒŽ30“ú`11ŒŽ2“úA‰—Ž­Ž™“‡Žs

    9. —é–Ø—TAŒ›œ—tŽqFŽRŒ`Œ§‚É‚š‚¯‚é2014”N‚©‚ç2016”N‚É•ª—£‚µ‚œ”x‰Šƒ}ƒCƒRƒvƒ‰ƒYƒ}‚̉uŠw“I“®ŒüA‘æ38‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA•œ¬29”N10ŒŽ28“úE29“úA‰—’·ˆäŽs

    10. £ŒË‡ŽŸA˜a“c’”VA—é–Ø—TA’r“c’C–çA…“cŽ–€Aˆ¢•F’‰”VFŒ‹Šj‹Û•ªŽq‰uŠw‚É‚æ‚è”»–Ÿ‚µ‚œ‰“Šu’n‚É‚š‚¯‚éŒŸžŽº“àŒð·‰˜õŽ–—áA‘æ2‰ñRŽ_‹ÛŒ€‹†‰ïA•œ¬29”N11ŒŽ23“úA‰—“Œ‹ž
      Ë‘æ2‰ñRŽ_‹ÛŒ€‹†‰ïƒxƒXƒgƒvƒŒƒ[ƒ“ƒe[ƒVƒ‡ƒ“Ü‚É‘I‚΂ê‚Ü‚µ‚œI

    11. ‹î—ÑŒ«ˆêA’r“c’C–çA£ŒË‡ŽŸA“c’†Ã‰ÀA—é–Ø—TA“Iê—m•œAŠC–ì^‹IA…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚é–ƒ‚µ‚ñ‚̏W’c”­¶A‘æ‚S‚S‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA•œ¬30”N3ŒŽ8“úA‰—ŽRŒ`Žs

    12. Seto J, Wada T, Suzuki Y, Ikeda T,Mizuta K, and Ahiko T. A case of cross-contamination in a laboratory at remote location clarified by molecular epidemiology for Mycobacterium tuberculosis. U.S.-Japan Cooperative Medical Sciences Program, 52nd Mycobacteria Panel Meeting, March 15-16, 2018,Niigata, Japan

    •œ¬28”N“xi2016”N4ŒŽ\2017”N3ŒŽj

    \H28˜_•¶”­•\“™\

    1. Aoki Y, Matoba Y, Tanaka S, Yahagi K, Ito S, Yoshida H, Itagaki T, Mizuta K. Chance isolation of non-pathogenic vaccine-derived measles and rubella viruses from children with acute respiratory infections. Jpn J InfectDis. 2016;69:350-351.

    2. Aoki Y, Matoba Y, Tanaka S, Yahagi K, Itagaki T, Katsushima F, Katsushima Y, Takeda M, Mizuta K. Chronological changes of mumps virus genotypes in Japan between 1999 and 2013. Infect Dis (Lond). 2016;48:524-529.

    3. Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Kuwahara T, Shimazu Y, Shimomura T, Watanabe S, Odagiri T, The Influenza Virus Surveillance Group of Japan. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016. Euro Surveill. 2016;21(24).

    4. Matsuzaki Y, Sugawara K, Furuse Y, Shimotai Y, Hongo S, Oshitani H, Mizuta K, Nishimura H. Genetic lineage and reassortment of influenza C viruses circulating between 1947 and 2014. J Virol. 2016;90:8251-8265.

    5. Matoba Y, Aoki Y, Tanaka S, Yahagi K, Katsushima Y, Katsushima F, Sugawara K, Matsuzaki Y, Mizuta K. Hela-ACE2-TMPRSS2 cells are useful for the isolation of human coronavirus 229E. Jpn J Infect Dis. 2016;69:452-454.

    6. Suzuki Y, Shimanuki M, Seto J, Yahagi K, Mizuta K. A case of scrub typhus imported from South Korea to Yamagata, Japan. Jpn J Infect Dis. 2016;69:454-456.

    7. Suzuki Y, Seto J, Shimotai Y, Ikeda T, Yahagi K, Mizuta K, Matsuzaki Y, Hongo s. Development of an endpoint genotyping assay to detect the Mycoplasma pneumoniae 23S rRNA gene and distinguish the existence of macrolide resistance-associated mutations at position 2063. J Microbiol Methods. 2016;131:130-134.

    8. Seto J, Suzuki Y, Nakao R, Otani K, Yahagi K, Mizuta K. Meterological factors affecting Scrub typhus occurrence: a retrospective study of Yamagata Prefecture, Japan, 1984-2014. Epidemiol Infect. 2017;145:462-470.

    9. Seto J, Wada T, Suzuki Y, Ikeda T, Mizuta K, Yamamoto T, Ahiko T. Mycobacterium tuberculosis transmission among elderly persons, Yamagata Prefecture, Japan, 2009-2015. Emerg Infect Dis. 2017;23:448-455.

    10. Tanaka S, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Matsuzaki Y, Mizuta K. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol. 2016;60:854-858.

    11. ¬–쎛Œ[Aã–k—m“¿A“n粒B–çA•œƒJƒ„ƒmA“n•”ç¹AâV“¡”ŽŽqA£ŒË‡ŽŸA—é–Ø—TA¡‰ª_ˆêFƒ‰ƒbƒg™ù—ð‚ª”F‚ß‚ç‚ê‚È‚¢‘l™ùÇ—áA•aŒŽ”÷¶•šŒŸoî•ñ 2017;38:43-44.

    \H28Šw‰ï”­•\\

    1. £ŒË‡ŽŸA—é–Ø—TA˜a“c’”VAˆ¢•F’‰”VFŒ‹Šj‹Û”œ•œ”z—ñ‘œŒ^•ªÍŒ‹‰Ê‚ƈâ“`Œn“î•ñ‚Ì‘g‚ݍ‡‚킹‚É‚æ‚éV‚œ‚È•ªŽq‰uŠwî•ñ‚Ì’ñ‹ŸA•œ¬28”N5ŒŽ27“úA‘æ91‰ñ“ú–{Œ‹Šj•aŠw‰ï‘‰ïA‰—‹à‘òŽs

    2. …“cŽ–€AŒ›œ—tŽqA’|“cœF—Տ°ŒŸ‘Ì‚©‚ç‚̃EƒCƒ‹ƒX•ª—£Š”‚Ì“¯’肪¢“ï‚Å‚ ‚Á‚œŒoŒ±‚©‚çA•œ¬28”N6ŒŽ19“úA‘æ57‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA‰—ŒSŽRŽs

    3. —é–Ø—TA£ŒË‡ŽŸA“‡ŠÑ”ü˜aA–îìˆêŽ}A…“cŽ–€FŠØ‘‚©‚çŽRŒ`Œ§‚Ö‚Ì—A“ü‚‚‚ª’Ž•a‚Ì‚PÇ—áA•œ¬28”N8ŒŽ19-19“úA‘æ70‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA‰—\˜a“cŽs

    4. £ŒË‡ŽŸA˜a“c’”VA—é–Ø—TA’r“c’C–çA…“cŽ–€AŽR–{‘Ÿ˜YAˆ¢•F’‰”VF‚—îŽÒŒ‹Šj‚ª‘唌‚ðè‚ß‚éW’c‚É‚š‚¯‚éÅ‹ß‚ÌŒ‹ŠjŠŽõFŽRŒ`Œ§‚É‚š‚¯‚é2009|2015”N‚Ì–Ô—…“I‚ÈŒ‹Šj•ªŽq‰uŠw’²žŒ‹‰ÊA‘æ‚P‰ñRŽ_‹ÛŒ€‹†‰ïA2016”N9ŒŽ29|30“úA‰—‰«“êË‘æ‚P‰ñRŽ_‹ÛŒ€‹†‰ï§—ãÜ‚É‘I‚΂ê‚Ü‚µ‚œI

    5. £ŒË‡ŽŸA˜a“c’”VFŒ‹Šj‹Û•ªŽq‰uŠw‚̏«—ˆ“W–]A‘æ90‰ñ“ú–{×‹ÛŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒEƒ€uÏ‹É“I‰uŠw’²ž‚ƍ׋ۊw‚̐ړ_vA2017”N3ŒŽ19“úA‰—å‘ä

    •œ¬27”N“xi2015”N4ŒŽ\2016”N3ŒŽj

    \H27˜_•¶”­•\“™\

    1. Saitoh H, Koizumi N, Seto J, Ajitsu S, Fujii A, Takasaki S, Yamakage S, aoki S, Nakayama K, Ashino Y, Chagan-Yasutan C, Kiyomoto H, Hattori T. Leptospirosis in the Tohoku Region: Re-emerging Infectious Disease. Tohoku J Exp Med. 2015;236:33-37.

    2. Katsushima Y, Katsushima Y, Suzuki Y, Seto J, Mizuta K, Nishimura H, Matsuzaki Y. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic. Pediatr Int. 2015;57:247-252.

    3. Aoki Y, Matoba Y, Tanaka S, Yahagi K, Hirokawa C, Tamura T, Itagaki T, Matsuzaki Y. Mizuta K. Isolation of Saffold virus type 2 from children with acute respiratory infections using the RD-18S-Niigata cell line. Jpn J Infect Dis. 2015;68:438-441.
      ËFeigin and Cherry's Textbook of Pediatric Infectious Diseases 8th edition, ElsvierŽÐA2019‚ňø—p‚³‚ê‚Ü‚µ‚œI

    4. Matoba Y, Aoki Y, Tanaka S, Yahagi K, Shimotai Y, Matsuzaki Y, Itagaki T, Mizuta K. An outbreak of human coronavirus OC43 during the 2014-2015 influenza season in Yamagata, Japan. Jpn J Infect Dis. 2015;68:442-445..

    5. Seto J, Wada T, Iwamoto T, Tamaru A, Maeda S, Yamamoto K, Hase A, Murakami K, Maeda E, Oishi A, Migita Y, Yamamoto T, Ahiko T. Phylogenetic assignment of Mycobacterium tuberculosis Beijing Clinical isolates in Japan by maximum a posteriori estimation. Infect Genet Evol. 2015;35:82-88.

    6. Yokoyama E, Hachisu Y, Iwamoto T, Nakanishi N, Arikawa K, Wada T, Seto J, Kishida K. Comparative analysis of Mycobacterium tuberculosis Beijing strains isolated in three remote areas of Japan. Infect Genet Evol. 2015;34:444-449.

    7. Hirai S, Yokoyama E, Etoh Y, Seto J, Ichihara S, Suzuki Y, Maeda E, Sera N, Horikawa K, Sato S, Yamamoto T. Putative classification of clades of enterohemorrhagic Esherichia coli O157 using an IS-printing system. Lett Appl Microbiol. 2015;61:267-273.

    8. Kuroki T, Ito K, Ishihara T, Furukawa I, Kaneko A, Suzuki Y, Seto J, Kamiyama T. Turtle-associated Salmonella infections in Kanagawa, Japan. Jpn J Infect Dis. 2015;68:333-337.

    9. Shimizu Y, Abiko C, Ikeda T, Mizuta K, Matsuzaki Y. Influenza C virus and human metapneumovirus infections in hospitalized children with lower respiratory tract illness. Pediatr Infect Dis J. 2015;34:1273-1275.

    10. Mizuta K, Yamakawa T, Kurokawa K, Chikaoka S, Shimizu Y, Itagaki t, Katsushima F, Katsushima Y, Ito S, Aoki Y, Matoba Y, Tanaka S, Yahagi K. Epidemic myalgia and myositis associated with human parechovirus type 3 infections occur not only among adults but also among childnre: Findings in Yamagata, Japan, in 2014. Epidemiol Infect. 2016;144:1286-1290.

    11. Ooka T, Ogura Y, Katsura K, Seto K, Kobayashi H, Kawano K, Tokuoka E, Furukawa M, Harada S, Yoshino S, Seto J, Ikeda T, Yamaguchi K, Murase K, Gotoh Y, Imuta N, Nishi J, Gomes TA, Beutin L, Hayashi T. Defining the Genome Features of Escherichia albertii, an Emerging Enteropathogen Closely Related to Escherichia coli. Genome Biol Evol. 2015;7:3170-3179.

    12. Takashita E, Fujisaki S, Shirakura M, Nakamura K, Nishida N, Kuwahara T, Ohmiya S, Sato K, Ito H, Chiba F, Nishimrura H, Shindo S, Watanabe S, Odagiri T, The Influenza Virus Surveillance Group of Japan. Characterization of an A(H1N1)pdm09 virus imported from India, March 2015. Jpn J Infect Dis. 2016;69:83-86..

    13. £ŒË‡ŽŸA—é–Ø—TAˆ¢•F’‰”VFƒGƒ“ƒhƒgƒLƒVƒ“¬“üŽ–ˆÄ‘OŒã‚ł̃NƒHƒ“ƒeƒBƒtƒFƒƒ“TBƒS[ƒ‹ƒhŒŸž¬Ñ”äŠrAŒ‹Šj 2016;91:49-52.

    14. “c’†Ã‰ÀA“Iê—m•œAÂ–Ø—mŽqA–îìˆêŽ}A…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚Ì•ª—£ó‹µi2014jAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2015;48:5-8.

    \H27Šw‰ï”­•\\

    1. —é–Ø—TA£ŒË‡ŽŸA”Š_•ׁAŒ›œ—tŽqA–{‹œœŽ¡FƒNƒ‰ƒŠƒXƒƒ}ƒCƒVƒ“ˆ•ûŒã‚ÌŠ³ŽÒ‚©‚番—£‚³‚ꂜMycoplasma pneumoniae‚̃}ƒNƒƒ‰ƒCƒh‘ϐ«ˆâ“`Žq•ψق̌ŸoA‘æ89‰ñ“ú–{ŠŽõÇŠw‰ïŠwpu‰‰‰ïA2015”N4ŒŽ15-17“úA‰—‹ž“s

    2. …“cŽ–€F—Տ°ŒŸ‘Ì‚©‚ç‚̃EƒCƒ‹ƒX•ª—£‚É‚à‚Æ‚¢‚œ‰uŠwŒ€‹†[’†’·Šú“I‚ȃEƒCƒ‹ƒXŠŽõÇ‘΍ô‚ւ̍vŒ£‚ð–ÚŽw‚µ‚ā[A‘æ56‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2015”N6ŒŽ13-14“úA‰—‰ªŽR

    3. “Iê—m•œAÂ–Ø—mŽqA“c’†Ã‰ÀA–îìˆêŽ}A‰º•œ‹`—²AŒ›œ—tŽqA”Š_•ׁA…“cŽ–€F2014/2015ƒCƒ“ƒtƒ‹ƒGƒ“ƒU—¬sŠú‚É‚š‚¯‚éŽRŒ`Œ§‚̃qƒgƒRƒƒiƒEƒCƒ‹ƒXOC43‚Ì—¬sA‘æ69‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2015”N8ŒŽ21-22“úA‰—ŒSŽR

    4. £ŒË‡ŽŸF’á– ‰„’nˆæ‚É‚š‚¯‚éŒ‹Šj•ªŽq‰uŠw‚Ì•K—v«‚ɂ‚¢‚āA‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ïAƒVƒ“ƒ|ƒWƒEƒ€hŽg‚¢‚œ‚­‚Ȃ錋Šj•ªŽq‰uŠwF•ÛŒ’Š‚ł̊ˆ—pŽ–—á‚ÆŒ‹Šj‘΍ô‚̏«—ˆ“I“W–]hA2015”N11ŒŽ4“úA‰—’·è

    5. —é–Ø—TA£ŒË‡ŽŸA¯Ž¡—T—ºAŽ–ì—S”üA–kàVr•FFŽRŒ`Œ§‚̈ê’nˆæ‚Å•ª—£‚³‚ꂜƒTƒ‹ƒ‚ƒlƒ‰‚̉uŠw“IŒŸ“¢A‘æ36‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA2015”N11ŒŽ7-8“úA‰—’߉ª

    6. …“cŽ–€Fƒx[ƒVƒbƒNƒŒƒNƒ`ƒƒ[‚Qhƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚ƃ{ƒJƒEƒCƒ‹ƒX‚ÌŽÀ‘ԁhA‘æ27‰ñ“ú–{—Տ°”÷¶•šŠw‰ï‘‰ïEŠwpW‰ïA2016”N1ŒŽ29-31“úA‰—å‘ä

    7. £ŒË‡ŽŸAŒäŽèô‘FSapphinreAmp@Fast@PCR@Master@Mix@‚ð—p‚¢‚œv‘¬AˆÀ‰¿‚ÈŒ‹Šj‹Û”œ•œ”z—ñ‘œŒ^•ªÍ–@‚ÌŠm—§A‘æ27‰ñ“ú–{—Տ°”÷¶•šŠw‰ï‘‰ïEŠwpW‰ïA2016”N1ŒŽ29-31“úA‰—å‘ä

    •œ¬26”N“xi2014”N4ŒŽ\2015”N3ŒŽj

    \H26˜_•¶”­•\“™\

    1. Matsuzaki Y, Sugawara K, Abiko C, Ikeda T, Aoki Y, Mizuta K, Katsushima N, Katsushima F, Katsushima Y, Itagaki T, Shimotai Y, Hongo S, Muraki Y. Nishimura H. Epidemiological information regarding the periodic epidemics of influenza C virus in Japan (1996-2013) and the seroprevalence of antibodies to different antigenic groups. J Clin Virol. 2014;61-87-93.

    2. Mizuta K, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Katsushima F, Katsushima Y, Ito S, Hongo S, Matsuzaki Y. Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J Med Microbiol. 2014;63:1356-1362.

    3. Matsuzaki Y, Sugawara K, Nakauchi M, Takahashi Y, Onodera T, Tsunetsugu-Yokota Y, Matsumura T, Ato M, Kobayashi K, Shimotai Y, Mizuta K, Hongo S, Tashiro M, Nobusawa E. Epitope Mapping of the Hemagglutinin Molecule of A/(H1N1)pdm09 Virus by Using Monoclonal Antibody Escape Mutants. J Virol. 2014;88:12364-12373..

    4. Hirai S, Yokoyama E, Etoh Y, Seto J, Ichihara S, Suzuki Y, Maeda E, Sera N, Horikawa K, Yamamoto T. Analysis of the population genetics of clades of enterohaemorrhagic Escherichia coli O157: H7/H- isolated in three areas in Japan. J Appl Microbiol. 2014;117:1191-1197.

    5. Nishizuka M, Suzuki H, Ara T, Watanabe M, Morita M, Sato C, Tsuchida F, Seto J, Amemura-Maekawa J, Kura F, Takeda H. A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem. J Infect Chemother. 2014;20:390-393.

    6. Matoba Y, Aoki Y, Tanaka S, Yahagi K, Itagaki T, Matsuzaki Y, Mizuta K. Picornavirus-like cytopathic effects on RD-18S cell lines were induced by human coronavirus 229E not picornaviruses. Jpn J Infect Dis. 2015;68:78-79.

    7. Tanaka S, Aoki Y, Matoba Y, Yahagi K, Mizuta K, Itagaki T, Katsushima F, Katsushima Y, Matsuzaki Y. The dominant antigenic group of influenza C infections changed from C/SaoPaulo/378/82-lineage to C/Kanagawa/1/76-lineage in Yamagata, Japan in 2014. Jpn J Infect Dis. 2015;68:166-168.

    8. Matoba Y, Abiko C, Ikeda T, Aoki Y, Suzuki Y, Yahagi K, Matsuzaki Y, Itagaki T, Katsushima F, Katsushima Y, Mizuta K. Detection of the human coronavirus 229E, HKU1, NL63 and OC43 between 2010 and 2013 in Yamagata, Japan. Jpn J Infect Dis. 2015;68:138-141.
      ËFeigin and Cherry's Textbook of Pediatric Infectious Diseases 8th edition, ElsvierŽÐA2019‚ňø—p‚³‚ê‚Ü‚µ‚œI

    9. Wada T, Iwamoto T, Tamaru A, Seto J. Ahiko T, Yamamoto K, Hase A, Maeda S. Yamamo T. Clonality and Micro-Diversity of a Nationwide Spreading Genotype of Mycobacterium tuberculosis in Japan. PLoS One. 2015;10:e0118495.

    10. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqA¬‹{‹MŽqAŽR–{–Ÿ•FFŽRŒ`Œ§‚É‚š‚¯‚éŽ”‚¢”L‚̃WƒtƒeƒŠƒA“Å‘fŒŽ«Corynebacterium ulceransŠŽõó‹µ’²žA“úb‰ïŽ 2014;67:613-616.

    11. £ŒË‡ŽŸAˆ¢•F’‰”V: ÚGŽÒŒ’Nf’f‚É‚š‚¯‚é‚—îŽÒ‚ɑ΂·‚éƒCƒ“ƒ^[ƒtƒFƒƒ“ƒÁ—V—£ŽŽŒ±‚Ì—L—p«‚ÌŒŸ“¢AŒ‹Šj 2014;89:503-508.
      ËŒ‹ŠjŒ€‹†§—ãÜ‚É‘I‚΂ê‚Ü‚µ‚œI

    12. —é–Ø—TA£ŒË‡ŽŸA”Š_•ׁAÂ–Ø•q–çAˆÀ‘·ŽqçŒbŽqAŒ›œ—tŽqFŽRŒ`Œ§‚Å2004”N‚©‚ç2013”N‚Ì10”NŠÔ‚É•ª—£‚µ‚œMycoplasma pneumoniae‚̃}ƒNƒƒ‰ƒCƒh‘ϐ«ˆâ“`Žq•ÏˆÙ‚š‚æ‚Ñp1ˆâ“`ŽqŒ^‰ðÍAŠŽõÇŠwŽGŽ 2015;89:16-22D

    13. £ŒË‡ŽŸA—é–Ø—TA–îìˆêŽ}FŽRŒ`Œ§‚É‚š‚¯‚éƒ}ƒ_ƒj•ª•z’²žAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2014;47:1-3.

    \H26Šw‰ï”­•\\

    1. …“cŽ–€AŒ›œ—tŽqA–{‹œœŽ¡FŽRŒ`‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX71Œ^‚Ì•ªŽq‰uŠwi1990`2013”NjA‘æ55‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2014”N6ŒŽ14-15“úA‰—ŽD–y

    2. ’|“cœA’†“‡“TŽqA…“cŽ–€FhŽåƒvƒƒeƒA[ƒ[TMPRSS2‚́A‹}«ŒÄ‹zŠíŠŽõÇƒEƒCƒ‹ƒX‚̐¶‘Ì“àŠˆ«‰»y‘f‚Å‚ ‚éA‘æ55‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2014”N6ŒŽ14-15“úA‰—ŽD–y

    3. —é–Ø—TA£ŒË‡ŽŸA”Š_•ׁAŸ“‡—R—˜ŽqAŸ“‡Žj•vAÂ–Ø•q–çAˆÀ‘·ŽqçŒbŽqA–îìˆêŽ}A…“cŽ–€AŒ›œ—tŽqA–{‹œœŽ¡FŽRŒ`Œ§‚Å•ª—£‚³‚ꂜMycoplasma pneumoniae ‚ÌP1ˆâ“`ŽqŒ^‰ðÍA‘æ68‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2014”N8ŒŽ22|23“úA‰—å‘ä

    4. …“cŽ–€AÂ–Ø—mŽqA“Iê—m•œA“c’†Ã‰ÀA–îìˆêŽ}A”Š_•ׁAŒ›œ—tŽqFƒTƒtƒH[ƒhƒJƒ‹ƒfƒBƒIƒEƒCƒ‹ƒX2Œ^‚ÌRD-18S×–E‚É‚æ‚镪—£A‘æ68‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2014”N8ŒŽ22-23“úA‰—å‘ä

    5. •œˆäWˆê˜YA‰¡ŽR‰h“ñA]“¡—ÇŽ÷A£ŒË‡ŽŸAŽsŒŽËŽqA—é–Ø—TA‘O“c‰r—¢ŽqA–xì˜a”üFIS-printing‚ð—p‚¢‚œ’°ŠÇoŒŒ«‘å’°‹Û O157‚Ìclade„’è–@‚ÌŠm—§A‘æ35‰ñ“ú–{H•i”÷¶•šŠw‰ïA2014”N9ŒŽ18-19“úA‰—‘åã

    6. ‘剪—B—SAšŒË˜aŽqA¬–ì‰prA‰Í–ìŠì”üŽqA¬—яGŽ÷A‹g–ìCŽiA£ŒË‡ŽŸAŽRŒûŒhŽ¡AŒÃì^“lA“¿‰ª‰p—ºAˆäŒûƒAåa–Ž“c’ŒŽqAŒŽ“cœ–çAŒ‡ˆê˜YAŒjŒ[‰îA¬–ž‹`rA—Ñ“N–çFV‹»•aŒŽ‘ÌEscherichia albertii‚̃Qƒmƒ€‚š‚æ‚Ñ‰uŠw‰ðÍA‘æ35‰ñ“ú–{H•i”÷¶•šŠw‰ïA2014”N9ŒŽ18-19“úA‰—‘åã

    7. —é–Ø—TA£ŒË‡ŽŸA”Š_ •ׁAˆÀ‘·ŽqçŒbŽqA–îìˆêŽ}A…“cŽ–€AŒ›œ—tŽq:ŽRŒ`Œ§‚Å•ª—£‚³‚ꂜMycoplasma pneumoniae‚̃}ƒNƒƒ‰ƒCƒh‘ϐ«ˆâ“`Žq•ψىðÍA‘æ35‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA2014”N10ŒŽ25“ú-26“úA‰—’·ˆä

    8. £ŒË‡ŽŸFŽRŒ`Œ§‚É‚š‚¯‚é‹CÛƒf[ƒ^‚ð—p‚¢‚œ‚‚‚ª’Ž•aгŽÒ”—\‘ªƒ‚ƒfƒ‹‚̍\’zA‘æ21‰ñƒŠƒPƒbƒ`ƒAŒ€‹†‰ïA2014”N12ŒŽ20“úA‰—“Œ‹ž

    9. “c’†Ã‰ÀA“Iê—m•œAÂ–Ø—mŽqA–îìˆêŽ}A…“cŽ–€AŸ“‡Žj•vAŸ“‡—R—˜ŽqA”Š_•ׁAŒ›œ—tŽqF2014”NŽRŒ`Œ§‚É‚š‚¯‚éCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚Ì•ª—£ó‹µA‘æ41‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2015”N3ŒŽ5“úA‰—ŽRŒ`

    10. ŽR“cŒhŽqAˆî–Ñ–«A•œŠÔ‹IsA¬â‘Ÿ—SA’†–슰”VA•“cÉA£ŒË‡ŽŸAˆ¢•F’‰”VF’nˆæ‚ł̏W’cŠŽõŽ–—á‚©‚çŠw‚ԁA‘æ90‰ñ“ú–{Œ‹Šj•aŠw‰ï‘‰ïA2015”N3ŒŽ27-28“úA‰—’·è

    11. ˜a“c’”VA£ŒË‡ŽŸAŽR–{‘Ÿ˜YAˆ¢•F’‰”VF’áœëг—Š’nˆæ‚É‚š‚¯‚éŒ‹Šj‹Û—Տ°•ª—£Š”‚Ì“`”dŒo˜H’ǐՁA‘æ90‰ñ“ú–{Œ‹Šj•aŠw‰ï‘‰ïA2015”N3ŒŽ27-28“úA‰—’·è

    •œ¬25”N“xi2013”N4ŒŽ\2014”N3ŒŽj

    \H25˜_•¶”­•\“™\

    1. Mizuta K, Abiko C, Aoki Y, Ikeda T, Matsuzaki Y, Hongo S, Itagaki T, Katsushima N, Ohmi A, Nishimura H, Ahiko T. Molecular epidemiology of coxsackievirus A16 strains isolated from children in Yamagata, Japan between 1988 and 2011. Microbiol Immunol. 2013;57:400-405.

    2. Mizuta K, Yamakawa T, Nagasawa H, Itagaki T, Katsushima F, Katsushima Y, Shimizu Y, Ito S, Aoki Y, Ikeda T, Abiko C, Kuroda M, Noda M, Kimura H, Ahiko T. Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: findings from Yamagata, Japan, in 2011. J Clin Virol. 2013;58:188-193.
      ËMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 8th edition, ElsevierŽÐA2014‹y‚Ñ9th edition ElsevierŽÐA2020‚ňø—p‚³‚ê‚Ü‚µ‚œI

    3. Aoki Y, Mizuta K, Ikeda T, Abiko C, Itagaki T, Ahiko T. Isolation of vaccine-derived measles viruses from children with acute respiratory infection. Tohoku J Exp Med. 2013;230:111-115..

    4. Ikuta K, Mizuta K, Suzutani T. Anti-influenza virus activity of two extracts of the blackcurrant (Ribes Nigrum L.) from New Zealand and Poland. Fukushima J Med Sci. 2013;59:35-38.

    5. Sekizuka H, Ikuta K, Mizuta K, Takechi S, Suzutani T. Relationship between polyphenol content and anti-influenza viral effects of berries. J Sci Food Agric. 2013;93:2239-2241.

    6. Takashita E, Fujisaki S, Kishida N, Xu H, Imai M, Tashiro M, Odagiri T, the influenza virus surveillance group of Japan. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan. Influenza other respiratory viruses. 2013;7:1390-1399.

    7. Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, Kawase M, Noda M, Kimura H, Matsuyama S, Fukuhara H, Mizuta K, Maenaka K, Ami Y, Esumi M, Kato A, Takeda M. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol. 2013;87:11930-11935.

    8. Takeuchi F, Sekizuka T, Ogasawara Y, Mizuta K, Kuroda M. MePIC, megagenomic pathogen identificatiion for clinical specimens. Jpn J Infect Dis. 2014;67:62-65.

    9. Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Lupisan S, Roy C, Hiramatsu H, Sugawara K, Mizuta K, Matsuzaki Y, Suzuki Y, Oshitani H. Antigenic and receptor binding properties of Enterovirus 68. J Virol. 2014;88:2374-2384.

    10. Mizuta K, Tsukagoshi H, Ikeda T, Aoki Y, Abiko C, Itagaki T, Nagano M, Noda M, Kimura H. Molecular evolution of hemagglutinin-neuraminidase gene in human parainfluenza virus type 3 (HPIV3) isolates from children with acute respiratory illness in Yamagata prefecture, Japan. J Med Microbiol. 2014;63:570-577.

    11. £ŒË‡ŽŸAˆ¢•F’‰”VA˜a“câM”VA’·’J“āAŽR“cŒhŽqFŒ‹Šj’á– ‰„’nˆæ‚É‚š‚¯‚é–Ô—…“I‚ÈŒ‹Šj‹Û”œ•œ”z—ñ‘œŒ^iVNTR)•ªÍ‚Ì—L—p«A Œ‹Šj 2013;88:535-542.

    \H25Šw‰ï”­•\\

    1. —é–Ø—TA£ŒË‡ŽŸA”Š_•ׁAŒ›œ—tŽqAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚é–òÜ‘ϐ«Mycoplasma@pneumoniae‚Ì“®Œü”cˆ¬A‘æ87‰ñ“ú–{ŠŽõÇŠw‰ïŠwpu‰‰‰ïA2013”N6ŒŽ5“ú-6“úA‰—‰¡•l

    2. …“cŽ–€A–ì“c‰ë”ށF¬Ž™‚É‚š‚¯‚éƒpƒŒƒRƒEƒCƒ‹ƒX‚RŒ^—¬s‚Ɛ¬l‚̋ؒɏǁF‘æ54‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2013”N6ŒŽ8“ú-9“úA‰—‘q•~

    3. •œ–ì‰pŽqAŽR–{ŠóA…“cŽ–€AŒ“cr“ñA–ì“c‰ë”ށF•ŸˆäŒ§‚É‚š‚¯‚éƒqƒ^ƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚Ì•ªŽq‰uŠwF‘æ54‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2013”N6ŒŽ8“ú-9“úA‰—‘q•~

    4. ¡‘º’‰ŽkA‰ª–{“¹ŽqA—é–Ø—zAŒ›œ—tŽqA…“cŽ–€A‰Ÿ’JmFƒGƒ“ƒeƒƒEƒCƒ‹ƒX68Œ^‚̃tƒBƒŠƒsƒ“‚É‚š‚¯‚é‰uŠwERŒŽ«•ω»‚š‚æ‚ÑŽó—e‘ÌŒ‹‡—lŽ®‚̉ðÍA‘æ67‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2013”N8ŒŽ30-31“úA‰—å‘ä

    5. …“cŽ–€AÂ–Ø—mŽqAŸ“‡Žj•vAŸ“‡—R—˜ŽqA”Š_•ׁAŒ›œ—tŽqA–{‹œœŽ¡Aˆ¢•F’‰”VFƒGƒ“ƒeƒƒEƒCƒ‹ƒX71Œ^‚Ì•ªŽq‰uŠwA‘æ67‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2013”N8ŒŽ30-31“úA‰—å‘ä

    6. •œˆäWˆê˜YA‰¡ŽR‰h“ñA]“¡—ÇŽ÷A£ŒË‡ŽŸAŽsŒŽËŽqA‘O“c‰r—¢ŽqA–xì˜a”üF‘“à‚R’nˆæ‚É‚š‚¯‚é’°ŠÇoŒŒ«‘å’°‹ÛO157Š”‚ÌClade•ª•z‚Ì”äŠrA‘æ34‰ñ“ú–{H•i”÷¶•šŠw‰ïŠwpW‰ïA2013”N10ŒŽ3“úA‰—“Œ‹ž

    7. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFŽ”‚¢”L‚̃WƒtƒeƒŠƒA“Å‘fŒŽ«Corynebacterium ulceransŠŽõó‹µ’²žA•œ¬‚Q‚T”N“xbˆãŠwp“Œ–k’n‹æŠw‰ïA2013”N10ŒŽ‚P1“úA‰—ŒSŽR
      Ë“ú–{bˆãŒöO‰q¶Šw‰ï“Œ–k’n‹æŠw‰ï’·Ü‚É‘I‚΂ê‚Ü‚µ‚œI

    8. Œ’˕ɁA—é–Ø”Ž‹MAr—FA“n糖ƒä»A·“c–ƒ”üA²“¡çŽÑA“y“c•¶GA•“c”Ž–ŸA£ŒË‡ŽŸF“–‰@‚É‚š‚¯‚éƒŒƒWƒIƒlƒ‰”x‰Š‚̗Տ°“IŒŸ“¢A‘æ62‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•ûŠwpW‰ïA2013”N10ŒŽ31“úA‰—“Œ‹ž

    9. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFŽRŒ`‚É‚š‚¯‚éŽ”‚¢”L‚̃WƒtƒeƒŠƒA“Å‘fŒŽ«Corynebacterium ulceransŠŽõó‹µ’²žA•œ¬‚Q‚T”N“x“ú–{bˆãŽt‰ïbˆãŠwp”NŽŸ‘å‰ïA2014”N2ŒŽ21“úA‰—ç—t

    •œ¬24”N“xi2012”N4ŒŽ\2013”N3ŒŽj

    \H24˜_•¶”­•\“™\

    1. Mizuta K, Kuroda M, Kurimura M, Yahata Y, Sekizuka T, Aoki Y, Ikeda T, Abiko C, Noda M, Kimura H, Mizutani T, Kato T, Kawanami T, Ahiko T. Epidemic myalgia in adults associated with human parechovirus type 3 infection, Yamagata, Japan, 2008. Emerg Infect Dis. 2012;18:1787-1793.
      ËMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 8th edition, ElsevierŽÐA2014‹y‚Ñ9th edition ElsevierŽÐA2020‚ňø—p‚³‚ê‚Ü‚µ‚œI

    2. Mizuta K, Abiko C, Aoki Y, Ikeda T, Itagaki T, Katsushima F, Katsushima Y, Matsuzaki Y, Noda M, Kimura H, Ahiko T. Epidemiology of parainfluenza virus type 1, 2, and 3 infections based on virus isolation between 2002 and 2011 in Yamagata, Japan. Microbiol Immunol. 2012;56:855-858.

    3. Mizuta K, Abiko C, Aoki Y, Ikeda T, Matsuzaki Y, Itagaki T, Katsushima F, Katsushima Y, Noda M, Kimura H, Ahiko T. Seasonal patterns of respiratory syncytial virus , influenza A, human metapenuovirus, and parainfluenza type 3 infections based on virus isolation between 2004 and 2011 in Yamagata, Japan. Jpn J Infect Dis. 2013;66:140-145.
      ËHuman Respiratory Viral Infections, CRC press, 2014 ‚ňø—p‚³‚ê‚Ü‚µ‚œI

    4. Aoki Y, Abe A, Ikeda T, Abiko C, Mizuta K, Yamaguchi I, Ahiko T. An outbreak of exanthematous disease due to coxsackievirus A9 in a nursery in Yamagata, Japan February to March 2012. Jpn J Infect Dis. 2012;65:367-369.

    5. Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y. Community outbreak of Macrolide-Resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237-240.

    6. Abiko C, Mizuta K, Aoki Y, Ikeda T, Itagaki T, Noda M, Kimura H, Ahiko T. An outbreak of parainfluenza virus type 4 infections among children with acute respiratory infections in the 2011-12 winter season in Yamagata, Japan. Jpn J Infect Dis. 2013;66:76-78.

    7. Seto J, Suzuki Y, Otani K, Qiu Y, Nakao R, Sugimoto C, Abiko C. Proposed vector candidate: Leptotrombidium palpale for Shimokoshi type Orientia tsutsugamushi. Microbiol Immunol. 2013;57:111-117.

    8. Nakajima N, Kitamori Y, Ohnaka S, Mitoma Y, Mizuta K, Wakita T, Shimizu H, Arita M. Development of a transcription-reverse transcription concerted reaction method for specific detection of human enterovirus 71 from clinical specimen. J Clin Microbiol. 2012;50:1764-1768.

    9. Matsuzaki Y, Ikeda T, Abiko C, Aoki Y, Mizuta K, Shimotai Y, Sugawara K, Hongo S. Detection and quantification of influenza C virus in pediatric respiratory specimens by real-time PCR and comparison with infectious viral counts. J Clin Virol. 2012;54:130-134.

    10. Matsuzaki Y, Itagaki T, Ikeda T, Aoki Y, Abiko C, Mizuta K. Human metapneumovirus infection among family members. Epidemiol Infect. 2013;141:827-832.

    11. Yoshida A, Kiyota N, Kobayashi M, Nishimura K, Tsutsui R, Tsukagoshi H, Hirano E, Yamamoto N, Ryo A, Saitoh M, Harada S, Inoue O, Kozawa K, Tanaka R, Noda M, Okabe N, Tashiro M, Mizuta K, Kimura H. Molecular epidemiology of attachment glycoprotein (G) gene in respiratory syncytial virus in children with acute respiratory infection in Japan in 2009/2010. J Med Microbiol. 2012;61:820-829.

    12. Yamayoshi S, Izuka S, Yamashita T, MinagawaH, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S. Human SCARB2-dependent Infection by Coxsackievirus A7, A14, A16 and Enterovirus 71. J Virol. 2012;86:5685-5696.

    13. Kon M, Watanabe K, Tazawa T, Watanabe K, Tamura T, Tsukagoshi H, Noda M, Kimura H, Mizuta K. Detection of human coronavirus NL63 and OC43 from children with acute respiratory infections in Niigata, Japan, between 2010 and 2011. Jpn J Infect Dis. 2012;65:270-271.

    14. Yamaya M, Nishimura H, Hatachi Y, Yasuda H, Deng X, Sasaki T, Mizuta K, Kubo H, Nagatomi R. Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Antimicrob Agents Chemother. 2012;56:4052-4061.
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014 ‚ňø—p‚³‚ê‚Ü‚µ‚œI

    15. Obuchi M, Toda S, Tsukagoshi H, Oogane T, Abiko C, Funatogawa K, Mizuta K, Shirabe K, Kozawa K, Noda M, Kimura H, Tashiro M. Molecular analysis of pandemic influenza A (H1N1) 2009 virus genome associated with fatal infection in Gunma, Tochigi, Yamagata, and Yamaguchi Prefectures, Japan during the first pandemic wave. Jpn J Infect Dis. 2012;65:363-367.

    16. Iguchi A, Iyoda S, Ohnish M, on behalf of the EHEC study group. Molecular characterization reveals three distinct clonal groups among clinical Shiga toxin-producing Esherichia coli strains of serogroup O103. J Clin Microbiol. 2012;50:2894-2900.

    17. Kobayashi M, Tsukagoshi H, Ishioka T, Mizuta K, Noda M, Morita Y, Ryo A, Kozawa K, Kimura H. Seroepidemiology of Saffold cardiovirus (SAFV) genotype 3 in Japan. J Infect. 2013;66:191-193.

    18. Nakamura M, Hirano E, Ishiguro F, Mizuta K, Noda M, Tanaka R, Tsukagoshi H, Kimura H. Molecular epidemiology of human metapneumovirus from 2005 to 2011 in Fukui, Japan. Jpn J Infect Dis. 2013;66:56-59.

    19. Itagaki T, Suzuki Y, Seto J, Abiko C, Mizuta K, Matsuzaki Y. Two cases of macrolide resistance in Mycoplasma pneumoniae acquired during the treatment period. J Antimicrob Chemother. 2013;68:724-725.

    20. Urakawa T, Seto J, Yamamoto A, Nakajima T, Goto S. Subcutaneous abscess formation in the upper extremity caused by toxigenic Corynebacterium ulcerans. J Med Microbiol. 2013;62:489-493.

    21. Saitoh M, Takeda M, Gotoh K, Takeuchi F, Sekizuka T, Kuroda M, Mizuta K, Ryo A, Tanaka R, Ishii H, Takada H, Kozawa K, Yoshida A, Noda M, Okabe N, Kimura H. Molecular evolution of hemagglutinin (H) gene in measles virus genotypes D3, D5, D9 and H1. PLoS One. 2012;7:e50600.

    22. £ŒË‡ŽŸAˆî–Ñ–«FDiffuse outbreakгŽÒ‚©‚番—£‚³‚ꂜCTX-M-15Œ^ŠîŽ¿Šg’£Œ^ƒÀƒ‰ƒNƒ^ƒ}[ƒ[ˆâ“`Žq•Û—LShigella sonneiAŠŽõÇŠwŽGŽ 2012;86:608-609.

    23. …“cŽ–€FŒÄ‹zŠíŠŽõÇ‚Ì•aŒŽf’fAƒGƒ“ƒeƒƒEƒCƒ‹ƒXEƒ‰ƒCƒmƒEƒCƒ‹ƒXA—Տ°‚ƃEƒCƒ‹ƒX 2012;40:134-141.

    24. £ŒË‡ŽŸA—é–Ø—TAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚é–ìƒlƒYƒ~Šñ¶ƒcƒcƒKƒ€ƒVŽí‚Ì‹GßÁ’·AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2012;45:12-14.

    25. ’r“c’C–çAÂ–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚éƒ‰ƒCƒmƒEƒCƒ‹ƒXŒŸoó‹µi2011)AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2012;45:15-17.

    26. —é–Ø—TA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚éMycoplasma@pneumoniae—Տ°•ª—£Š”p1ˆâ“`ŽqŒ^•ʉðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2012;45:18-20.

    \H24Šw‰ï”­•\\

    1. ŽRì’BŽuCŽRŒû‰À„C‰i‘òŒõC•ìŽ˜NC…“cŽ–€:2008C2011”N‚É‘œ”­‚µ‚œƒpƒŒƒRƒEƒCƒ‹ƒX‚RŒ^‚É‚æ‚é—¬s«‹Ø’ɏǂ̗Տ°“IŒŸ“¢,‘æ53‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ïA2012”N5ŒŽ22“ú-24“úA‰—“Œ‹ž

    2. Œ›œ—tŽqA’r“c’C–çAÂ–Ø—mŽqA›ŒŽŠš‰xA‰º•œ‹`—²A–{‹œœŽ¡AˆÀ‘·ŽqçŒbŽqA…“cŽ–€FƒŠƒAƒ‹ƒ^ƒCƒ€PCR–@‚ð—p‚¢‚œ—Տ°ŒŸ‘Ì‚©‚ç‚ÌCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŒŸoA‘æ26‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïƒVƒ“ƒ|ƒWƒEƒ€A2012”N5ŒŽ24-26“úA‰—•Ÿ“‡

    3. …“cŽ–€A–ì“c‰ë”ށA–Ø‘º”ŽˆêFƒpƒŒƒRƒEƒCƒ‹ƒX3Œ^‚É‚æ‚鐬l‚̋ؒɏǂ̗¬sA‘æ53‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2012”N6ŒŽ16-17“úA‰—‘åã

    4. Ž“c’ŒŽqAŒ‘º_ˆêA…“cŽ–€A–ì“c‰ë”ށA–Ø‘º”ŽˆêFŒF–{Œ§‚É‚š‚¯‚éƒqƒgƒ‰ƒCƒmƒEƒCƒ‹ƒX‚ÆRSƒEƒCƒ‹ƒX‚Ì•ªŽq‰uŠwA‘æ53‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2012”N6ŒŽ16-17“úA‰—‘åã

    5. m•œ–«A…“cŽ–€A–ì“c‰ë”ށA–Ø‘º”ŽˆêFˆŸ”M‘Ñ’nˆæ‚É‘®‚·‚鉫“ꌧ‚É‚š‚¯‚éƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚̉uŠwA‘æ53‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2012”N6ŒŽ16-17“úA‰—‘åã

    6. ‹g‰ª­ƒA®–ì^—R”üA…“cŽ–€A–ì“c‰ë”ށA–Ø‘º”ŽˆêF¬Ž™‚É‚š‚¯dÇŒÄ‹zŠíŠŽõÇ‚©‚ç‚̃qƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚ÌŒŸoE•ª—£‚ƉuŠw“I‚š‚æ‚Ñ—Õ°“IŒŸ“¢-‚Æ‚­‚É‹¹•”Xü‰æ‘œŠŒ©‚ƏdÇ‰»—vˆö‚ɂ‚¢‚Ä-A‘æ53‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2012”N6ŒŽ16-17“úA‰—‘åã

    7. …“cŽ–€AÂ–Ø—mŽqA’r“c’C–çAˆÀ‘·ŽqçŒbŽqAˆ¢•F’‰”VA–ì“c‰ë”ށA–Ø‘º”ŽˆêA•“cœAŠÖ’ˍ„ŽjAŒI‘º³”VA”ª”Š–F˜aA…’J“N–çA‰Á“¡ä•vAì•À“§FƒpƒŒƒRƒEƒCƒ‹ƒX3Œ^‚É‚æ‚鐬l‚̋ؒɏǂ̗¬sA‘æ66‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2012”N8ŒŽ23-24“úA‰—å‘ä

    8. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚éŒ¢‚ÌBabesia gibsoniR‘ۗ̕Ló‹µA•œ¬24”N“x“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–k’n‹æjA•œ¬24”N10ŒŽ11“úA‰—ŽRŒ`

    9. —é–Ø—TA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFPOT–@‚ð—p‚¢‚œ‰©FÌÞÄÞ³‹…‹Û‚Ì•ªŽq‰uŠw‰ðÍ‚ÌŒŸ“¢A‘æ33‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA•œ¬24”N11ŒŽ10-11“úA‰—’߉ª

    10. Œ’˕ɁA—é–Ø”Ž‹MAr—FA“n粖ƒä»A·“c–ƒ”üA²“¡çŽÑA“y“c•¶GA•“cG–ŸA£ŒË‡ŽŸFLegionella pneumophila ŒŒŽŒQ12‚É‚æ‚é”x‰Š‚̈ê—áA‘æ61‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•û‰ïŠwpW‰ïA•œ¬24”N10ŒŽ10-12“úA‰—“Œ‹ž

    11. £ŒË‡ŽŸA—é–Ø—TA‘å’JŽŽÀA緉iWA’†”ö—ºA™–{çqAˆÀ‘·ŽqçŒbŽqFShimokoshiŒ^Orientia@tsutsugamushiƒxƒNƒ^[Œó•â‚Ì’ñ¥A‘æ19‰ñƒŠƒPƒbƒ`ƒAŒ€‹†‰ïA•œ¬24”N12ŒŽ8-9“úA‰—Ž ‰ê

    12. £ŒË‡ŽŸA—é–Ø—TAˆÀ‘·ŽqçŒbŽqAˆ¢•F’‰”VFŒ‹Šj’á– ‰„’nˆæ‚É‚š‚¯‚é–Ô—…“I‚ÈŒ‹Šj‹Û”œ•œ”z—ñ‘œŒ^iVNTRj•ªÍ‚Ì—L—p«A‘æ39‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA•œ¬25”N3ŒŽ6“úA‰—ŽRŒ`

    13. £ŒË‡ŽŸAˆ¢•F’‰”VF‚—îŽÒ‚É‚š‚¯‚éƒNƒIƒ“ƒeƒBƒtƒFƒƒ“TBƒS[ƒ‹ƒh(QFT-3GjŒŸž‚Ì—L—p«A‘æ88‰ñ“ú–{Œ‹Šj•aŠw‰ï‘‰ïA2013”N3ŒŽ28-29“úA‰—ç—t

    •œ¬23”N“xi2011”N4ŒŽ\2012”N3ŒŽj

    \H23˜_•¶”­•\“™\

    1. Mizuta K, Saitoh M, Kobayashi M, Tsukagoshi H, Aoki Y, Ikeda T, Abiko C, Katsushima N, Itagaki T, Noda M, Kozawa K, Ahiko T, Kimura H. Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan. Virology J. 2011;8:533.

    2. Ikeda T, Mizuta K, Abiko C, Aoki Y, Itagaki T, Katsushima F, Katsushima Y, Matsuzaki Y, Fuji N, Imamura T, Oshitani H, Noda M, Kimura H, Ahiko T. Acute respiratory infections due to enterovirus 68, in Yamagata, Japan between 2005 and 2010. Microbiol Immunol. 2012;56:139-143.
      ËHuman Respiratory Viral Infections, CRC press, 2014 ‚ňø—p‚³‚ê‚Ü‚µ‚œI
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014 ‚ňø—p‚³‚ê‚Ü‚µ‚œI


    3. Nakauchi M, Ujike M, Obuchi M. Takayama I, Ejima M, Oba K, Konomi N, Odagiri T,Tashiro M, Kageyama T, the influenza virus surveillance group of Japan. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex onestep RT-PCR assay. J Med Virol. 2011;83:1121-1127.

    4. Itagaki T, Abiko C, Aoki Y, Ikeda T, Mizuta K, Noda M, Kimura H, Matsuzaki Y. Saffold cardiovirus infection in children associated with respiratory disease and its similarity to coxsackievirus infection. Pediatr Infect Dis J. 2011;30:680-683.

    5. Tsukagoshi H, Mizuta K, Abiko C, Itagaki T, Yoshizumi M, Kobayashi M, Kuroda M, Kozawa K, Noda N, Ryo A, Kimura H. The impact of saffold cardiovirus (SAFV) in patients with acute respiratory infection in Yamagata, Japan. Scand J Infect Dis. 2011;43:669-671.

    6. Fujitsuka A, Tsukagoshi H, Arakawa M, Goto-Sugai K, Ryo A, Okayama Y, Mizuta K, Nishina A, Yoshizumi M, Kaburagi Y, Noda M, Tashiro M, Okabe N, Mori M, Yokota S, Kimura H. A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness. BMC Infect Dis. 2011;11:168.

    7. Arakawa M, Okamoto-Nakagawa R, Toda S, Tsukagoshi H, Kobayashi M, Ryo A, Mizuta K, Hasegawa S, Hirano R, Wakiguchi H, Kudo K, Tanaka R, Morita Y, Noda M, KOzawa K, Ichiyama T, Shirabe K, Kimura H. Molecular epidemiological study of human rhonivurs species ABCs from patients with acute respiratory illness in Japan. J Med Microbiol. 2012;61:410-419.

    8. Iguchi A, Iyoda S, Seto K, Ohnishi M, on behalf of the EHEC study group. Emergence of a novel shiga toxin-producing Escherichia coli O serogroup cross-reacting with Shigella boydii type 10. J Clin Microbiol. 2011;49:3678-3680..

    9. ‹àŽq ‹IŽqA£ŒË ‡ŽŸAÂ–Ø •q–çA‘å’J ŸŽÀF‚‚‚ª’Ž•aгŽÒ—R—ˆ‚Ì Karp Œ^ Orientia tsutsugamushi 56-kDa ƒ^ƒ“ƒpƒNˆâ“`ŽqƒV[ƒNƒGƒ“ƒX‚É‚æ‚鈟Œ^•ª—ށA ŠŽõÇŠwŽGŽ 2011;85:626-631.

    10. Â–Ø—mŽqA’r“c’C–çAˆÀ‘·ŽqçŒbŽqA…“cŽ–€F–ƒ‚µ‚ñ‚ð‹^‚€Š³ŽÒŒŸ‘Ì‚©‚猟o‚³‚ꂜ•—]ƒEƒCƒ‹ƒXi—A“üŽ–—ájAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2011;44:6-8.

    11. ’r“c’C–çAÂ–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€FŽRŒ`Œ§“à‚É‚š‚¯‚éƒmƒƒEƒCƒ‹ƒXŒŸoó‹µ‚š‚æ‚Ñ‚»‚̈â“`Žq‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2011;44:9-11.

    \H23Šw‰ï”­•\\

    1. …“cŽ–€AŒ›œ—tŽqA–{‹œœŽ¡AŸ“‡‹éŽqA–ì“c‰ë”ށA–Ø‘º”ŽˆêF¬Ž™‚Ì‹}«‹C“¹ŠŽõÇ‚É‚š‚¯‚éƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚̉uŠwA‘æ52‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2011”N6ŒŽ11-12“úA‰—’Ã

    2. …“cŽ–€FƒVƒ“ƒ|ƒWƒEƒ€‚RuŽs’†ƒEƒCƒ‹ƒXŠŽõÇ‚ÆŽÀŒ±Žºf’fvhƒEƒCƒ‹ƒX•ª—£‚ð–¢—ˆ‚ÌŠ³ŽÒ‚Ì‚œ‚߂ɁhA‘æ52‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2011”N6ŒŽ11-12“úA‰—’Ã

    3. …“cŽ–€AˆÀ‘·ŽqçŒbŽqAÂ–Ø—tŽqA’r“c’C–çAŒ›œ—tŽqA–{‹œœŽ¡A”Š_•ׁAŸ“‡‹éŽqA‹ß]²AŒ‘ºGˆêAˆ¢•F’‰”VF1988”N‚©‚ç2010”N‚ÉŽRŒ`‚Å•ª—£‚³‚ꂜƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA16Œ^‚̉uŠwŒ€‹†A‘æ65‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2011”N8ŒŽ18-19“úA‰—ŽRŒ`

    4. Œ›œ—tŽqA’r“c’C–çAÂ–Ø—mŽqA›ŒŽŠš‰xA‰º•œ‹`—²A–{‹œœŽ¡AˆÀ‘·ŽqçŒbŽqA…“cŽ–€FƒŠƒAƒ‹ƒ^ƒCƒ€PCR–@‚ð—p‚¢‚œCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŒŸo‚ÌŽŽ‚ÝA‘æ65‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2011”N8ŒŽ18-19“úA‰—ŽRŒ`

    5. £ŒË‡ŽŸ:ŽRŒ`Œ§‚É‚š‚¯‚éShimokoshiŒ^‚‚‚ª’Ž•a‚Ì1Ç—áA‘æ57‰ñŠñ¶’ŽŠw‰ïE“ú–{‰q¶“®•šŠw‰ï–k“ú–{Žx•”‡“¯‘å‰ï,•œ¬23”N10ŒŽ1“úA‰—ŽRŒ`

    6. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqAˆ¢•F’‰”VFŽRŒ`Œ§‚É‚š‚¯‚éŒ‹Šj‹Û•ªŽq‰uŠw’²žA‘æ124‰ñ“ú–{Œ‹Šj•aŠw‰ï“Œ–kŽx•”Šw‰ïA•œ¬24”N3ŒŽ3“úA‰—·‰ª

    7. ‘å’JŸŽÀA‹àŽq‹IŽqA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqF‰Í–k’¬‚É‚š‚¯‚é‰Ä‹G‚̃cƒcƒKƒ€ƒV’²žA‘æ38‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA•œ¬24”N3ŒŽ7“úA‰—ŽRŒ`@

    •œ¬22”N“xi2010”N4ŒŽ\2011”N3ŒŽj

    \H22˜_•¶”­•\“™\

    1. Aoki Y, Suto A, Mizuta K, Ahiko T, Osaka K, Matsuzaki Y. Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients. J Hosp Infect. 2010;75:42-46.
      ËFIELDS@Virology, 6th@edition, Wolters KluwerŽÐA2013 ‚ňø—p‚³‚ê‚Ü‚µ‚œI

    2. Mizuta K, Abiko C, Aoki Y, Ikeda T, Itagaki T, Katsushima N, Matsuzaki Y, Hongo S, Noda M, Kimura H, Ahiko T. Endemicity of human metapneumovirus subgenogroups A2 and B2 in Yamagata, Japan between 2004 and 2009. Microbiol Immunol. 2010;54:634-638.

    3. Matsuzaki Y. Mizuta K, Takashita E, Okamoto M, Itagaki T, Katsushima F, Katsushima Y, Nagai Y, Nishimura H. Comparison of virus isolation using the Vero E6 cell line with real-time PCR assay for the detection of human metapneumovirus. BMC Infect Dis. 2010;10:170.
      ËHuman Respiratory Viral Infections, CRC press, 2014 ‚ňø—p‚³‚ê‚Ü‚µ‚œI

    4. Itagaki T, Abiko C, Ikeda T, Aoki Y, Seto J, Mizuta K, Ahiko T, Tsukagoshi H, Nagano M, Noda M, Mizutani T, Kimura H. Sequence and phylogenetic analyses of Saffold cardiovirus from children with exudative tonsillitis in Yamagata, Japan. Scand J Infect Dis. 2010;42:950-952.
      ËFeigin and Cherry's Textbook of Pediatric Infectious Diseases 8th edition, ElsvierŽÐA2019‚ňø—p‚³‚ê‚Ü‚µ‚œI

    5. Ujike M, Shimabukuro K, Mochizuki K, Obuchi M, Kageyama T, Shirakura M, Kishida N, Yamashita K, Horikawa H, Kato Y, Fujita N, Tashiro M, Odagiri T; Working Group for Influenza Virus Surveillance in Japan. Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg Infect Dis. 2010;16:926-35.

    6. Tsukagoshi H, Masuda Y, Mizutani T, Mizuta K, Saitoh M, Morita Y, Nishina A, Kozawa K, Noda M, Ryo A, Kimura H. Sequence and phylogenetic analyses of Saffold cardiovirus (SAFV) genotype 3 isolates from children with upper respiratory infection in Gunma, Japan. Jpn J Infect Dis. 2010;63:378-380.
      ËFeigin and Cherry's Textbook of Pediatric Infectious Diseases 7th edition, ElsvierŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI

    7. Goto-Sugai K, Tsukagoshi H, Mizuta K, Matsuda S, Noda M, Sugai M, Saito Y, Okabe N, Tashiro M, Kozawa K, Tanaka R, Morita Y, Nishina A, Kimura H. Genotyping and phylogenetic analyses of major genes in respiratory syncytial virus isolated from infants with bronchiolitis. Jpn J Infect Dis. 2010;63:393-400.

    8. Omura T, Iizuka S, Tabara K, Tsukagoshi H, Mizuta K, Matsuda S, Noda M, Kimura H. Detection of human metapneumovirus (HMPV) genomes during an outbreak of bronchitis and pneumonia in an old-age home in Shimane, Japan, in autumn 2009. Jpn J Infect Dis. 2011;64:85-87.

    9. Goto Y, Sato K, Yahagi K, Komatsu O, Hoshina H, Abiko C, Yamasaki H, Kawanaka M. Frequent isolation of Echinococcus multilocularis from the livers of racehorses slaughtered in Yamagata, Japan. Jpn J Infect Dis. 2010;63:449-451.

    10. Ujike M, Ejima M, Anraku A, Shimabukuro K, Mochizuki K, Obuchi M, Kishida N, Hong X, Takashita E, Fujisaki S, Yamashita K, Horikawa H, Kato Y, Oguchi A, Fujita N, Tashiro M, Odagiri T; Influenza Virus Surveillance Group ofJapan. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis. 2011;17:470-479.

    11. ‹àŽq‹IŽqA£ŒË‡ŽŸA‘å’JŸŽÀAŠpâÆ‹MFŽRŒ`Œ§‚É‚š‚¯‚éƒcƒcƒKƒ€ƒV¶‘§’²žAMed Entomol Zool. 2010;61:79-84.

    12. ó‰©^—ŽqAÂ–Ø—mŽqAŠ}ŒŽ‹`³A…“cŽ–€FŒ§ŽYHÞ‚©‚ç‚̍RƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠˆ«•šŽ¿‚Ì•ª—£AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2010;43:6-10.

    13. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqFƒJƒ‚ðŽæ‚èˆµ‚€“®•šŽæˆµ‹ÆŽ{Ý‚É‚š‚¯‚éƒTƒ‹ƒ‚ƒlƒ‰‰˜õŽÀ‘Ô’²žAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2010;43:11-13.

    14. ‹àŽq‹IŽqA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqA‘å’JŸŽÀAˆ¢•F’‰”VFLegionella@Pneumophilia‚ÌVNTR‰ðÍ‚ÌŽŽ‚Ý‚É‚Â‚¢‚āAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2010;43:14-20.

    15. ’r“c’C–çAÂ–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€FŽRŒ`Œ§‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX(A/H1N1pdm)ŒŸoó‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2010;43:21-23.

    16. Â–Ø—mŽqA’r“c’C–çAˆÀ‘·ŽqçŒbŽqA…“cŽ–€F2009”NŠŽõÇ”­¶“®Œü’²ž‚É‚š‚¯‚éƒEƒCƒ‹ƒX•ª—£ó‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2010;43:24-26.

    \H22Šw‰ï”­•\\

    1. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqA‘å’JŸŽÀAŽRŒûˆê˜YAˆäŸºˆÀ—YAŽR“cŒhŽqAŒ“c“OAˆ¢•F’‰”VFŽRŒ`Œ§‚É‚š‚¯‚é•ªŽq‰uŠw‰ðÍ‚ð‘g‚Ý“ü‚ꂜŒ‹Šj‘΍ô‚Ö‚ÌŽæ‚è‘g‚݁A‘æ59‰ñ“Œ–kŒöO‰q¶Šw‰ïA2010”N7ŒŽ23“úA‰—ŽRŒ`

    2. …“cŽ–€A’r“c’C–çAÂ–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA”Š_•ׁAŸ“‡Žj•vAŸ“‡—R—˜ŽqAˆ¢•F’‰”VFVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚É‚æ‚éŒÄ‹zŠíƒEƒCƒ‹ƒX—¬s‚Ö‚ÌInterference‚ɂ‚¢‚āA‘æ64‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2010”N8ŒŽ19-20“úA‰—å‘ä

    3. ”Š_•ׁA’r“c’C–çAˆÀ‘·ŽqçŒbŽqA…“cŽ–€AŒ›œ—tŽqA’ˉz”Ž”VA–ì“c‰ë”ށA–Ø‘º”ŽˆêFSaffold@cardiovirus@ŠŽõÇ‚Ɛf’f‚³‚ꂜ5—áA‘æ20‰ñ“ú–{ŠO—ˆ¬Ž™‰ÈŠw‰ï”NŽŸW‰ïA2010”N8ŒŽ27-29“úA‰—•Ÿ‰ª

    4. £ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFƒJƒ‚ðŽæ‚èˆµ‚€“®•šŽæ‚èˆµ‚¢‹ÆŽÒŽ{Ý‚É‚š‚¯‚éƒTƒ‹ƒ‚ƒlƒ‰‰˜õŽÀ‘Ô’²žA•œ¬22”N“x“Œ–k’n‹æbˆãŽt‘å‰ïA2010”N9ŒŽ16-17“úA‰—H“c

    5. …“cŽ–€FŠŽõÇ—Տ°‚ÌŒ»ê‚Æ’n‰qŒ€‚Ƃ̘AŒg-—Տ°ŒŸ‘Ì‚©‚ç‚̃EƒCƒ‹ƒX•ª—£‚É‚à‚Æ‚¢‚œ‰uŠwŒ€‹†-A‘æ59‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{’n•û‰ïŠwpW‰ïA2010”N10ŒŽ21-22“úA‰—“Œ‹ž

    6. £ŒË‡ŽŸA›àV“āA羗́A‘å’JŸŽÀA[”ö²FƒwƒŠƒRƒoƒNƒ^[EƒsƒƒŠŠŽõÇ‚É‚š‚¯‚é–«ˆÞk«ˆÝ‰Š‚Ɛڐێæ‰h—{‘f‚Ƃ̊֘A«A‘æ21‰ñ“ú–{‰uŠw‰ïA2011”N1ŒŽ21-22“úA‰—ŽD–y

    7. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqAˆ¢•F’‰”VFŒ‹ŠjŠŽõÇf’f‚ð–Ú“I‚Æ‚µ‚œQFTŒŸž¬Ñ‚Æ”N—î‚Æ‚ÌŠÖ˜AA‘æ37‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2011”N3ŒŽ2“úA‰—ŽRŒ`

    8. ‹àŽq‹IŽqA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚éƒcƒcƒKƒ€ƒV¶‘§’²žA‘æ37‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2011”N3ŒŽ2“úA‰—ŽRŒ`

    •œ¬21”N“xi2009”N4ŒŽ\2010”N3ŒŽj

    \H21˜_•¶”­•\“™\

    1. Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, Ohmi A, Okamoto M, Nishimura H, Matsuzaki Y, Hongo S, Sugawara K, Shimizu H, Ahiko T. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine. 2009;27:3153-3158.
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI

    2. Mizuta K, Hirata A, Suto A, Aoki Y, Ahiko T, Itagaki T, Tsukagoshi H, Morita Y, Obuchi M, Akiyama M, Okabe N, Noda M, Tashiro M, Kimura H. Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan. Virus Res. 2010;147:265-274.

    3. Aoki Y, Mizuta K, Suto A, Ikeda T, Abiko C, Yamaguchi I, Miura K, Ahiko T. Importation of an evolving measles virus genotype D9 to Yamagata, Japan from Thailand in 2009. Jpn J Infect Dis. 2009;62:481-482.

    4. Hishinuma-Igarashi I, Mizuta K, Saito Y, Ohuchi Y, Noda M, Akiyama M, Sato H, Tsukagoshi H, Okabe N, Tashiro M, Kimura H. Phylogenic analysis of human bocavirus (HBoV) detected from children with acute respiratory infection in Japan. J Infect. 2009;58:311-313.

    5. Akiyama M, Kimura H, Tsukagoshi H, Taira K, Mizuta K, Saitoh M, Nagano M, Sutoh A,@Noda M,@Morita Y,@Sakatsume O, Okabe N, Tashiro M. Development of an assay for the detection and quantification of the measles virus nucleoprotein (N) gene using real-time reverse transcriptase PCR.J Med Microbiol. 2009;58:638-643.

    6. Matsuzaki Y, Takashita E, Okamoto M, Mizuta K, Itagaki T, Katsushima F, Katsushima Y, Nagai Y, Nishimura H. Evaluation of a new rapid antigen test using immunochromatography for the detection of human metapneumovirus compared with real-time PCR assay. J Clin Microbiol. 2009;47:2981-2984.

    7. Okamoto M, Sugawara K, Takashita E, Muraki Y, Hongo S, Mizuta K, Itagaki T, Nishimura H, Matsuzaki Y. Development and evaluation of whole virus-based enzyme-linked immunosorbent assay for detection of human metapneumovirus antibodies in human sera. J Virol Methods. 2010;164:24-29.
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI

    8. Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virology J. 2010;7:53.

    9. Toda S, Kimura H, Noda M, Mizuta K, Matsumoto T, Suzuki E, Shirabe K. Phylogenetic analysis of human metapneumovirus from children with acute respiratory infection in Yamaguchi, Japan, during summer 2009. Jpn J Infect Dis. 2010;63:139-140.

    10. ‘å’JŸŽÀA‹àŽq‹IŽqAÂ–Ø•q–çA‘º“c•q•vFŽRŒ`Œ§‚Å”­¶‚µ‚œKawasakiŒ^‚‚‚ª’Ž•aAŠŽõÇŠwŽGŽ 2009;83:496-499.

    11. ”Š_•ׁA{“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€AŒ›œ—tŽqF1Î–¢–žŽ™‚̃qƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXŠŽõÇ-“Á‚É6ƒPŒŽ–¢–žŽ™‚̐f’fƒ|ƒCƒ“ƒg-@“ú–{¬Ž™‰Èˆã‰ï‰ï•ñ@2009;37:110-112.

    12. ‘å’JŸŽÀA‹àŽq‹IŽqAÂ–Ø•q–çA“¡“c”ŽŒÈFŽRŒ`Œ§‚Å”­¶‚µ‚œShimokoshiŒ^ƒŠƒPƒbƒ`ƒAŠŽõ‚É‚æ‚é‚‚‚ª’Ž•a‚Ì‚P—áAMed Entomol Zool. 2009;60:317-321.

    13. ‹àŽq‹IŽqA£ŒË‡ŽŸAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚ÌŽs’¬‘º•ʂɂ݂œ‚‚‚ª’Ž•aœëг—Š‚̕ω»AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2009;42:1-3.

    14. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚ét‚̂‚‚ª’ŽŠ³ŽÒ”‚Æ‹CÛˆöŽq‚ÌŠÖŒWAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2009;42:4-5.

    \H21Šw‰ï”­•\\

    1. Œ›œ—tŽqA‚‰ºŒb”üA‰ª–{“¹ŽqA…“cŽ–€A”Š_•ׁA‰iˆäK•vAŒ‘ºGˆêFƒCƒ€ƒmƒNƒƒ}ƒgƒOƒ‰ƒtƒB[–@‚É‚æ‚éƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXv‘¬f’fƒLƒbƒg‚Ì•]‰¿‚ƃEƒCƒ‹ƒX•ª—£‚Ƃ̔äŠrA‘æ83‰ñ“ú–{ŠŽõÇŠw‰ïA2009”N4ŒŽ23-24“úA‰—“Œ‹ž

    2. •œ“c–Ÿ“ú”üA…“cŽ–€AŒÜ\—’ˆè”üAHŽR”ü•äA–Ø‘º”ŽˆêA‰ª•”M•FA–ì“c‰ë”ށA“c‘ãáÁlF“Œ–k’nˆæ‚Å•ª—£‚³‚ꂜƒ‰ƒCƒmƒEƒCƒ‹ƒX‚Ì•ªŽq‰uŠwA‘æ50‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2009”N6ŒŽ13-14“úA‰—‚’m

    3. ŒÜ\—’ˆè”üA…“cŽ–€A‘å“àD”üA“c’†çŽqAâV“¡‹`OAHŽR”ü•äA–Ø‘º”ŽˆêA‰ª•”M•FA–ì“c‰ë”ށA“c‘ãáÁlFÅ‹ßŒŸo‚³‚ꂜƒqƒgƒ{ƒJƒEƒCƒ‹ƒXiHBoV)‚Ì•ªŽq‰uŠwA‘æ50‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2009”N6ŒŽ13-14“úA‰—‚’m

    4. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqA‘å’JŸŽÀFLamp–@‚É‚æ‚é‚‚‚ª’Ž•aˆâ“`Žq‚ÌŒŸoA‘æ63‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2009”N8ŒŽ20-21“úA‰—·‰ª

    5. ‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀA”Š_•ׁFŽRŒ`Œ§‚É‚š‚¯‚éƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚Ì•ªŽq‰uŠw“IŒŸ“¢A‘æ31‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA2009”N11ŒŽ15“úA‰—ŠŠ‰Í]

    6. £ŒË‡ŽŸA‹àŽq‹IŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘å’JŸŽÀAˆ¢•F’‰”VF”œ•œ”z—ñ‘œŒ^•ªÍ–@‚É‚æ‚錋Šj‹Û‚Ì•ªŽq‰uŠw‰ðÍA‘æ36‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2010”N3ŒŽ3“úA‰—ŽRŒ`

    7. Â–Ø—mŽqA’r“c’C–çAˆÀ‘·ŽqçŒbŽqA…“cŽ–€Aˆ¢•F’‰”VF2012”N–ƒ‚µ‚ñ”rœ‚ÉŒü‚¯‚œŽÀŒ±Žºf’f‚̏d—v«A‘æ36‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2010”N3ŒŽ3“úA‰—ŽRŒ`

    •œ¬20”N“xi2008”N4ŒŽ\2009”N3ŒŽj

    \H20˜_•¶”­•\“™\

    1. Mizuta K, Abiko C, Aoki Y, Suto A, Hoshina H, Itagaki T, Katsushima N, Matsuzaki Y, Hongo S, Noda M, Kimura H, Ootani K. Analysis on monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in Yamagata, Japan. Jpn J Infect Dis. 2008;61:196-201.

    2. Mizuta K, Matsuzaki Y, Hongo S, Ohmi A, Okamoto M, Nishimura H, Itagaki T, Katsushima N, Oshitani H, Suzuki A, Furuse Y, Noda M, Kimura H, Ahiko T. Stability of the seven hexon hypervariable region sequence of adenovirus types 1-6 isolated in Yamagata, Japan between 1988 and 2007. Virus Res. 2009;140:32-39.

    3. Matsuzaki Y, Itagaki T, Abiko C, Aoki Y, Suto A, Mizuta K. Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan. J Med Virol. 2008;80:1084-1089.
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI
      ËFeigin and cherry's Textbook of Pediatric Infectious Diseases 7th edition, ElsvierŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI


    4. ”Š_•ׁA{“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€AŒ›œ—tŽqF1Î–¢–ž‚̃qƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXŠŽõÇAŽRŒ`Œ§¬Ž™‰Èˆã‰ï‰ï•ñ 2008;52:15-18.

    5. {“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€FŽRŒ`Œ§“à‚Ì—¬s«Žš‰º‘B‰Š‚Ì”­¶ó‹µAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2008;41:23-25.

    6. Â–Ø—mŽqA{“¡ˆŸŽõ‰ÀA…“cŽ–€A‘å’JŸŽÀF2006/07ƒV[ƒYƒ“ŽRŒ`Œ§‚Å•ª—£‚³‚ꂜAH3Œ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚ɂ‚¢‚āAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2008;41:26-28.

    7. ‹àŽq‹IŽqA‘å’JŸŽÀAÂ–Ø•q–çF’°ŠÇoŒŒ«‘å’°‹Û0157‚ÌPFGE‚š‚æ‚ÑIS-printing@System‚É‚æ‚镪Žq‰uŠw“I‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2008;41:29-31.

    8. ‹àŽq‹IŽqA‘å’JŸŽÀAÂ–Ø•q–çF‰·ò‚É‚š‚¯‚éLegionella@Pneumophilia‚Ì•ªŽq‰uŠw“I’²žAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2008;41:32-34.

    \H20Šw‰ï”­•\\

    1. ‘å’JŸŽÀA‹àŽq‹IŽqAÂ–Ø•q–çFŽRŒ`Œ§‚É‚š‚¯‚é‚‚‚ª’Ž•a”­¶ó‹µA‘æ60‰ñ“ú–{‰q¶“®•šŠw‰ï‘å‰ïA‘æ23‰ñƒ_ƒjŒ€‹†”ǏW‰ïA2008”N4ŒŽ17“úA‰—ީޡˆã‰È‘å

    2. ”Š_•ׁA{“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€AŒ›œ—tŽqF‚±‚ê‚Á‚Ä–{“–‚É‚ˆ‚l‚o‚uŠŽõÇH-0ÎŽ™‚Ì‚ˆ‚l‚o‚uŠŽõÇ-A‘æ18‰ñ“ú–{ŠO—ˆ¬Ž™‰ÈŠw‰ïA2008”N8ŒŽ30-31“úA‰—–ŒŒÃ‰®

    3. ‘å’JŸŽÀA‹àŽq‹IŽqAÂ–Ø•q–çA“¡“c”ŽŒÈFŽRŒ`Œ§‚Å”­¶‚µ‚œShimokoshiŒ^‚É‚æ‚é‚‚‚ª’Ž•aA‘æ62‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2008”N8ŒŽ21-22“úA‰—\˜a“cŽs

    4. £ŒË‡ŽŸA‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀFƒpƒ‹ƒXƒtƒB[ƒ‹ƒh“d‹C‰j“®–@‚É‚æ‚éSalmonella@Poona‚Ì•ªŽq‰uŠw’²žA“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA2008”N9ŒŽ28“úA‰—å‘ä

    5. Œ›œ—tŽqAŽOžŠ‰Á“ÞŽqA{“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€Aށ‰ÆœA¬Ÿº³ŽŸA¬“cØFlA“c‘ãáÁl:ŽRŒ`Œ§‚É‚š‚¯‚éƒIƒZƒ‹ƒ^ƒ~ƒrƒ‹‘ϐ«H1N1ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚Ì•ª—£‚ƈꏬŠwZ‚ł̗¬sA‘æ85‰ñ“ú–{¬Ž™ŠŽõÇŠw‰ïŽRŒ`’n•û‰ïA2008”N12ŒŽ7“úA‰—ŽRŒ`

    6. £ŒË‡ŽŸA‹àŽq‹IŽqAÂ–Ø•q–çA¬’r‰›A‘å’JŸŽÀF–쐶ƒJƒ‰ƒX’°“à—e•š‚©‚ç‚Ì•aŒŽ×‹Û‚Ì•ª—£‚ɂ‚¢‚āA‘æ35‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2009”N3ŒŽ6“úA‰—ŽRŒ`

    7. ‹àŽq‹IŽqA£ŒË‡ŽŸA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚é‚‚‚ª’Ž•a‚̉uŠw’²žA‘æ35‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2009”N3ŒŽ6“úA‰—ŽRŒ`

    8. ˜ð“c¬–ë‰ÁA—͐ΐŸŽqAŒ›œ—tŽqAÂ–Ø—mŽqA{“¡ˆŸŽõ‰ÀA…“cŽ–€A¬âŒ’Fá‚ª‚¢ŽÒŽ{Ý‚É‚š‚¯‚éƒmƒƒEƒCƒ‹ƒXˆÝ’°‰Š‚̏W’c”­¶‚ƃEƒCƒ‹ƒX”rŸ•ŠúŠÔ‚ÌŒŸ“¢A‘æ35‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2009”N3ŒŽ6“úA‰—ŽRŒ`

    9. “c“‡‚©‚š‚éAŒ•õËŽqAŠOèˆèŽÀAŒ›œ—tŽqAŽOžŠ‰Á“ÞŽqAÂ–Ø—mŽqA{“¡ˆŸŽõ‰ÀA…“cŽ–€Aށ‰ÆœA¬Ÿº³ŽŸA¬“cØFlA“c‘ãáÁlFƒIƒZƒ‹ƒ^ƒ~ƒrƒ‹‘ϐ«A/H1N1ƒEƒCƒ‹ƒX‚É‚æ‚邯l‚Š‚ç‚ꂜˆê¬ŠwZ‚ł̃Cƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ35‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2009”N3ŒŽ6“úA‰—ŽRŒ`

    •œ¬19”N“xi2007”N4ŒŽ\2008”N3ŒŽj

    \H19˜_•¶”­•\“™\

    1. Abiko C, Mizuta K, Itagaki T, Katsushima N, Ito S, Matsuzaki Y, Okamoto M, Nishimura H, Aoki Y, Murata T, Hoshina H, Hongo S, Ootani K. Outbreak of human metapneumovirus detected by Vero E6 cell line in Yamagata, Japan between 2004 and 2005. J Clin Microbiol. 2007;45:1912-1919.

    2. Muraki Y, Murata T, Takashita E, Matsuzaki Y, Sugawara K, Hongo S. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein. J Virol. 2007;81:8766-8773.

    3. Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H. An attenuated strain of enterovirus 71 belonging to the genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol. 2007;81:9386-9395.

    4. Saijo M, Suzutani T, Mizuta K, Kurane I, Morikawa S. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Arch Virol. 2008;153:303-314.

    5. Â–Ø•q–çA‹àŽq‹IŽqA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚éƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚Ì•ªŽq‰uŠw“IŒŸ“¢AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;40:42-46.

    6. ‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀF‰·ò—‘…•ǖؔ‚©‚ç‚ÌLegionella‘®‹Û‚Ì•ª—£‹y‚Ñ‘BŒo‰ßAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;40:47-49.

    7. Â–Ø—mŽqA{“¡ˆŸŽõ‰ÀA…“cŽ–€A•ۉȐmA‘å’JŸŽÀFƒŠƒAƒ‹ƒ^ƒCƒ€PCR–@‚ð—p‚¢‚œ–@‚ÌŒŸ“¢AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;40:50-52.

    8. {“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€F2007”N‚Ì–ƒ‚µ‚ñƒEƒCƒ‹ƒX•ª—£ó‹µ‹y‚Ñ‚»‚̈â“`Žq‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;40:53-55.

    \H19Šw‰ï”­•\\

    1. ‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀF‰·ò—‘…•ǖؔ‚©‚ç‚ÌLegionella‘®‹Û‚Ì•ª—£‹y‚Ñ‘BŒo‰ßA‘æ61‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2007”N8ŒŽ23“úA‰—å‘ä

    2. ‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀAŽR“c•qOA‹g“cáÁ’qŽqFŽRŒ`Œ§“à‚Å•ª—£‚³‚ꂜSalmonella@Poona‚ÌPFGE‰ðÍA‘æ34‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2008”N3ŒŽ5“úA‰—ŽRŒ`

    3. {“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€FŽRŒ`Œ§‚Å•ª—£‚³‚ꂜƒ€ƒ“ƒvƒXƒEƒCƒ‹ƒX‚̈â“`ŽqŒ^•ʁA‘æ34‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2008”N3ŒŽ5“úA‰—ŽRŒ`

    4. Â–Ø•q–çA‹àŽq‹IŽqA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚éƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚Ì•ªŽq‰uŠw“IŒŸ“¢A‘æ34‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2008”N3ŒŽ5“úA‰—ŽRŒ`

    •œ¬18”N“xi2006”N4ŒŽ\2007”N3ŒŽj

    \H18˜_•¶”­•\“™\

    1. Mizuta K, Abiko C, Aoki Y, Murata T, Katsushima N, Sakamoto M, Itagaki T, Hoshina H, Ootani K. A slow spread of adenovirus type 7 infection after its re-emergence in Yamagata, Japan, in 1995. Microbiol Immunol. 2006;50:553-558.

    2. Matsuzaki Y, Katsushima N, Nagai Y, Shoji M, Itagaki T, Sakamoto M, Kitaoka S, Mizuta K, Nishimura H. Clinical features of influenza C virus infection in children. J Infect Dis. 2006;193:1229-1235.

    3. Murata T, Katsushima N, Mizuta K, Muraki Y, Hongo S. Matsuzaki Y. Prolonged norovirus shedding in infants 6 months of age with gastroenteritis. Pediatr Infect Dis J. 2007;26:46-49.
      ËFIELDS@Virology, 6th@edition, Wolters KluwerŽÐA2013 ‚ňø—p‚³‚ê‚Ü‚µ‚œI

    4. Matsuzaki Y, Abiko C, Mizuta K, Sugawara K, Takashita E, Muraki Y, Suzuki H, Mikawa M, Shimada S, Sato K, Kuzuya M, Takao S, Wakatsuki K, Itagaki T, Hongo S, Nishimura H. A nationwide epidemic of influenza C virus in Japan in 2004. J Clin Microbiol. 2007;45:783-788.
      ËFeigin and cherry's Textbook of Pediatric Infectious Diseases 7th edition, ElsvierŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI

    5. ”Š_•ׁA…“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘å’JŸŽÀA‘º“c•q•vAÅã‹v”üŽqFŽRŒ`‚Ì•—Ž×‚ðl‚Š‚é-2004”N‚̃EƒCƒ‹ƒXE”x‰Šƒ}ƒCƒRƒvƒ‰ƒYƒ}•ª—£Œ‹‰Ê‚ð‚à‚Æ‚É‚µ‚ā[A“ú–{¬Ž™‰Èˆã‰ï‰ï•ñ 2006;31:183-187.

    6. ‘º“c•q•vA‘å’JŸŽÀFƒoƒ“ƒRƒ}ƒCƒVƒ“‚ƃeƒCƒRƒvƒ‰ƒjƒ“‚ɒ኎Žó«‚ðŽŠ‚·‘œÜ‘ϐ«‰©FƒuƒhƒE‹…‹Û‚É‚æ‚é‰@“àŠŽõiŽRŒ`Œ§G2004”N5ŒŽ-2005”N6ŒŽjAŠŽõÇŠwŽGŽ 2007;81:183-188.

    7. ”Š_•ׁAÅã‹v”üŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘å’JŸŽÀFŠJ‹Æˆã‚©‚ç‚Ý‚œ”x‰Šƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇf’fA“ú–{¬Ž™‰Èˆã‰ï‰ï•ñ 2007;33:137-140.

    8. …“cŽ–€AÂ–Ø—mŽqA{“¡ˆŸŽõ‰ÀA•ۉȐmA‘å’JŸŽÀF2005”N‚ÌŽRŒ`Œ§“à‚É‚š‚¯‚é•—]A–ƒ‚µ‚ñ‚ɑ΂·‚éR‘ۗ̕Ló‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;39:34-36.

    9. Â–Ø•q–çA‹àŽq‹IŽqA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚é•œ¬17”N‚̂‚‚ª’Ž•a”­¶ó‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;39:37-40.

    10. Â–Ø—mŽqA{“¡ˆŸŽõ‰ÀA…“cŽ–€A•ۉȐmA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX•ª—£ó‹µi2003-2005”NjAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;39:41-44.

    11. ‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀFl‹y‚Ñ‹‚©‚番—£‚³‚ꂜŽu‰ê“Å‘fŽY¶«‘å’°‹Û‚ÌŽu‰ê“Å‘fˆâ“`ŽqŒ^AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2007;39:45-48.

    \H18Šw‰ï”­•\\

    1. ”Š_•ׁA…“cŽ–€AˆÀ‘·ŽqçŒbŽqAÂ–Ø—mŽqFhMPV69—á‚ÌŒŸ“¢-”N—îAŽžŠúA—¬s«A“¯–E“àŠŽõ‚Ì•ªÍ-‘æ80‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2006”N6ŒŽ4“úA‰—ŽRŒ`

    2. ”Š_•ׁA…“cŽ–€AˆÀ‘·ŽqçŒbŽqAÂ–Ø—mŽqFhMPV‚̗Տ°Çó@‘æ80‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2006”N6ŒŽ4“úA‰—ŽRŒ`

    3. {“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA…“cŽ–€A•ۉȐmA‘å’JŸŽÀFPCR–@‚É‚æ‚éƒEƒCƒ‹ƒXŒŸž‚ւ̃hƒbƒgƒnƒCƒuƒŠƒ_ƒCƒ[[ƒVƒ‡ƒ“‚ÌŠˆ—pA‘æ50‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2006”N6ŒŽ16“úA‰—ŽRŒ`

    4. ‘å’JŸŽÀA羗́A•“cO–ŸA•Ÿˆä’‰‹vA‰Í“cƒ’jAÎìmA[”ö²F‹Û‘̐ڒ…ˆöŽqSabA‚̈â“`Žq\‘¢‚ÆH.pyloriŠŽõ‚Ƃ̊֘AA‘æ55‰ñ“Œ–kŒöO‰q¶Šw‰ïA2006”N7ŒŽ21“úA‰—·‰ª

    5. Â–Ø•q–çA‹àŽq‹IŽqAÅã‹v”üŽqA‘º“c•q•vA‘å’JŸŽÀFŒŒŽŒ^KawasakiŠŽõ‚É‚æ‚é‚‚‚ª’Ž•aA‘æ60‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2006”N8ŒŽ24-25“úA‰—•Ÿ“‡

    6. …“cŽ–€AÂ–Ø—mŽqA{“¡ˆŸŽõ‰ÀA•ۉȐmA‘å’JŸŽÀA”Š_•ׁF‚U‚‚̍זE‚ðŽg—p‚µ‚œƒ}ƒCƒNƒƒvƒŒ[ƒg•Ï–@‚É‚æ‚éƒEƒCƒ‹ƒX•ª—£A2006”N8ŒŽ24-25“úA‰—•Ÿ“‡

    7. …“cŽ–€AÂ–Ø—mŽqA{“¡ˆŸŽõ‰ÀA•ۉȐmA‘å’JŸŽÀAŒ›œ—tŽqA–{‹œœŽ¡A‹ß]²A‰ª–{“¹ŽqAŒ‘ºGˆêF1990~2003”N‚ÌŽRŒ`‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX71Œ^‚Ì•ªŽq‰uŠwA2006”N8ŒŽ24-25“úA‰—•Ÿ“‡

    8. ”Š_•ׁAŸ“‡‹éŽqA…“cŽ–€AˆÀ‘·ŽqçŒbŽqAÂ–Ø—mŽqFŽRŒ`Žs‹ßx‚É‚š‚¯‚éhMPV‚Ì—¬s‚ɂ‚¢‚Ä-hMPV‚̈â“`ŽqŒ^‚Æ’nˆæ—¬s-A‘æ16‰ñ“ú–{ŠO—ˆ¬Ž™‰ÈŠw‰ïA2006”N9ŒŽ2-3“úA‰—‰¡•l

    9. ‘å’J ŸŽÀA羗́A•“cO–ŸA•Ÿˆä’‰‹vA‘啐‚³‚⍁A‰Í“cƒ’jA[”ö@²FHelicobactor pylori—Տ°•ª—£Š”‚̐ڒ…ˆöŽqsabA‚Ì•ªŽq‰uŠw“IŒ€‹†A‘æ48‰ñ“ú–{Á‰»Ší•aŠw‰ïA2006”N10ŒŽ11-12“úA‰—ŽD–y

    10. ‹àŽq‹IŽqAÂ–Ø•q–çFl‹y‚Ñ‹‚©‚番—£‚³‚ꂜ’°ŠÇoŒŒ«‘å’°‹Û‚ÌŽu‰ê“Å‘fˆâ“`ŽqƒoƒŠƒAƒ“ƒg•Û—Ló‹µA‘æ28‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA2006”N11ŒŽ11-12“úA‰—“ì—z

    11. Â–Ø•q–çA‹àŽq‹IŽqFŽRŒ`Œ§“à‚É‚š‚¯‚éŽU”­‰º—ŸÇ‚©‚ç‚̃Tƒ‹ƒ‚ƒlƒ‰•ª—£ó‹µA‘æ28‰ñŽRŒ`Œ§ˆãŠwŒŸžŠw‰ïA2006”N11ŒŽ11-12“úA‰—“ì—z

    12. Â–Ø•q–çA‹àŽq‹IŽqA‘å’JŸŽÀAˆ¢•F’‰”VFŒ‹ŠjгŽÒÚGŽÒŒŸf‚É‚š‚¯‚é‘SŒŒƒCƒ“ƒ^[ƒtƒFƒƒ“ƒÁ‰ž“š‘ª’è–@‚ÌŽÀŽ{ó‹µAŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2007”N3”N7“úA‰—ŽRŒ`

    13. {“¡ˆŸŽõ‰ÀAÂ–Ø—mŽqA•ۉȐmA…“cŽ–€A‘å’JŸŽÀFŽRŒ`Œ§–¯‚Ì“ú–{”]‰ŠƒEƒCƒ‹ƒX‚ɑ΂·‚éR‘ۗ̕Ló‹µAŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2007”N3ŒŽ7“úA‰—ŽRŒ`

    14. –ö¶—TŽqA”ŒŽ‚é‚݁A‘º“c•q•vA‹àŽq‹IŽqAÂ–Ø•q–çA‘å’JŸŽÀF‰@“à‚Å•ª—£‚³‚ꂜMRSA‚̍׋ۊw“I«ó‚š‚æ‚ÑPFGE‰ðÍAŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2007”N3ŒŽ7“úA‰—ŽRŒ`

    •œ¬17”N“xi2005”N4ŒŽ\2006”N3ŒŽj

    \H17˜_•¶”­•\“™\

    1. Mizuta K, Abiko C, Murata T, Yamada K, Ahiko T, Sakamoto M, Tsuchida S, Matsuzaki Y, Hongo S, Kudo K. An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004.Jpn J Infect Dis. 2005;58:98-100.

    2. Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan between 1998 and 2003. J Clin Microbiol. 2005;43:6171-6175.
      ËViral Infections of Humans, Epidemiology and Control 5th edition, SpringerŽÐA2014‚ňø—p‚³‚ê‚Ü‚µ‚œI

    3. Matsumoto M, Sakae K, Ohta M, Endo M, Okuno R, Murayama S, Hirasawa K, Suzuki R, Isobe J, Tanaka D, Katsukawa C, Tamaru A, Tomita M, Ogata K, Yasuoka T, Ikebe T, Watanabe H. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11. Int J Antimicrobial Agents. 2005;25:142-147.

    4. “c’†”ށA•–؏r˜YA“n•Ó—SŽqAóˆä—Ç•vA‘å’JŸŽÀA{Š˜‹v”üŽqA‹Úìr•FA’†“ˆ—mA»ŒŽçŽõŽqA”¿‘«Šì‹v—YAŽRŒûmFA‹v‚A‚‹Ž‰p”VAˆäã”Ž—YAŽRˆäŽu˜NA‰vì–M•FA“n•ÓŽ¡—YF‚킪‘‚ÌŒ’NŽÒ‚É‚š‚¯‚é‘–Œ‰Š‹Û‚̕ۋۏ󋵁A ŠŽõÇŽ 2005;79:527-533.

    5. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€AŸ“‡‹éŽqAˆÉ“¡––ŽuAŒ›œ—tŽqA‘º–Ø–õA–{‹œœŽ¡F’nˆæ‚Å—¬s‚µ‚Ä‚¢‚éNorovirus‚ƃJƒL‚ÌŠÖ˜A«‚ɂ‚¢‚āAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2005;38:5-8.

    6. ˆÀ‘·ŽqçŒbŽqAÂ–Ø—mŽqA…“cŽ–€A•ۉȐmA‘å’JŸŽÀF‘gD”|—{–@‚ÆRT-PCR–@‚É‚æ‚éƒpƒ‰ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX1-3Œ^ƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚Ì•ª—£AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2005;38:27-29.

    7. Â–Ø—mŽqAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A•ۉȐmA‘å’JŸŽÀFƒhƒbƒgƒnƒCƒuƒŠƒ_ƒCƒ[[ƒVƒ‡ƒ“‚É‚æ‚éƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚ÌŠm”FAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2005;38:30-32.

    8. Åã‹v”üŽqA’r“c’C–çA‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚é‰ß‹Ž10”NŠÔ‚̂‚‚ª‚Þ‚µ•a”­¶ó‹µAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2005;38:33-35.

    9. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çFŠÂ‹«E•Ö‚©‚ç‚ÌPCR‚É‚æ‚éHelicobacter@Pyloriˆâ“`ŽqŒŸo–@‚ÌŒŸ“¢AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2005;38:36-37.

    \H17Šw‰ï”­•\\

    1. Muraki Y, Murata T, Sugawara K, Takashita E, Matsuzaki Y. and Hongo S. Reverse Genetics Study of Influenza C Virus. XIII International Congress of Virology, July 23-28, 2005, San Francisco, California, USA, Moscone Convention Center.

    2. ‰ªè‘¥’jA‘剮“ú“o”üA¬“cŒõ¶A‘å’JŸŽÀA²X–ØŽŸ—YFÅ‹ß•ª—£‚³‚ꂜ”x‰Šƒ}ƒCƒRƒvƒ‰ƒYƒ}‚Ì–òÜŠŽŽó«A‘æ79‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ïA2005”N4ŒŽ14-15“úA‰—–ŒŒÃ‰®

    3. 羗́A•“cO–ŸA‘å’JŸŽÀA•Ÿˆä’‰‹vAÎˆäŒ’ˆêAì“cƒ’jA[”ö²F–{–M‚É‚š‚¯‚éHelicobacter pylori•ª—£Š”‚ÌcagA¥babA¥sabAˆâ“`Žq—z«—Š‚ÌŒŸ“¢A‘æ91‰ñ“ú–{Á‰»Ší•aŠw‰ïA2005”N4ŒŽ14-16“úA‰—“Œ‹ž

    4. ‘å’JŸŽÀA’r“c’C–çA£ìr•vA‚‹Ž‰ë‹PAóŒ©¬ŽuA²“¡”ށA_“c—²Aˆä“c³–€A²“¡Ž–€A’†–{¬•FAd–ÎŽ•FA•iì–M”āF‹‚©‚番—£‚³‚ꂜ’°ŠÇoŒŒ«‘å’°‹ÛO157‚š‚æ‚ÑO26‚̂̍׋ۊw“IA•ªŽqˆâ“`Šw“I«óA‘æ9‰ñ’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇƒVƒ“ƒ|ƒWƒEƒ€A2005”N6ŒŽ23-24“úA‰—·‰ª

    5. ‘å’JŸŽÀFŽRŒ`Œ§‚É‚š‚¯‚é‰ß‹Ž10”NŠÔ‚̂‚‚ª’Ž•a”­¶ó‹µA‘æ49‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2005”N6ŒŽ17“úA‰—ŽRŒ`

    6. ”Š_•ׁA‰q¶Œ€‹†Š”÷¶•𕔁FŽRŒ`‚̃Jƒ[‚ðl‚Š‚éA“Œ–kŠO—ˆ¬Ž™‰ÈŒ€‹†‰ïA2005”N7ŒŽ3“úA‰—ŽRŒ`Žs

    7. ”Š_•ׁA‘å’JŸŽÀA’r“c’C–çAÅã‹v”üŽqFƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚̗Տ°f’f‚͓‚¢A‘æ15‰ñŠO—ˆ¬Ž™‰ÈŠw‰ïA2005”N8ŒŽ20“úA‰—‘åã

    8. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAÂ–Ø—mŽqA”Š_•ׁAŒ›œ—tŽqA–{‹œœŽ¡FŽRŒ`Œ§‚É‚š‚¯‚éƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚̉uŠwA‘æ59‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2005”N8ŒŽ25-26“úA‰—ŽRŒ`

    9. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡A…“cŽ–€AŒ‘ºGˆêF 2004”N‚É—¬s‚µ‚œCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐«ó‰ðÍA‘æ59‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2005”N8ŒŽ25-26“úA‰—ŽRŒ`

    10. ‘º“c•q•vA…“cŽ–€AŸ“‡‹éŽqAŒ›œ—tŽqA‘º–Ø–õA–{‹œœŽ¡F NorovirusiNVjŠŽõŒã‚̃EƒCƒ‹ƒX”rŸ•ŠúŠÔA‘æ59‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2005”N8ŒŽ25-26“úA‰—ŽRŒ`

    11. ‘å’JŸŽÀA’r“c’C–çA£ìr•vA‚‹Ž‰ë‹PAóŒ©¬ŽuA²“¡”ށA_“c—²Aˆä“c³–€A²“¡Ž–€A’†–{¬•FAd–ÎŽ•FA•iì–M”āF‚Æ’{ê‚É”À“ü‚³‚ꂜƒEƒV‚É‚š‚¯‚é’°ŠÇoŒŒ«‘å’°‹ÛO157‚š‚æO26‚ۗ̕Ló‹µA‘æ59‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2005”N8ŒŽ25-26“úA‰—ŽRŒ`

    12. ‘º–Ø –õA‘º“c•q•vA›ŒŽŠš‰xA‚‰ºŒb”üAŒ›œ—tŽqA–{‹œœŽ¡FƒŠƒo[ƒXEƒWƒFƒlƒeƒBƒNƒX‚É‚æ‚éCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̍쐻A‘æ59‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2005”N8ŒŽ25-26“úA‰—ŽRŒ`

    13. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø –õA‘º“c•q•vA–{‹œœŽ¡A…“cŽ–€A‚”öMˆêA“‡“cTˆêA—é–ØGAŒ‘ºGˆêF2004”N‚ÌCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬s‚ƐV‚µ‚¢ˆâ“`ŽqW‡‘̂̏oŒ»‘æ53‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2005”N11ŒŽ20-22“úA‰—‰¡•l

    14. Åã‹v”üŽqA‘º“c•q•vA‘å’JŸŽÀFŽRŒ`Œ§‚ÌŠ|‚¯—¬‚µ‰·ò‚É‚š‚¯‚é•aŒŽ”÷¶•š‰˜õŽÀ‘Ô’²žA‘æ32‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2006”N3ŒŽ8“úA‰—ŽRŒ`

    15. …“cŽ–€AˆÀ‘·ŽqçŒbŽqAÂ–Ø—mŽqA”Š_•ׁAŸ“‡‹éŽqAŒ›œ—tŽqA–{‹œœŽ¡FŽRŒ`Œ§‚É‚š‚¯‚éƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒX‚̉uŠwA‘æ32‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2006”N3ŒŽ8“úA‰—ŽRŒ`

    •œ¬16”N“xi2004”N4ŒŽ\2005”N3ŒŽj

    \H16˜_•¶”­•\“™\

    1. Mizuta K, Itagaki T, Abiko C, Murata T, Takahashi T, Murayama S. Epidemics of two Victoria and Yamagata influenza B lineages in Yamagata, Japan. Epidemiol Infect. 2004;132:721-726.

    2. Matsuzaki Y, Takao S, Shimada S, Mizuta K, Sugawara K, Takashita E, Muraki Y, Hongo S, Nishimura H. Characterization of antigenically and genetically similar influenza C viruses isolated in Japan during the 1999-2000 season. Epidemiol Infect. 2004;132:709-720.

    3. Matsuzaki Y, Sugawara K, Takashita E, Muraki Y, Hongo S, Katsushima N, Mizuta K, Nishimura H. Genetic diversity of influenza B virus: The frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol. 2004;74:132-140.

    4. ”ª–öAÄ“¡Žu•ÛŽqA‹{“‡‰Ã“¹AŒŽ“cœŽO˜YA—é–Ø‹IsA‘å—F—ÇŒõAŒF’JŠwAÄ“¡KˆêA²“¡‘ìA›ŒŽŠìOA¬—Ñ—Ç—YA‚‹Ž’qŽqA{“¡³‰pA‘å’JŸŽÀAŽRŒû—F”üA”©ŽRŒhAÄ“¡‹IsA”’ÎœAsAœA£¹ŽqAŒF’JiA•iì–M”āF“Œ–k’n•û‚É‚š‚¯‚é’°‰ŠƒrƒuƒŠƒIŽU”­‰º—ŸÇ‚Ì”­¶ó‹µAŠC…EŠC“D‚©‚ç‚Ì’°‰ŠƒrƒuƒŠƒI‚Ì•ª—£A‚š‚æ‚ÑŠe•ª—£Š”‚Ì•ªŽq‰uŠw“I«óA“ú–{H•i”÷¶•šŠw‰ïŽGŽ 2004G21:30-37.

    5. ‘º“c•q•vA…“cŽ–€AŸ“‡‹éŽqAŒ›œ—tŽqA‘º–Ø–õA–{‹œœŽ¡F¬Ž™‰º—ŸÇгŽÒ‚Æ‹}«ˆÝ’°‰Š‚̏W’c”­¶Ž–—á‚©‚猟o‚³‚ꂜNorovirusiNVj‚Ì•ªŽq‰uŠwi2000”N4ŒŽ‚©‚ç2001”N7ŒŽFŽRŒ`Œ§jA—Տ°‚ƃEƒCƒ‹ƒX 2004;32:388-395.

    6. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€AH“¡Ÿ”ށAŸ“‡‹éŽqAˆÉ“¡––ŽuFŽRŒ`Œ§‚ÅŒŸo‚³‚ꂜNorovirusiNVj‚Ì•ªŽq‰uŠw(1998-2003”N)AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:5-7.

    7. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAH“¡Ÿ”ށF2003”N‚É‚š‚¯‚éŽRŒ`Œ§‚̃RƒNƒTƒbƒL[ƒEƒCƒ‹ƒXB1-5Œ^Nˆúó‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:39-41.

    8. ’r“c’C–çAÅã‹v”üŽqA‘å’JŸŽÀAH“¡Ÿ”ށF’°‰ŠƒrƒuƒŠƒIH’†“ł̔­¶—vˆö‚ÉŠÖ‚·‚é’²ž-гŽÒ”­¶ó‹µ‚ÆŠŽõŒ¹‚ɂ‚¢‚āi‘æ‚Q•ñj-AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:42-45.

    9. Åã‹v”üŽqA’r“c’C–çA‘å’JŸŽÀAH“¡Ÿ”ށFAŒQ—nŒŒ«ƒŒƒ“ƒT‹…‹Û‚Ì•ª—£ó‹µ‚ÆTŒ^•ʁAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:46-47.

    10. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çAH“¡Ÿ”ށFŽRŒ`Œ§“à‚ÌŽ{Ý‚ł݂ç‚ꂜÔ—ŸƒAƒ[ƒo‚̏W’cŠŽõAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:48-50.

    11. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vAH“¡Ÿ”ށF2001-04ƒV[ƒYƒ“‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:51-54.

    12. aŒû“ñ˜YA‚‹Ž—ǘaA…“cŽ–€AˆÀ‘·ŽqçŒbŽqFŽRŒ`Œ§‚É‚š‚¯‚é•—‚µ‚ñ‚Ì’nˆæ—¬sAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2004;37:55-59.

    \H16Šw‰ï”­•\\

    1. Œ›œ—tŽqA–{‹œœŽ¡AŸ“‡‹éŽqA‰iˆäK•vA…“cŽ–€AŒ‘ºGˆêFAŒ^‚ÆBŒ^‚Æ“¯ŽžŠú‚É—¬s‚µ‚œCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐«ó‰ðÍA‘æ45‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2004”N6ŒŽ13“úA‰—‘åã

    2. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡A…“cŽ–€A‚”öMˆêA“‡“cTˆêAŠ‹’JŒõ—²A²“¡Ž•FAŽOì³GA—é–ØGAŒ‘ºGˆêF2004”N‚ÌCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ19‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïƒVƒ“ƒ|ƒWƒEƒ€A2005”N3ŒŽ3“úA‰—‘q•~

    3. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€AH“¡Ÿ”ށA–{‹œœŽ¡FŽRŒ`Œ§‚ÅŒŸo‚³‚ꂜNorovirusiNVj‚Ì•ªŽq‰uŠwA‘æ53‰ñ“Œ–kŒöO‰q¶Šw‰ïA2004”N7ŒŽ23“úA‰—ŽRŒ`

    4. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAŒ›œ—tŽqA”Š_•ׁAŽOžŠ‰Á“ÞŽqAâ–{”üç‘ãA–{‹œœŽ¡AH“¡Ÿ”ށF“~‹G‚Ì2002-2003ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒV[ƒYƒ“‚É—¬s‚µ‚œ‰Ä‚©‚ºŽè‘«Œû•aA‘æ53‰ñ“Œ–kŒöO‰q¶Šw‰ïA2004”N7ŒŽ23“úA‰—ŽRŒ`

    5. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAH“¡Ÿ”ށAâ–{”üç‘ãA“y“cG“ñAŽR“cŒhŽqAˆ¢•F’‰”VF’†ŠwZ‚É‚š‚¯‚éAˆâ“`ŽqŒ^D9‚É‚æ‚é–ƒ]‚Ì—¬sA‘æ53‰ñ“Œ–kŒöO‰q¶Šw‰ïA2004”N7ŒŽ23“úA‰—ŽRŒ`

    6. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAŒ›œ—tŽqA–{‹œœŽ¡A”Š_•ׁAŽOžŠ‰Á“ÞŽqAâ–{”üç‘ãAH“¡Ÿ”ށF2002-03ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒV[ƒYƒ“‚É—¬s‚µ‚œƒGƒ“ƒeƒƒEƒCƒ‹ƒX71Œ^‚É‚æ‚éŽè‘«Œû•aA‘æ58‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2004”N8ŒŽ19-20“úA‰—å‘ä

    7. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡AŸ“‡‹éŽqA‰iˆäK•vA…“cŽ–€AŒ‘ºGˆêFAŒ^ABŒ^‚Æ“¯ŽžŠú‚É—¬s‚µ‚œCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐«ó‰ðÍA‘æ58‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2004”N8ŒŽ19-20“úA‰—å‘ä

    8. ’r“c’C–çA‘å’JŸŽÀFŽRŒ`Œ§“à‚̉º—ŸÇгŽÒ—R—ˆSalmonella Enteritidis‚̉uŠw‰ðÍA•œ¬16”N“x“ú–{bˆãŒöO‰q¶Šw‰ï(“Œ–k)A2004”N10ŒŽ15“úA‰—H“c

    9. ‘å’JŸŽÀA’r“c’C–çFŽ{Ý‚ł̃Aƒ[ƒoÔ—Ÿ‚Ì”­¶‚ƍR‘Ì‘ª’è‚𒆐S‚Æ‚µ‚œ•aŒŽŠw“IŒŸžA•œ¬16”N“x“ú–{bˆãŒöO‰q¶Šw‰ï(“Œ–k)A2004”N10ŒŽ15“úA‰—H“c

    10. áÁ•¿TˆêA“Y–숀ŠîAªŠÝAŒŽ“c˜a‰ÀA‹g“cGAˆÉ“¡––ŽuA‘º“c•q•vA…“cŽ–€F–{”N‚Ì‚¢‚í‚ä‚é‰Ä‚©‚º‚ÌŒŽˆöƒEƒCƒ‹ƒX‚Æ‚»‚̗Տ°‘œ‚ɂ‚¢‚āA‘æ23‰ñ¯“àˆãŽtW’k‰ïŽ˜^A2004”N11ŒŽ28“úA‰—’߉ª

    11. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çAH“¡Ÿ”ށA‘âWˆêA羗́FŠÂ‹«E•Ö‚©‚ç‚ÌPCR‚É‚æ‚éHelicobacter Pyloriˆâ“`ŽqŒŸo•û‚ÌŒŸ“¢A‘æ31‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2005”N3ŒŽ8“úA‰—ŽRŒ`

    12. ŽR“c•qOA—é–Ø“¹ŽqA’r–ì’mNA‘å’JŸŽÀFŠÂ‹«i‰Íì…AˆäŒË…j‚©‚ç‚ÌHelicobacter Pyloriˆâ“`Žq‚ÌŒŸoA‘æ31‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2005”N3ŒŽ8“úA‰—ŽRŒ`

    13. ‘º“c•q•vA…“cŽ–€AˆÀ‘·ŽqçŒbŽqAH“¡Ÿ”ށFNorovirusiNVjŠŽõŒã‚̃EƒCƒ‹ƒX”rŸ•ŠúŠÔA‘æ31‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2005”N3ŒŽ8“úA‰—ŽRŒ`

    14. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vAH“¡Ÿ”ށAâ–{”üç‘ãA“y“cG“ñAŽR“cŒhŽqAˆ¢•F’‰”VFˆâ“`ŽqŒ^D9‚É‚æ‚é–ƒ]‚Ì—¬sA‘æ31‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2005”N3ŒŽ8“úA‰—ŽRŒ`

    •œ¬15”N“xi2003”N4ŒŽ\2004”N3ŒŽj

    \H15˜_•¶”­•\“™\

    1. Mizuta K, Katsushima N, Ito S, Sanjoh K, Murata T, Abiko C, Murayama S. A rare appearance of influenza A(H1N2) as a reassortant in a community such as Yamagata where A(H1N1) and A(H3N2) co-circulate. Microbiol Immunol. 2003;47:359-361.

    2. Mizuta K, Abiko C, Goto H, Murata T, Murayama S. Enterovirus isolation from children with acute respiratory infections and presumptive identification by a modified microplate method. Int J Infect.Dis. 2003;7:138-142.

    3. Mizuta K, Abiko C, Murata T, Itagaki T, Katsushima N, Akiba T, Sakamoto M, Ootani K, Murayama S. Re-emergence of echovirus type 13 infections in 2002 in Yamagata, Japan. J Infect. 2003;47:243-247.

    4. Ikebe T, Murai N, Endo M, Okuno R, Murayama S, Saitoh K, Yamai S, Suzuki R, Isobe J, Tanaka D, Katsukawa C, Tamaru A, Katayama A, Fujinaga Y, Hoashi K, Ishikawa J, Watanabe H; Working Group for Group A Streptococci in Japan. Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol Infect. 2003;130:569-572.

    5. Ikebe T, Murayama S, Saitoh K, Yamai S, Suzuki R, Isobe J, Tanaka D, Katsukawa C, Tamaru A, Katayama A, Fujinaga Y, Hoashi K, Watanabe H; Working Group for Group A Streptococci in Japan. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan. Epidemiol Infect. 2004;132:145-149.

    6. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘ºŽR®ŽqFW’cˆÝ’°‰ŠŽ–—á‚É‚š‚¯‚é—·ŠÙ]‹Æˆõ‚©‚猟o‚³‚ꂜNovovirus‚Ì•ªŽq‰uŠwAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:15-20.

    7. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqF2002”N‚É‚š‚¯‚éŽRŒ`Œ§–¯‚̃pƒŒƒR[ƒEƒCƒ‹ƒX‚ɑ΂·‚éR‘ۗ̕Ló‹µAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:58-59.

    8. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqF2001-02”N‚É‚š‚¯‚éŽRŒ`Œ§–¯‚ÌAŒ^ŠÌ‰ŠR‘ۗ̕Ló‹µAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:60-61.

    9. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqF2001-02”N‚É‚š‚¯‚éŽRŒ`Œ§–¯‚̃|ƒŠƒIƒEƒCƒ‹ƒXR‘ۗ̕Ló‹µAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:62-63.

    10. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqF2002-03”NƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒV[ƒYƒ“‚É‚š‚¯‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX71Œ^‚É‚æ‚éŽè‘«Œû•a‚Ì—¬sAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:64-66.

    11. ’r“c’C–çAÅã‹v”üŽqA‘å’JŸŽÀA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚éƒTƒ‹ƒ‚ƒlƒ‰Š³ŽÒ”­¶ó‹µ‚Æ•ª—£‹Û‚̈â“`Žq‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:67-70.

    12. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇ”­¶ó‹µ‚Æ•ª—£‹Û‚Ì“Á’¥AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:71-76.

    13. Åã‹v”üŽqA’r“c’C–çA‘å’JŸŽÀA‘ºŽR®ŽqFƒŒƒWƒIƒlƒ‰Ç‚Ì•aŒŽŠw“IŒŸž¬ÑAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2003;36:77-81.

    \H15Šw‰ï”­•\\

    1. ’r“c’C–çAÅã‹v”üŽqA‘å’JŸŽÀA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚éƒTƒ‹ƒ‚ƒlƒ‰Š³ŽÒ”­¶ó‹µ‚Æ•ª—£‹Û‚̈â“`Žq‰ðÍA“ú–{H•i‰q¶Šw‰ï‘æ86‰ñŠwpu‰‰‰ïA2003”N10ŒŽ30-31“úA‰—·‰ª

    2. Œ›œ—tŽqAŸ“‡‹éŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡A…“cŽ–€AŒ‘ºGˆêFYamagataŒn“‚̍RŒŽ«‚ð‚à‚ˆقȂéˆâ“`ŽqÄW‡‘̂ɂæ‚éBŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ51‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2003”N10ŒŽ27“úA‰—‹ž“s

    3. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çA‘ºŽR®ŽqF‰·ò‚ªŠŽõŒ¹‚Ɛ„’肳‚ꂜƒŒƒWƒIƒlƒ‰ÇA‘æ52‰ñ“Œ–kŒöO‰q¶Šw‰ïA2003”N7ŒŽ25“úA‰—H“c

    4. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡A…“cŽ–€AŒ‘ºGˆêFYamagataŒn“‚̍RŒŽ«‚ð‚à‚ˆقȂéˆâ“`ŽqÄW‡‘̂ɂæ‚éBŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ57‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2003”N8ŒŽ21-22“úA‰—H“c

    5. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqFŽRŒ`‚É‚š‚¯‚éƒGƒR[13Œ^‚̍ďoŒ»A‘æ57‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2003”N8ŒŽ21-22“úA‰—H“c

    6. –Ø“‡ˆêŒÈA—é–Ø—zA–ö“c‹I”VAç—t–¯•FA‹{àVKmA…“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA”Š_•ׁF‰@“à‚Å—¬s‚µ‚œƒpƒ‰ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠŽõÇ‚ɂ‚¢‚āA‘æ‚W‰ñŽRŒ`¬Ž™_ŒoŒ€‹†‰ïA2003”N9ŒŽ5“úA‰—ŽRŒ`

    7. ‘å’JŸŽÀA’r“c’C–çF’°ŠÇoŒŒ«‘å’°‹ÛŠŽõŽÒ“™‚©‚番—£‚³‚ꂜ‘å’°‹Û‚ÌŽu‰ê“Å‘f2ˆâ“`ŽqƒoƒŠƒAƒ“ƒg•Û—Ló‹µA•œ¬15”N“x“ú–{bˆãŒöO‰q¶Šw‰ï(“Œ–k)A2003”N10ŒŽ3“úA‰—ÂX

    8. Åã‹v”üŽqAÂ–Ø•q–çAAŒ‚·‚ÝŽqFHUSгŽÒ‚©‚番—£‚³‚ꂜ’°ŠÇoŒŒ«‘å’°‹ÛO165FH|‚̈â“`ŽqŠw“IŒŸ“¢A‘æ26‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA2003”N11ŒŽ9“úA‰—’߉ª

    9. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqA‘âWˆêF2003”N‚̃RƒNƒTƒbƒL[ƒEƒCƒ‹ƒXB1-5Œ^‚ɑ΂·‚é’†˜aR‘ۗ̕Ló‹µA‘æ30‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2004”N3ŒŽ10“úA‰—ŽRŒ`

    10. Åã‹v”üŽqA’r“c’C–çA‘å’JŸŽÀA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇ”­¶ó‹µ‚Æ•ª—£‹Û‚Ì“Á«A‘æ30‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2004”N3ŒŽ10“úA‰—ŽRŒ`

    •œ¬14”N“xi2002”N4ŒŽ\2003”N3ŒŽ)

    \H14˜_•¶”­•\“™\

    1. Matsuzaki Y, Mizuta K, Sugawara K, Tsuchiya E, Muraki Y, Hongo S, Suzuki H, Nishimura H. Frequent ressortment among influenza C viruses. J Virol. 2003;77:871-881.

    2. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘ºŽR®ŽqAŸ“‡‹éŽqAˆÉ“¡––ŽuFƒJƒL‚Ƃ͊֘A‚Ì”F‚ß‚ç‚ê‚È‚¢ƒm[ƒEƒI[ƒNƒEƒCƒ‹ƒX(NV)‚É‚æ‚éW’cŠŽõŽ–—á‚Æ¬Ž™ŠŽõ«ˆÝ’°‰ŠŽU”­—á‚Ì•ªŽq‰uŠwi2000-2001FŽRŒ`Œ§jAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:21-24.

    3. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqFƒpƒ‰ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚ÌMDCK×–E‚É‚æ‚镪—£AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:53-55.

    4. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqF2002”N‚ÌŽRŒ`Œ§‚É‚š‚¯‚éƒGƒR[ƒEƒCƒ‹ƒX13Œ^‚̍ďoŒ»AŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:56-58.

    5. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqF2001”N‚ÌŽRŒ`Œ§“à‚É‚š‚¯‚é•—]A–ƒ]‚ɑ΂·‚éR‘ۗ̕LóAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:59-61.

    6. ‘å’JŸŽÀA‘ºŽR®ŽqFV‚µ‚¢ŒŒŽŒ^ƒcƒcƒKƒ€ƒV•a•aŒŽ‘̂ɑ΂·‚éR‘Ì’²žAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:66-68.

    7. Åã‹v”üŽqAŒã“¡—TŽqA’r“c’C–çA‘å’JŸŽÀA‘ºŽR®ŽqFShigella@Sonnei‚ÌPFGE‚É‚æ‚éˆâ“`Žq‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:69-72.

    8. ’r“c’C–çAŒã“¡—TŽqA‘å’JŸŽÀA‘ºŽR®ŽqF’°‰ŠƒrƒuƒŠƒIH’†“ł̔­¶—vˆö‚ÉŠÖ‚·‚é’²ž-гŽÒ”­¶ó‹µ‚ÆŠŽõŒ¹‚ɂ‚¢‚āAŽRŒ`Œ§‰q¶Œ€‹†ŠŠ•ñ 2002;35:73-76.

    9. ”Š_•ׁAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘º“c•q•vA‘ºŽR®ŽqA‘âWˆêF2001-2002ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒV[ƒYƒ“‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠÈˆÕf’fƒLƒbƒg‚ƃEƒCƒ‹ƒX•ª—£”|—{Œ‹‰Ê‚Ì”äŠrŒŸ“¢AŽRŒ`Œ§ˆãŽt‰ï•ñ 2003;618:19-21.

    \H14Šw‰ï”­•\\

    1. Œ›œ—tŽqAŒ‘ºGˆêA‚”öMˆêA“‡“cTˆêA…“cŽ–€FŽRŒ`A‹{éAé‹ÊAL“‡‚Ì4Œ§‚Å“¯ŽžŠú‚É•ª—£‚³‚ꂜCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐«óA‘æ43‰ñ—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2002”N6ŒŽ6-7“úA‰—H“c

    2. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA‘º–Ø–õA–{‹œœŽ¡AŒ‘ºGˆêA…“cŽ–€F‹{éŒ§‚É‚š‚¯‚é10”NŠÔ‚̃T[ƒxƒCƒ‰ƒ“ƒX‚Å•ª—£‚³‚ꂜCŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐«óA‘æ50‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïA2002”N10ŒŽ16-18“úA‰—ŽD–y

    3. ˆÀ‘·ŽqçŒbŽqF‚U‚‚̍זE‚ð—p‚¢‚œƒ}ƒCƒNƒƒvƒŒ[ƒg–@‚É‚æ‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX‚Ì•ª—£‚Æ“¯’èA‘æ46‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2002”N5ŒŽ24“úA‰—ŽRŒ`

    4. ’r“c’C–çA‘å’JŸŽÀF’°‰ŠƒrƒuƒŠƒIгŽÒ”­¶ó‹µ‚Ɖ˜õŒ¹’²žA‘æ46‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2002”N5ŒŽ24“úA‰—ŽRŒ`

    5. Ÿ“‡‹éŽqA…“cŽ–€AŒ‘ºGˆêA‹ß]²A‰ª–{“¹ŽqF¬Ž™‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“‚ÌŒø‰ÊA‘æ72‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2002”N6ŒŽ2“úA‰—ŽRŒ`

    6. ¬“ˆŒŠŽqA¬—Ñ—æAåŒŽŽˆêAŒŽ“c˜a‰ÀA‹g“cGAˆÉ“¡––ŽuAˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA…“cŽ–€F01/02ƒV[ƒYƒ“‚É‚š‚¯‚é“–’n‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŠŽõÇ‚©‚ç-v‘¬f’f–@‚Æ”|—{Œ‹‰Ê‚Ƃ̔äŠr-A‘æ72‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2002”N6ŒŽ2“úA‰—ŽRŒ`

    7. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqF‚U‚‚̍זE‚ð—p‚¢‚œƒ}ƒCƒNƒƒvƒŒ[ƒg–@‚É‚æ‚éƒGƒ“ƒeƒƒEƒCƒ‹ƒX‚Ì•ª—£‚ƊȈՓ¯’èA‘æ56‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2002”N8ŒŽ29-30“úA‰—·‰ª

    8. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqFŽRŒ`‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUAiH1N2j‚̃XƒNƒŠ[ƒjƒ“ƒO’²žŒ‹‰ÊA‘æ56‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2002”N8ŒŽ29-30“úA‰—·‰ª

    9. ’r“c’C–çA‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêFì‚©‚ç‚ÌTDH/TRH—z«’°‰ŠƒrƒuƒŠƒI•ª—£ó‹µ‚Æ‚»‚̈â“`Žq‰ðÍA‘æ56‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2002”N8ŒŽ29-30“úA‰—·‰ª

    10. ‘å’JŸŽÀAŒ£ËˆêAÅã‹v”üŽqA’r“c’C–çA‘ºŽR®ŽqA‘âWˆêFŽ{Ý‚Å”­¶‚µ‚œÔ—ŸƒAƒ[ƒoW’cŠŽõŽ–—á‚É‚š‚¯‚é•aŒŽŠw“IŒŸ“¢A‘æ56‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2002”N8ŒŽ29-30“úA‰—·‰ª

    11. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘ºŽR®ŽqFƒJƒL‚Ƃ͊֘A‚Ì”F‚ß‚ç‚ê‚È‚¢Norwalk@Virus‚É‚æ‚éW’cŠŽõ‚Ə¬Ž™ŽU”­Ž–—á‚Ì•ªŽq‰uŠwA‘æ56‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2002”N8ŒŽ29-30“úA‰—·‰ª

    12. ‘å’JŸŽÀA’r“c’C–çA‘ºŽR®ŽqA‘âWˆêF–ƉuŒŒŽ‚ð—p‚¢‚œ‰º—ŸŒŽ«‘å’°‹Û‚ÌŒŸž–@‚ÉŠÖ‚·‚錟“¢A•œ¬14”N“x“Œ–k“ûŽ_‹ÛŒ€‹†‰ï‘‰ïA2002”N7ŒŽ4“úA‰—å‘ä

    13. ‘å’JŸŽÀAŒ£ËˆêAÅã‹v”üŽqA’r“c’C–çA‘ºŽR®ŽqA‘âWˆêA‚‹Ž’B–çA[”ö²FŽRŒ`Œ§“à‚ÌŽ{Ý‚ł݂ç‚ꂜÔ—ŸƒAƒ[ƒo‚̏W’cŠŽõA‘æ51‰ñ“Œ–kŒöO‰q¶Šw‰ïA2002”N7ŒŽ26“úA‰—ÂX

    14. Åã‹v”üŽqAŒã“¡—TŽqFShigella sonnei‚ÌPFGE‚É‚æ‚éˆâ“`Žq‰ðÍA‘æ25‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA2002”N11ŒŽ9“úA‰—•Ä‘ò

    15. Ÿ“‡‹éŽqA…“cŽ–€AˆÀ‘·ŽqçŒbŽqAŒ‘ºGˆêA‹ß]²A‰ª–{“¹ŽqF2002”N‚É—¬s‚µ‚œ‘œŽí—ނ̃Gƒ“ƒeƒƒEƒCƒ‹ƒX‚̗Տ°A‘æ73‰ñ“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2002”N12ŒŽ1“úA‰—ŽRŒ`

    16. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqA‘âWˆêFŽRŒ`Œ§‚É‚š‚¯‚éƒGƒR[ƒEƒCƒ‹ƒX13Œ^‚̍ďoŒ»A‘æ29‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2003”N3ŒŽ5“úA‰—ŽRŒ`

    17. ‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA…“cŽ–€A‘ºŽR®ŽqF¶ƒJƒL‚ð‹iH‚µ‚Ä”­¶‚µ‚œ¬Œ^‹…Œ`ƒEƒCƒ‹ƒX‚É‚æ‚éW’cH’†“ł̈â“`Žq‰ðÍA‘æ29‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2003”N3ŒŽ5“úA‰—ŽRŒ`

    18. ’r“c’C–çAÅã‹v”üŽqA‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêF‰º—ŸÇгŽÒ—R—ˆSalmonella@Enteritidis‚̈â“`Žq‰ðÍA‘æ29‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2003”N3ŒŽ5“úA‰—ŽRŒ`

    19. ‘å’JŸŽÀAÅã‹v”üŽqA’r“c’C–çA‘ºŽR®ŽqA‘âWˆêA‚‹Ž’B–çA[”ö²F’°ŠÇoŒŒ«‘å’°‹ÛгŽÒ“™‚©‚番—£‚³‚ꂜ‘å’°‹Û‚ÌŽu‰ê“Å‘fˆâ“`Žq•Û—Ló‹µA‘æ29‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2003”N3ŒŽ5“úA‰—ŽRŒ`

    •œ¬13”N“xi2001”N4ŒŽ\2002”N3ŒŽj

    \H13˜_•¶”­•\“™\

    1. Muyanga J, Matsuzaki Y, Sugawara K, Kimura K, Mizuta K, Ndumba I, Muraki Y, Tsuchiya E, Hongo S, Kasolo F.C, Numazaki Y, Nakamura K. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch Virol. 2001;146:1667-1679.

    2. Matsuzaki Y, Sugawara K, Mizuta K, Tsuchiya E, Muraki Y, Hongo S, Suzuki H, Nakamura K. Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998. J Clin Microbiol. 2002;40:422-429.

    3. ‘âWˆêA‘å’JŸŽÀA‘ºŽR®ŽqA^‰Æ‹»—²FŽRŒ`Œ§‚É‚š‚¯‚éƒcƒcƒKƒ€ƒV•a”­¶ó‹µ‚Æ•aŒŽŠw“IŒŸž‚ɂ‚¢‚āi•œ¬‚P‚PC‚P‚Q”N“xjAŽRŒ`Œ§ˆãŽt‰ï•ñ 2001;597:21-23.

    4. …“cŽ–€AF.C.KasoloA‰Ÿ’JmAŸ“‡‹éŽqAâ–{”üç‘ãA‘ºŽR®ŽqA—é–ØGFŽRŒ`‚ƃUƒ“ƒrƒA‚Å‹}«‹C“¹ŠŽõÇ‚̏¬Ž™‚©‚番—£‚³‚ꂜƒAƒfƒmƒEƒCƒ‹ƒX3Œ^‚̐§ŒÀy‘fØ’fƒpƒ^[ƒ“‚É‚æ‚é”äŠr\’nˆæ“y’…«‚ɂ‚¢‚ā[AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:7-10.

    5. …“cŽ–€A‰Ÿ’JmAŸ“‡‹éŽqAâ–{”üç‘ãA‘ºŽR®ŽqA—é–ØGF1986”N‚©‚ç1998”N‚܂łɎRŒ`‚Å‹}«‹C“¹ŠŽõÇ‚̏¬Ž™‚©‚番—£‚³‚ꂜƒAƒfƒmƒEƒCƒ‹ƒX3Œ^‚ÌHypervariable@region‚̈â“`Žq”z—ñ‚̈À’萫AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:11-14.

    6. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqAŸ“‡‹éŽqAˆÉ“¡––ŽuF“ûŽ™Ž{Ý‚É‚š‚¯‚éƒm[ƒ’[ƒNƒEƒCƒ‹ƒX(NV)W’cŠŽõ‚Æ2000/01ƒV[ƒYƒ“‚̏¬Ž™ŽU”­—á‚Ì•ªŽq‰uŠwAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:33-36.

    7. ˆÀ‘·ŽqçŒbŽqA…“cŽ–€AŒã“¡—TŽqA‘º“c•q•vA‘ºŽR®ŽqFƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚ÌHA/HIŽŽŒ±‚É‚ ‚œ‚Á‚Ăǂ̌Œ‹…‚ð‘I‘ð‚·‚×‚«‚©H|AŒ^‚̓‚ƒ‹ƒ‚ƒbƒgABŒ^‚̓jƒƒgƒŠ‚ª‚¢‚¢H|AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:65-67.

    8. …“cŽ–€AŒã“¡—TŽqAŒ‘ºGˆêAˆÀ‘·ŽqçŒbŽqA‘ºŽR®ŽqF”­¶“®Œü’²ž‚ւ̃AƒfƒmƒEƒCƒ‹ƒXEƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXˆâ“`ŽqŒŸoPCR–@‚Ì“±“üAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:68-72.

    9. …“cŽ–€AŒã“¡—TŽqA‘º“c•q•vAˆÀ‘·ŽqçŒbŽqA‘ºŽR®ŽqFŽRŒ`Œ§‚̃GƒR[6Œ^AƒGƒR[30Œ^‚ɑ΂·‚é”N—î‘w•ʁA’†˜aR‘ۗ̕Ló‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:73-75.

    10. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqFƒŒƒWƒIƒlƒ‰Ç‚Ì•aŒŽŠw“IŒŸž\”A’†RŒŽ‘ª’è‚̈Ӌ`\AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:81-86.

    11. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqF‰·ò‚̃ŒƒWƒIƒlƒ‰‹Û¶‘§ó‹µ’²žAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:87-89.

    12. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é×‹ÛŒŸžŠO•”ž“xŠÇ—i‘æ‚U•ñjAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2001;34:90-92.

    13. ‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêA^‰Æ‹»—²A‰Hª“c‚₊ŽqFŽã“ÅŠ”ikawasakiCshimokoshij‚É‚æ‚é‚‚‚ª’Ž•a|ŽRŒ`Œ§.•aŒŽ”÷¶•šŒŸoî•ñA2001”N9ŒŽ†D

    14. ‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêA¬ì³Œ©A–Ø‘º~F‚‚‚ª’Ž•a‚É‚æ‚鎀–SŽ–—á|ŽRŒ`Œ§.•aŒŽ”÷¶•šŒŸoî•ñA2001”N9ŒŽ†D

    \H13Šw‰ï”­•\\

    1. Œ›œ—tŽqA’†‘ºŠì‘ãlA…“cŽ–€AŒ‘ºGˆêA‰iˆäK•vA—é–ØGF‹{éŒ§“à‚É‚š‚¯‚é‚P‚O”NŠÔ‚Ì‚bŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX•ª—£ó‹µA‘æ‚S‚Q‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA2001”N6ŒŽ7-8“úA‰—–ŒŒÃ‰®

    2. ’r“c’C–çA‘å’JŸŽÀA¬—ÑŽ“TA•“cM•FFŽRŒ`Œ§‚É‚š‚¯‚él—R—ˆ’°ŠÇoŒŒ«‘å’°‹Û•ª—£ó‹µ‚Æ‚»‚ÌDNA‰ðÍA‘æ‚S‚T‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2001”N5ŒŽ24“úA‰—ŽRŒ`

    3. {“¡³‰pA‘å’JŸŽÀA’r“c’C–çA–kð¹–ŸF‰º…‚š‚æ‚ÑƒCƒk•³•Ö‚©‚ç‚Ì’°ŠÇŒn•aŒŽ”÷¶•š‚ÌŒŸoA‘æ‚S‚T‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2001”N5ŒŽ24A‰—ŽRŒ`

    4. ²“¡Žu•äA²X–؏GA’r“c’C–çF‚Æ’{ê‚Å•ª—£‚³‚ꂜƒTƒ‹ƒ‚ƒlƒ‰‚ɂ‚¢‚āA‘æ‚S‚T‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2001”N5ŒŽ24“úA‰—ŽRŒ`

    5. ‘âWˆêA‘å’JŸŽÀA‘ºŽR®ŽqF•aŒŽˆöŽq‚ÌŒŸžŒ‹‰Ê‚©‚ç‚Ý‚œ•aŒŽ‘å’°‹ÛŒŸoó‹µA‘æ32‰ñ“Œ–k“ûŽ_‹ÛŒ€‹†‰ïA2001”N7ŒŽ6“úA‰—å‘ä

    6. ‘å’JŸŽÀA‘ºŽR®ŽqFŽRŒ`Œ§‚ł݂ç‚ꂜŽã“ÅŠ”ikawasakiCshimokoshij‚É‚æ‚é‚‚‚ª’Ž•aA‘æ55‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA2001”N8ŒŽ23|24“úA‰—å‘ä

    7. ŽRì—T‰EA•ۉȐmA’O‰H‰p“ñA¬—яŸ“TA{“¡³‰pA‘å’JŸŽÀF’°ŠÇ‹ÃWÚ’…«‘å’°‹Û‘Ï”M«“Å‘fiEAST1jˆâ“`Žq•Û—L‘å’°‹Û‚É‚æ‚éW’cH’†“ÅŽ–—áA•œ¬13”N“x“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA2001”N11ŒŽ16“úA‰—å‘ä

    8. ²“¡Žu•äA‘º“cƒÆA’r“c’C–çF“Ø‹¹–Œ”x‰Š‚ÌŒŒŽŒ^•Ê’²ž‚Ɛ¶ŽYƒTƒCƒh‚ւ̏î•ñŠÒŒ³A•œ¬13”N“x“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA2001”N11ŒŽ16“úA‰—å‘ä

    9. …“cŽ–€AˆÀ‘·ŽqçŒbŽqA‘º“c•q•vA‘ºŽR®ŽqA‘âWˆêFŒ§“à‚É‚š‚¯‚éƒEƒCƒ‹ƒX«ŽŸŠ³‚Ì”­¶“®Œü’²žŒ‹‰Ê•ñA‘æ28‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2002”N2ŒŽ14“úA‰—ŽRŒ`

    10. ‘å’JŸŽÀAˆÀ‘·ŽqçŒbŽqAŒã“¡—TŽqA’r“c’C–çA‘ºŽR®ŽqA‘âWˆêA‚‹Ž’B–çA[”ö²FƒŒƒWƒIƒlƒ‰ÇгŽÒ‹y‚шê”ʏZ–¯‚̃ŒƒWƒIƒlƒ‰R‘Ì’²žA‘æ28‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2002”N2ŒŽ14“úA‰—ŽRŒ`

    •œ¬12”N“xi2000”N4ŒŽ\2001”N3ŒŽj

    \H12˜_•¶”­•\“™\

    1. Matsuzaki Y, Mizuta K, Kimura H, Sugawara K, Tsuchiya E, Suzuki H, Hongo S, Nakamura K, Mizuta K, Kameyama K. Characterization of antigenically unique influenza C virus strains isolated in Yamagata and Sendai cities, Japan, during 1992-1993. J Gen Virol. 2000;81:1447-1452.

    2. Œ›œ—tŽqA’†‘ºŠì‘ãlA…“cŽ–€AŸ“‡‹éŽqAâ–{”üç‘ãA—é–ØGF‚P‚X‚X‚U”N‚Æ‚X‚X‚W”N‚ÉŽRŒ`Œ§“à‚łƂ炊‚ç‚ꂜ‚bŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA—Տ°‚ƃEƒCƒ‹ƒX 2000;28:41-46.

    3. ‘âWˆêA‘å’JŸŽÀA‘ºŽR®ŽqA—é–Ø”Ž‹MAŠâ•£ŸDAˆ¢•”CˆêAŒÜ\—’”ü°AŽRŒû—T”VAˆî–Ñ–«FƒŒƒWƒIƒlƒ‰Ç‚Ì•aŒŽŠw“IŒŸž‚ɂ‚¢‚āAŽRŒ`Œ§ˆãŽt‰ï‰ï•ñ ‘æ587† 2000;20-22.

    4. …“cŽ–€AŸ“‡‹éŽqAâ–{”üç‘ãA‘哇•ŽqA‹ß]²A‰ª–{“¹ŽqA‰““¡’qŒb”üAç—t‚Ó‚ÝŽqA—é–ØGFŽRŒ`‚̏¬Ž™‹}«‹C“¹ŠŽõÇ‚̉uŠw\‚P‚X‚W‚W”N‚©‚ç‚P‚X‚X‚W”N‚܂ł̃}ƒCƒNƒƒvƒŒ[ƒg–@‚É‚æ‚éƒEƒCƒ‹ƒX•ª—£ŒoŒ±\AŽRŒ`Œ§ˆãŽt‰ï‰ï•ñ 2000;589:25-34.

    5. Šâ•£ŸDA¬ì³WA•ŸŒŽ’B˜NA•œŠÔ‹IsA—Lì‘ìA“c’†Š²—YA”â“NA‘å’JŸŽÀF‹z“üŒ¹‚ª“¯ˆê‚̉·ò‚Ɛ„’肳‚ꂜƒŒƒWƒIƒlƒ‰ŠŽõÇ‚Ì‚Q—áAŽRŒ`Œ§ˆãŽt‰ï‰ï•ñ 2000;589:21-24.

    6. …“cŽ–€A—é–ØGAÀè‹`•vFƒAƒtƒŠƒJ‚Æ“ú–{‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒU~ƒTƒ“ƒrƒA‚ł̌oŒ±‚𒆐S‚É-AŠŽõ‚ƍR‹Û–ò 2000;3:370-374.

    7. {“¡³‰pA‘å’JŸŽÀFƒTƒ‹ƒ‚ƒlƒ‰H’†“ł̋ۊw“I“Á«‚©‚猩‚œDiffuse OutbrakAŽRŒ`Œ§bˆãŽt‰ï•ñ 2000;103:3-4.

    8. ›ŒŽ—T”üŽqAÂ–Ø•q–çA‚‹Ž’qŽqAAŒ‚·‚ÝŽqG“Å‘fŒŽ«‘å’°‹Û‚n25F‚g42‚É‚æ‚éŠCŠO—·sŽÒ‰º—ŸÇAŽRŒ`ˆãŠwŒŸž 2001;10:4-7.

    9. …“cŽ–€AŸ“‡‹éŽqAâ–{”üç‘ãA‹ß]²A‰ª–{“¹ŽqAŒã“¡—TŽqA‘º“c•q•vA‘ºŽR®ŽqA—é–ØGFŽRŒ`Œ§‚Å1986-1998”N‚É•ª—£‚³‚ꂜƒAƒfƒmƒEƒCƒ‹ƒX3Œ^‚̐§ŒÀy‘fØ’fƒpƒ^[ƒ“‚É‚æ‚é‰uŠw‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:5-8.

    10. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqAŸ“‡‹éŽqAˆÉ“¡––ŽuF‹}«ˆÝ’°‰Š‚ÌŽU”­—á‚Æ•ÛˆçŽ{Ý‚ł̏W’cH’†“Å‚©‚猟o‚µ‚œƒm[ƒ’[ƒN—lƒEƒCƒ‹ƒX(NLVs)‚̈â“`ŽqŒn“‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:14-17.

    11. {“¡³‰pA‚‹Ž’qŽqA‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêFƒNƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€‚ƃWƒAƒ‹ƒWƒA‚É‚æ‚鐅“¹…‰˜õŽ–—áAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:48-50.

    12. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqF•aŒŽˆöŽq‚ÌŒŸžŒ‹‰Ê‚©‚ç‚Ý‚œ•aŒŽ‘å’°‹ÛŒŸoó‹µAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:51-55.

    13. {“¡³‰pA‚‹Ž’qŽqA‘å’JŸŽÀA‘ºŽR®ŽqFŒ’íŽÒ‚š‚æ‚Ñ‰º—ŸÇгŽÒ‚©‚ç‚ÌŽu‰ê“Å‘fŽY¶‘å’°‹Û(STEC)‚Ì•ª—£AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:56-57.

    14. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é×‹ÛŒŸžŠO•”ž“xŠÇ—i‘æ‚T•ñjAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 33:58-59,2000.

    15. Œã“¡—TŽqA‘º“c•q•vA…“cŽ–€A‘ºŽR®ŽqFŠŽõÇ”­¶“®Œü’²ž‚É‚š‚¯‚éŽè‘«Œû•aгŽÒ‚©‚ç‚̃EƒCƒ‹ƒX•ª—£ó‹µ(1998-2000”N)AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 2000;33:60-62.

    16. Œã“¡—TŽqA‘º“c•q•vA…“cŽ–€A‘ºŽR®ŽqA‘âWˆêA”Š_•ׁFŽRŒ`Œ§‚É‚š‚¯‚éŽè‘«Œû•aгŽÒ‚©‚ç‚̃RƒNƒTƒbƒL[ƒEƒCƒ‹ƒXA16Œ^(Cox.A16)‚Ì•ª—£A•aŒŽ”÷¶•šŒŸoî•ñ 2000;21:143.

    17. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqA‘âWˆêFŽRŒ`Œ§‚Å‘±”­‚µ‚œƒŒƒWƒIƒlƒ‰”x‰ŠA•aŒŽ”÷¶•šŒŸoî•ñ 2000;21:189-190.

    18. Œã“¡—TŽqA‘º“c•q•vA…“cŽ–€A‘ºŽR®ŽqAaŒû“ñ˜YA›–ì‰oˆêA‘âWˆêF2000”N‚ÌŽè‘«Œû•aгŽÒ‚©‚ç‚ÌCA16AEV71ACA10AE25‚Ì•ª—£|ŽRŒ`Œ§A•aŒŽ”÷¶•šŒŸoî•ñ 2000;21:274.

    \H12Šw‰ï”­•\\

    1. Œ›œ—tŽqA…“cŽ–€AŸ“‡‹éŽqAâ–{”üç‘ãA—é–ØGA›ŒŽŠš‰xA“y‰®Œb”üA–{‹œœŽ¡A’†‘ºŠì‘ãlF1996”N‚Æ1998”N‚ÉŽRŒ`Œ§“à‚łƂ炊‚ç‚ꂜ‚bŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ15‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïƒVƒ“ƒ|ƒWƒEƒ€A2000”N4ŒŽ22-24“úA‰—Ã‰ª

    2. …“cŽ–€A‰iˆäK•vA‰ª–{“¹ŽqA’†‘ºŠì‘ãlA‹{–{•ׁA—é–ØGFå‘äŽs‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚``Œ^HA1•”•ª‚̃V[ƒNƒGƒ“ƒX‚ÌŽŽ‚Ýi‚QjA‘æ15‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïƒVƒ“ƒ|ƒWƒEƒ€A2000”N4ŒŽ22-24“úA‰—Ã‰ª

    3. Ÿ“‡‹éŽqA…“cŽ–€FƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“‚ÌŒø‰Ê\ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠmŽÀ‚ȏǗá‚ÉŠî‚­ŒŸ“¢\A‘æ‚R‚Q‰ñ“ú–{¬Ž™ŠŽõÇŠw‰ï‘‰ïA2000”N11ŒŽ24-25“úA‰—“Œ‹ž

    4. ˆÉ“¡––ŽuA×“c˜aFA¬“cØ“OBAŒÜ\—’GŽOA‹g“cGA…“cŽ–€AŒã“¡—TŽqA‘âWˆêF¡ƒV[ƒYƒ“‚Ì“–‰È‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX•ª—£ó‹µ‚ƃƒNƒ`ƒ“ÚŽíŽÒ‚Ì“®ŒüA“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2000”N5ŒŽ28“úA‰—ŽRŒ`

    5. Ÿ“‡‹éŽqA‹ß]²A‰ª–{“¹ŽqAŒ‘ºGˆêAŒã“¡—TŽqA…“cŽ–€A‘âWˆêFƒCƒ“ƒtƒ‹ƒGƒ“ƒ“ƒUƒƒNƒ`ƒ“‚ÌŒø‰Ê-ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠŽõ‚ÌŠm”F‚³‚ꂜÇ—á‚©‚ç‚ÌŒŸ“¢A“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA2000”N5ŒŽ28“úA‰—ŽRŒ`

    6. {“¡³‰pA‘å’JŸŽÀFƒTƒ‹ƒ‚ƒlƒ‰H’†“ł̋ۊw“I“Á«‚©‚ç‚Ý‚œDiffuse OutbreakA‘æ44‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA2000”N5ŒŽ26“úA‰—ŽRŒ`

    7. ‘âWˆêA‘å’JŸŽÀA{“¡³‰pA‘ºŽR®ŽqF“Œ–k’n•û‚É‚š‚¯‚é’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇ‚Ì”­¶ó‹µ‹y‚Ñ•ª—£‹Û‚Ì“Á«A‘æ‚R‚P‰ñ“Œ–k“ûŽ_‹ÛŒ€‹†‰ïA2000”N7ŒŽ28“úA‰—å‘ä

    8. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqA‘âWˆêFƒŒƒWƒIƒlƒ‰Ç‚Ì•aŒŽŠw“IŒŸžŽ–—áA“ú–{×‹ÛŠw‰ï“Œ–kŽx•”E–kŠC“¹Žx•”‡“¯ŠwpW‰ïA2000”N9ŒŽ28-29“úA‰—O‘O

    9. {“¡³‰pA‘å’JŸŽÀA›ŒŽ—T”üŽqA‘ºŽR®ŽqA‘âWˆêF’°ŠÇoŒŒ«‘å’°‹ÛŠŽõÇ‚Ì”­¶ó‹µ‚Ƌۊw“I“Á«A“ú–{×‹ÛŠw‰ï“Œ–kŽx•”E–kŠC“¹Žx•”‡“¯ŠwpW‰ïA2000”N9ŒŽ28-29“úA‰—O‘O

    10. {“¡³‰pA‘å’JŸŽÀF–쐶ƒJƒ‚ƒVƒJ‚̉º—ŸŒŽ«•aŒŽ‘ۗ̕Ló‹µ‚Ɛ…Œn‰˜õ‚̉”\«A“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA2000”N10ŒŽ19“úA‰—•Ÿ“‡

    11. ›ŒŽ—T”üŽqAÂ–Ø•q–çi‘ºŽR•ÛŒ’ŠjF“Å‘fŒŽ«‘å’°‹Û‚n25F‚g42‚É‚æ‚éŠCŠO—·sŽÒ‰º—ŸÇA‘æ‚Q‚R‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA2000”N11ŒŽ11-12“úA‰—’߉ª

    12. Œã“¡—TŽqFŠŽõÇ”­¶“®Œü’²ž‚É‚š‚¯‚éŽè‘«Œû•aгŽÒ‚©‚ç‚̃EƒCƒ‹ƒX•ª—£ó‹µ(1998-2000”N)A‘æ‚Q‚R‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA2000”N11ŒŽ11-12“úA‰—’߉ª

    13. ‘å’JŸŽÀA›ŒŽ—T”üŽqA{“¡³‰pA‘ºŽR®ŽqF‰·ò‚̃ŒƒWƒIƒlƒ‰‹Û¶‘§’²žA‘æ‚S‚U‰ñŽRŒ`Œ§H•i‰q¶EŠÂ‹«‰q¶Œ€C‘å‰ïA2001”N1ŒŽ26“úA‰—ŽRŒ`

    14. ›ŒŽ—T”üŽqA{“¡³‰pA‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêFƒŒƒWƒIƒlƒ‰Ç‚Ì”­¶‚Ɗ‹«’†‚É‚š‚¯‚éƒŒƒWƒIƒlƒ‰‹Û¶‘§ó‹µA‘æ‚Q‚V‰ñŽRŒ`Œ§ŒöO‰q¶Šw‰ïA2001”N3ŒŽ1“úA‰—ŽRŒ`

    •œ¬11”N“xi1999”N4ŒŽ\2000”N3ŒŽj

    \H11˜_•¶”­•\“™\

    1. …“cŽ–€Aâ–{”üç‘ãAŸ“‡‹éŽqA‰iˆäK•vA‹{–{•ׁA—é–ØGFƒAƒfƒmƒEƒCƒ‹ƒX‚Ì•ª—£‚ÆŒŒŽ‰uŠwAƒ‚ƒ_ƒ“ƒƒfƒBƒA 1999;45:139-149.

    2. …“cŽ–€A—é–ØGFƒAƒfƒmƒEƒCƒ‹ƒX‚ÌŠî‘bA‰»Šw—Ö@‚̗̈æ 1999;15:47-53.

    3. ŽR’J–r—YA…“cŽ–€A²X–؏G’‰Fƒ‰ƒCƒmƒEƒCƒ‹ƒXA‰»Šw—Ö@‚̗̈æ 1999;15:36-41.

    4. …“cŽ–€A‰iˆäK•vA‹ß]²AÖ“¡ˆèŽqA—é–ØGFƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì‚·‚ׂÄ-ƒEƒCƒ‹ƒX‚Ì•ª—£‚ÆŒŒŽf’fAŠŽõ‚ƍR‹Û–ò 1999;2:376-379.

    5. Saijo M, Terunuma H, Mizuta K, Mpabalwani EM, Monze M, Oshitani H, Luo N, Suzuki H, Numazaki Y. Respiratory syncytial virus infection in children with acute respiratory infections in Zambia. Epidemiol Infect. 1998;121:397-400.

    6. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Mizuta K, Sasaki H. Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med. 1998;158:311-314.

    7. Kawasaki S, Oshitani H, Suzuki H, Arakawa M, Mizuta K, Imaizumi M, Tsuchiya S, Konno T. PCR-RFLP Analysis of Cytomegalovirus infections associated with bone marrow transplantation in Japanese children. Microbiol Immunol. 1999;43:359-364.

    8. Umenai T, Sakano S, Suzuki H, Mizuta K, Yanagiya T, Hiroi M, Kikuchi H, Nakamura H, Miura H, Hamada A. Study on Chlamydia Trachomatis infection among students and pregnant women in Japan: a step toward developing a reliable method for sexual behavior study. Tohoku J Exp Med. 1999;187:189-192.

    9. Saijo M, Suzutani T, Itoh K, Hirano Y, Murono K, Nagamine M, Mizuta K, Niikura M, Morikawa S. Nucleotide Sequence of Thymidine Kinase Gene of Sequential Acyclovir-resistant Herpes Simplex Virus Type 1 Isolates Recovered from a Child with Wiskott-Aldrich Syndrome: Evidence for Reactivation of Acyclovir-resistant Herpes Simplex Virus. J Med Virol. 1999;58:387-393.

    10. Murayama N, Suzuki H, Arakawa M, Nerome K, Mizuta K, Kameyama K. Two outbreaks of Influenza A(H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku J Exp Med. 1999;188:289-298.

    11. ŽR’J–r—YAŠÖ‘òŽ‹vA…“cŽ–€A²X–؏G’‰F‹C“¹ã”ç×–E‚Æ”x‚Ì‰ŠÇE‘@ˆÛ‰»AŒ»‘ãˆã—à 1999;31:379-383.

    12. ŽR’J–r—YA—é–Ø•üŽqAŽR“c‹ILAÎ’Ë‘A×“c¹—ǁAŠÖ‘òŽ‹vA…“cŽ–€A²X–؏G’‰FŠŽõÇ—\–h‘΍ôA‘‡—Տ° 1999;48:918-923.

    13. …“cŽ–€Aâ–{”üç‘ãA‰ª–{“¹ŽqAŒã“¡—TŽqA‘º“c•q•vA‘ºŽR®ŽqA—é–ØGF1997”N‚ÌŽRŒ`‚É‚š‚¯‚éƒAƒfƒmƒEƒCƒ‹ƒX1-7Œ^‚ÌŒŒŽ‰uŠwAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:5-7.

    14. {“¡³‰pA‚‹Ž’qŽqA‘å’JŸŽÀA‘ºŽR®ŽqFƒqƒg‹y‚ѐH•i—R—ˆE.ColiO157‚ÆS.Typhimurium‚Ì–òÜŠŽŽó«ŽŽŒ±AŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:33-34.

    15. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqFSalmonella Tompson‚ÌDNA‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:35-36.

    16. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqFSalmonella Oranienburg‚ÌDNA‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:37-39.

    17. ‘å’JŸŽÀA‚‹Ž’qŽqAÂ–ØŽl˜YŽŸA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é×‹ÛŒŸžŠO•”ž“xŠÇ—i‘æ‚R•ñjAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:43-45.

    18. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqFŽRŒ`Œ§‚É‚š‚¯‚é×‹ÛŒŸžŠO•”ž“xŠÇ—i‘æ‚S•ñjAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:46-49.

    19. {“¡³‰pA‘å’JŸŽÀFƒqƒg‹y‚ѐH•i—R—ˆE.ColiO157‚ÆS.Typhimurium‚Ì–òÜŠŽŽó«ŽŽŒ±AŽRŒ`Œ§bˆãŽt‰ï•ñ 1999;99:13-14.

    20. {“¡³‰pA‘å’JŸŽÀF–쐶“®•š‚É‚š‚¯‚é•aŒŽ”÷¶•š‚ۗ̕Ló‹µ’²žAŽRŒ`Œ§bˆãŽt‰ï•ñ 2000;100:7-9.

    21. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqA‘âWˆêAÖ“¡”Ž”VF‚Q‚‚̕ۈçŽ{Ý‚Å“¯Žž‚É”­¶‚µ‚œW’cH’†“ÅŠ³ŽÒ‚©‚猟o‚³‚ꂜ¬Œ^‹…Œ`ƒEƒCƒ‹ƒX‚̈â“`Žq‰ðÍAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:8-11.

    22. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqAŸ“‡‹éŽqAˆÉ“¡––ŽuF98/99ƒV[ƒYƒ“‚É‚š‚¯‚éŠŽõ«ˆÝ’°‰ŠŠ³ŽÒ‚©‚ç‚̏¬Œ^‹…Œ`ƒEƒCƒ‹ƒXˆâ“`Žq‚ÌŒŸoAŽRŒ`Œ§‰q¶Œ€‹†Š•ñ 1999;32:40-42.

    23. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqA‘âWˆêAŸ“‡‹éŽqAˆÉ“¡––ŽuF1998/99ƒV[ƒYƒ“‚É‚š‚¯‚éŠŽõ«ˆÝ’°‰ŠŠ³ŽÒ‚©‚ç‚̏¬Œ^‹…Œ`ƒEƒCƒ‹ƒX‚ÌŒŸo\ŽRŒ`Œ§A•aŒŽ”÷¶•šî•ñA1999;20:193-194.

    24. ‘º“c•q•vAŒã“¡—TŽqA…“cŽ–€A‘ºŽR®ŽqA‘âWˆêAŸ“‡‹éŽqAˆÉ“¡––ŽuF‹}«ˆÝ’°‰Š‚ÌŽU”­—á‚Æ•ÛˆçŽ{Ý‚ł̏W’c”­¶‚©‚猟o‚µ‚œƒm[ƒEƒI[ƒN—lƒEƒCƒ‹ƒX(NLVs)‚̈â“`ŽqŒn“‰ðÍ\ŽRŒ`Œ§A•aŒŽ”÷¶•šî•ñ 2000;21:32-33.

    \H11Šw‰ï”­•\\

    1. …“cŽ–€A‰iˆäK•vA‹{–{•ׁA—é–ØGFå‘äŽs‚É‚š‚¯‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚``Œ^HA1•”•ªRŒŽŒˆ’è—̈æ‚̃V[ƒNƒGƒ“ƒX‰ðÍ‚ÌŽŽ‚ÝA‘æ14‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïA1999”N2ŒŽ27-3ŒŽ1“úA‰—VŠƒ

    2. Œ›œ—tŽqA›ŒŽŠš‰xA‚‰ºŒb”üA–{‹œœŽ¡A’†‘ºŠì‘ãlA…“cŽ–€A‹{–{•ׁA—é–ØGF1992\93”N‚ɐå‘äŽs‚ÆŽRŒ`Žs‚Å•ª—£‚³‚ꂜ3Š”‚Ì‚bŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̓uƒ‰ƒWƒ‹—R—ˆ‚©HA‘æ14‰ñƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒ€‹†ŽÒŒð—¬‚̉ïA1999”N2ŒŽ27-3ŒŽ1“úA‰—VŠƒ

    3. Œ›œ—tŽqA’†‘ºŠì‘ãlA…“cŽ–€A‹{–{•ׁAŸ“‡‹éŽqAâ–{”üç‘ãA–{‹œœŽ¡A—é–ØGF1996”N‚Æ1998”N‚ÉŽRŒ`Œ§“à‚łƂ炊‚ç‚ꂜ‚bŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬sA‘æ40‰ñ“ú–{—Տ°ƒEƒCƒ‹ƒXŠw‰ïA1999”N5ŒŽ13-14“úA‰—‘åã

    4. {“¡³‰pA‚‹Ž’qŽqA‘å’JŸŽÀA‘ºŽR®ŽqA‘âWˆêFŒ’íŽÒ‹y‚щº—ŸÇгŽÒ‚©‚ç‚ÌŽu‰ê“Å‘fŽY¶‘å’°‹ÛiSTECj‚Ì•ª—£A‘æ20‰ñ“ú–{H•i”÷¶•šŠw‰ïŠwp‘‰ïA1999”N10ŒŽ7-8“úA‰—·‰ª

    5. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqA‘âWˆêF‰º—ŸÇгŽÒ‹y‚ÑŒ’íŽÒ‚©‚番—£‚³‚ꂜ‘å’°‹Û‚Ì•aŒŽˆöŽq•Û—Ló‹µA‘æ20‰ñ“ú–{H•i”÷¶•šŠw‰ïŠwp‘‰ïA1999”N10ŒŽ7-8“úA‰—·‰ª

    6. {“¡³‰pA‘å’JŸŽÀFƒNƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€‚ƃWƒAƒ‹ƒWƒA‚É‚æ‚鐅“¹…‰˜õŽ–—á‚Æ‚»‚Ì”wŒiA•œ¬‚P‚P”N“x“ú–{bˆãŒöO‰q¶Šw‰ïA2000”N2ŒŽ11“úA‰—Ã‰ª

    7. …“cŽ–€A‘ºŽR®ŽqAâ–{”üç‘ãAŸ“‡‹éŽqA‘哇•ŽqA—é–ØGF¬Ž™‚Ì‹}«‹C“¹ŠŽõÇ(ARI)‚É‚š‚¯‚éƒAƒfƒmƒEƒCƒ‹ƒX3Œ^(Ad3)ƒwƒLƒ\ƒ“Hypervariable Region‚̈À’萫A‘æ53‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA1999”N8ŒŽ19-20“úA‰—•Ÿ“‡

    8. ‘å’JŸŽÀA‚‹Ž’qŽqA{“¡³‰pA‘ºŽR®ŽqA“n粎¡—YFE.coliO157‚ÆS.Typhimurium‚Ì–òÜŠŽŽó«ŽŽŒ±A‘æ53‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA1999”N8ŒŽ19-20“úA‰—•Ÿ“‡

    9. ‚‹Ž’qŽqA{“¡³‰pA‘å’JŸŽÀA‘ºŽR®ŽqFŒ’íŽÒ‹y‚щº—ŸÇгŽÒ‚©‚ç‚ÌŽu‰ê“Å‘fŽY¶‘å’°‹ÛiSTECj‚Ì•ª—£A‘æ53‰ñ“ú–{×‹ÛŠw‰ï“Œ–kŽx•”‘‰ïA1999”N8ŒŽ19-20“úA‰—•Ÿ“‡

    10. Œã“¡—TŽqFŽRŒ`Œ§ŠŽõÇ”­¶“®Œü’²ž‚É‚š‚¯‚éƒEƒCƒ‹ƒX‚Ì•ª—£ó‹µA‘æ‚Q‚Q‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA1999”N11ŒŽ13-14“úA‰—“ì—z

    11. ‘å’JŸŽÀA{“¡³‰pA‚‹Ž’qŽqA‘ºŽR®ŽqF•aŒŽˆöŽq‚ÌŒŸžŒ‹‰Ê‚©‚ç‚Ý‚œ•aŒŽ‘å’°‹Û‚ÌŒŸoó‹µA‘æ‚S‚T‰ñŽRŒ`Œ§H•i‰q¶EŠÂ‹«‰q¶Œ€C‘å‰ïA2000”N1ŒŽ28“úA‰—ŽRŒ`

    12. {“¡³‰pA‘å’JŸŽÀA‚‹Ž’qŽqA‘ºŽR®ŽqFH•i—R—ˆŠŽõÇDiffuse Outbreak‘Šú’T’m‚ɂނ¯‚œ‹ÛŠ”ŽûW‚̈Ӌ`A‘æ‚S‚T‰ñŽRŒ`Œ§H•i‰q¶EŠÂ‹«‰q¶Œ€C‘å‰ïA2000”N1ŒŽ28“úA‰—ŽRŒ`

    13. ‚‹Ž’qŽqFŽRŒ`Œ§‚Å”­¶‚µ‚œS.Oranienburg‚É‚æ‚éH’†“łɂ‚¢‚āA‘æ‚Q‚Q‰ñŽRŒ`Œ§—Տ°‰q¶ŒŸžŠw‰ïA1999”N11ŒŽ13-14“úA‰—“ì—z

    14. ‘º“c‰pŽ¡AÖ“¡—F‰ÀA•Û‰È”ŽA‘å’JŸŽÀFŠÇ“à‚Æ’{ê‚É”À“ü‚³‚ꂜ‹‚Ì’°ŠÇoŒŒ«‘å’°‹ÛO157•ۋۏ󋵂Ƃ»‚ÌDNA‰ðÍA•œ¬11”N“x“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA1999”N9ŒŽ30“úA‰—ŽRŒ`

    15. {“¡³‰pA‘å’JŸŽÀFƒNƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€‚ƃWƒAƒ‹ƒWƒA‚É‚æ‚鐅“¹…‰˜õŽ–—áA•œ¬11”N“x“ú–{bˆãŒöO‰q¶Šw‰ïi“Œ–kjA1999”N9ŒŽ30“úA‰—ŽRŒ`

    16. {“¡³‰pA‘å’JŸŽÀFƒqƒg‹y‚ѐH•i—R—ˆE.ColiO157‚ÆS.Typhimurium‚Ì–òÜŠŽŽó«ŽŽŒ±Œ‹‰ÊA‘æ43‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA1999”N5ŒŽ28“úA‰—ŽRŒ`

    17. {“¡³‰pA‘å’JŸŽÀF–쐶“®•š‚É‚š‚¯‚é•aŒŽ”÷¶•š‚ۗ̕Ló‹µ’²žA‘æ‚S‚R‰ñŽRŒ`Œ§bˆã‹ZpŒ€C‰ïA1999”N5ŒŽ28“úA‰—ŽRŒ`

    18. Ÿ“‡‹éŽqA‘º“c•q•vA‘ºŽR®ŽqFSRSV‚É‚æ‚é‹}«ˆÝ’°‰Š‚Ì”­¶‚ƗՏ°A“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA1999”N5ŒŽA‰—ŽRŒ`

    19. ¬“cØ“OBAÀ–ì“¡lAŽRè”ɁA‹g“cGAˆÉ“¡––ŽuA‘ºŽR®ŽqA‘º“c•q•vF¬Œ^‹…Œ`ƒEƒCƒ‹ƒXiSRSVj«’°‰Š‚̗Տ°‘œ‚ɂ‚¢‚āA“ú–{¬Ž™‰ÈŠw‰ïŽRŒ`’n•û‰ïA1999”N5ŒŽA‰—ŽRŒ`

    20. ^‰Æ‹»—²A–؍ªŸºŽA‘å’JŸŽÀF—Տ°“I‚ÉŒyÇ‚ŁAIgGR‘̉¿ãž‚ª’x‚©‚Á‚œƒcƒcƒKƒ€ƒV•a‚̈ê—áA“ú–{”畆‰ÈŠw‰ï“Œ–k’n•û‰ïA2000”N2ŒŽ13“úA‰—å‘ä

ƒoƒi[ƒXƒy[ƒX

ŽRŒ`Œ§‰q¶Œ€‹†Š‚ւ̃AƒNƒZƒX

§990-0031
ŽRŒ`Œ§ŽRŒ`Žs\“ú’¬1-6-6

TEL 023-627-1358
FAX 023-641-7486
¶ŠˆŠé‰æ•”F627-1108
”÷¶•𕔁F627-1373
—‰»Šw•”F627-1110